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BENJAMIN MICHAEL SIEMSEN. Prelimbic cortical synaptic and structural
plasticity following cocaine self-administration and abstinence in rats: Role of
glutamatergic pathway specificity. (Under the direction of JACQUELINE F.
MCGINTY)
Abstract
The primary goal of this dissertation is to further examine the role of the prelimbic
(PrL) subdivision of the rodent medial prefrontal cortex in relapse to cocaine
seeking following abstinence, and to extend our understanding of pathway-specific
adaptations in the PrL cortex projection to the nucleus accumbens (NAc) core that
drives relapse. Previous findings indicate that the PrL cortex shows a biphasic
response to abstinence from cocaine exposure. Specifically, early withdrawal (two
hours after the final self-administration session) results in dephosphorylation of
glutamate NMDA receptors and glutamate signaling regulators including
extracellular signal-regulated kinase and the downstream transcription factor
cAMP response-element binding protein (CREB). One week of abstinence
enhances p-CREB and AMPA receptor subunit GluA1 phosphorylation in the PrL
cortex, and Synapsin I in the NAc core. Interventions that act to normalize
glutamate transmission in the PrL cortex during early withdrawal provide an
enduring suppression of drug-seeking by normalizing activity in the PrL-NAc core
pathway. Using a combination of biochemical and behavioral pharmacology
techniques, we have found that the cocaine-induced activation of STriatalEnriched protein tyrosine Phosphatase in the PrL cortex during early withdrawal
plays a role in subsequent cocaine seeking by dephosphorylating extra-cellular
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signal-regulated kinase. We also show that chemogenetic-mediated activation of
the PrL cortex, or PrL-NAc core neurons, immediately after self-administration
transiently reduces drug seeking which is not sustained. Finally, using an array of
immunohistochemistry, pathway-specific viral vectors, and high-resolution
confocal microscopy techniques, we provide evidence that PrL-NAc core neurons
show reduced immunoreactivity of the activity markers Fos and p-CREB, reduced
dendritic spine head diameter, and reduced GluA1/2 expression in subsets of
dendritic spines during early withdrawal. The opposite effect was found after one
week of abstinence. At this timepoint, PrL-NAc core neurons showed heightened
nuclear p-CREB, spine head diameter, and GluA1/2 expression in dendritic spines.
These findings suggest that the PrL cortex, and specifically PrL-NAc core neurons,
undergoes an abstinence duration-dependent transformation in glutamate
transmission which may be regulated by the activation of STEP during early
withdrawal.

viii

Chapter 1: General Introduction
The role of the prefrontal cortex in drug-seeking behavior: Findings from
clinical studies
Illicit drug use in general is a major societal concern and in 2007 alone was
estimated to cost the United States economy 193 billion dollars annually in costs
related to crime, health, and productivity. For comparison, costs related to
treatment and management of diabetes in the United States was 173 billion dollars
in 2007 (NDIC, 2011). In 2011, approximately half of all emergency department
visits were related to illicit drug misuse. Importantly, cocaine misuse in particular
was responsible for approximately 40% of the emergency department visits related
to illicit drug misuse (SAMHSA, 2011). From the perspective of an addicted patient,
illicit drug abuse not only produces great external society harm, but also produces
internal harm by increasing the risk of developing a Substance Use Disorder
(SUD). Globally, of the total percentage of individuals initially experimenting with
illicit drug use, approximately 20% will meet criteria for diagnosis of a SUD
(Degenhardt and Hall, 2012).
A major clinical issue in the treatment of SUDs is the relatively high
propensity for relapse, even after prolonged periods of abstinence (Sinha, 2011).
In a metanalysis examining relapse rates of treatment-engaged patients, it was
found that following 50 days of discharge from a treatment center, less than half of
cocaine-addicted patients remain abstinent. Remarkably, after one year only
approximately 12.5% of patients remained abstinent (Sinha, 2011). Thus, a major
goal of drug addiction research is determining neural mechanisms underlying
1

relapse and finding pharmacological targets to prevent relapse. Craving, a
necessary precursor to relapse, can result from exposure of an addict to drugassociated contexts or cues, invigorating the unmanageable desire to seek and
ultimately use drugs (Kalivas, 2009). In clinical studies, the prefrontal cortex has
emerged as a critical regulator of relapse behavior (Goldstein and Volkow, 2011)
which is attributed to its downstream innervation of limbic-motor regions implicated
in the execution of motivated behavior, such as the ventral striatum (Kalivas and
Volkow, 2011). Furthermore, human addicts observing cocaine-related videos
show hyperactivation of the prefrontal cortex in response to cues (i.e.
paraphernalia), which positively correlates with self-reported craving (Robbins et
al., 1999; Garavan et al., 2000).
Interestingly, similar prefrontal cortical regions show reduced glucose
metabolism using Positron-Emission Tomography (PET) following several weeks
of abstinence from cocaine use (Volkow et al., 1992) a phenomena termed
‘hypofrontality’. This decreased activity is likely important for relapse because
repetitive transcranial magnetic stimulation (rTMS), a technique to elevate
neuronal activity in defined brain regions, of the dorsolateral prefrontal cortex
during abstinence appears to reduce cocaine use as well as craving (Terraneo et
al., 2016). Additionally, hypoactivity of the medial prefrontal cortex (mPFC) during
a cognitive challenge task correlates with propensity for relapse (Brewer et al.,
2008).
Structurally, grey matter volume is reduced in the mPFC in cocaine abusing
patients relative to healthy controls (Ersche et al., 2011), and grey matter volume
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negatively correlates with years of use (Ide et al., 2014). However, grey matter
volume normalizes after 6 months of abstinence (Parvaz et al., 2017). Collectively,
these findings indicate that cocaine use produces maladaptive structural and
functional alterations in prefrontal regions, which may serve as biomarkers for
relapse propensity. However, these cocaine-induced structural adaptations appear
to be plastic such that the recovery process during abstinence involves
reorganization of these regions involved in behavioral control, which may be
important for successful relapse prevention. Although neuroimaging and clinical
neuropsychological measurements of addicted patients are critical for the
development of pharmacological treatments for preventing relapse, preclinical
models have provided a wealth of knowledge pertaining to neurotransmitters and
circuitry involved in relapse-like events. Accordingly, animal models of addiction
remain essential for furthering our understanding of drug-induced adaptations and
how contexts and cues associated with drug reward gain salience to drive craving
and ultimately relapse (Garcia Pardo et al., 2017).
Role of the prefrontal cortex in relapse to cocaine seeking: Findings from
preclinical studies
Several decades of work have led to the conclusion that cocaine-induced
elevations in extracellular dopamine (Everitt and Wolf, 2002) within limbic-reward
regions are critical for not only the rewarding characteristics of acute cocaine, but
also the reinforcement learning that occurs between contexts, cues, and the
interoceptive state induced by cocaine (Wise et al., 2008; Volkow et al., 2017).
Chronic elevations in dopamine lead to increased transcription of genes involved
in reinforcement learning, facilitating the encoding of the association between the
3

rewarding
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or
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(Pulipparacharuvil et al., 2008; Taniguchi et al., 2017). Ultimately, this produces
heightened sensitivity to glutamatergic inputs, as discussed in detail below.
Preclinical models of addiction using self-administration (SA), followed by
extinction and reinstatement, in rodents have revealed a critical role for dopamine
release in the prelimbic (PrL) cortex (McGlinchey et al., 2016; James et al., 2018)
and the nucleus accumbens core (NAc core) (Shen et al., 2014a) in reinstating
cocaine seeking. However, the induction of cocaine seeking is dependent on
elevated PrL glutamate release in the NAc core (Figure 1.1) (Kalivas et al., 2005;
Kalivas, 2009). Thus, cocaine experience produces profound alterations in
glutamatergic plasticity, which may be due to chronic dopamine elevations, in both
the NAc core as well as the upstream PrL cortex, changes which are critical for
subsequent relapse following presentation of drug-associated stimuli (Kalivas,
2009).

Figure 1.1. Dopamine and glutamate pathways within the brain reward circuitry.
Cocaine-induced adaptations in dopamine transmission in the NAc core and PrL
4

cortex induce alterations in glutamatergic transmission in the NAc core.
Heightened glutamate release in the NAc core arising from the PrL cortex is highly
implicated in relapse to cocaine seeking following re-exposure to conditioned
contexts or cues after abstinence.
These findings suggest that targeting corticostriatal glutamatergic
dysfunction during abstinence may provide an enduring reduction in relapse
vulnerability following presentation of cocaine-associated contexts and stimuli.
Indeed, treatments which normalize corticostriatal glutamate transmission, such
as N-acetylcysteine (NAC) provide an enduring suppression of relapse in
preclinical models (Moussawi et al., 2009). However, such treatments have
provided mixed results in promoting abstinence in clinical populations (McClure et
al., 2014). Regardless, it is well-accepted that treatment approaches to promote
abstinence in human populations should be directed towards normalizing
glutamate transmission between the PFC and NAc core.
Several lines of evidence implicate heightened glutamatergic transmission
arising from PrL afferents in the NAc core as a mediator of cocaine-seeking
behavior. For example, optogenetic-mediated inactivation of the PrL, the NAc core,
or PrL axon terminals within the NAc core, immediately prior to a cue-induced
relapse test in rats suppresses cocaine seeking (Stefanik et al., 2013). Additionally,
glutamate release arising from PrL afferents in the NAc core mediates cocaine
prime-induced reinstatement, and glutamate levels in the NAc core are suppressed
following chronic cocaine SA and extinction training (McFarland et al., 2003).
However, other glutamatergic inputs to the NAc core are critical for cue-induced
reinstatement, including basolateral amygdala (BLA) afferents within the NAc core
(Stefanik and Kalivas, 2013).
5

However, in most experiments interrogating cocaine-induced plasticity in
corticostriatal circuits, interventions have been performed immediately prior to
relapse testing in rats. This approach has informed our understanding of plasticity
that mediates relapse occurring at this abstinence timepoint. However, this
approach may not be beneficial for preventing relapse in clinical populations
because neuroadaptations involved in relapse in brain reward circuitry have fully
developed and may be less malleable relative to earlier abstinence timepoints.
Relatively less is known about how chronic cocaine SA in rats alters excitatory
transmission between the PrL and the NAc core during early withdrawal, a
timepoint which may be particularly useful for interventions in clinical populations
(McGinty et al., 2015). Indeed, the early hours of drug withdrawal have been found
to be a critical timepoint for relapse prevention in preclinical models.
Early withdrawal, PrL cortex, and BDNF
In the last decade our laboratory has vigorously investigated alterations in
glutamatergic transmission within the PrL cortex during early withdrawal (i.e. two
hours after the final cocaine SA session). Several lines of evidence have shown
that this timepoint is critical for relapse prevention. First, we have found that a
single infusion of brain-derived neurotrophic factor (BDNF) into the PrL cortex
immediately after the final of 14 daily cocaine SA sessions provides an enduring
suppression of relapse to contexts, cues, as well as a priming injection of cocaine
for at least three weeks after the infusion (Berglind et al., 2007). Second, this
intervention normalizes glutamatergic neurotransmission within the NAc core
following extinction and prevents the cocaine prime-induced elevation in
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extracellular glutamate in the NAc core (Berglind et al., 2009). This is associated
with a normalization of augmented Synapsin phosphorylation, and presumably
glutamate release probability, in the NAc core during early withdrawal (Sun et al.,
2014a), suggesting BDNF normalizes PrL-NAc core glutamate transmission.
Third, the suppressive effect of PrL BDNF on cocaine seeking relies on the
normalization

of

a

cocaine-induced

dephosphorylation

of

several

key

glutamatergic signaling entities in the PrL cortex during early withdrawal; including
extracellular signal-regulated kinase 2 (ERK2), the downstream transcription factor
cAMP response-element binding protein (CREB), as well as the N-Methyl-DAspartate (NMDA) receptor subunits, GluN2A and GluN2B (Whitfield et al., 2011;
Go et al., 2016; Barry and McGinty, 2017). Specifically, preventing BDNF from
reversing the cocaine-induced dephosphorylation of these signaling molecules
with selective antagonists and kinase inhibitors prevents intra-PrL BDNF from
suppressing cocaine seeking

(Go et al., 2016; Barry and McGinty, 2017).

Interestingly, these dephosphorylation events are transient in nature such that the
ERK2 dephosphorylation is normalized 24 hours after the final SA session
(Whitfield et al., 2011). A major question resulting from this body of work is how
chronic cocaine SA results in these dephosphorylation events, and specifically,
what phosphatase might be activated in the PrL cortex during this early withdrawal
timepoint to drive these dephosphorylation events.
Striatal-enriched protein tyrosine phosphatase as a likely mediator of PrL
dysfunction during early withdrawal
The STriatal-Enriched protein tyrosine Phosphatase (STEP) has arisen as an
important regulator of ERK2 (Paul et al., 2003), GluN2B (Braithwaite et al., 2006),
7

and more recently, GluN2A (Tian et al., 2016) tyrosine phosphorylation.
GluN2AY1325 phosphorylation potentiates NMDA-mediated excitatory currents by
increasing GluN2A open channel probability (Taniguchi et al., 2009). GluN2BY1472
phosphorylation inhibits internalization of GluN2B-containing NMDA receptors,
enhancing synaptic activity (Carreno et al., 2011). Dephosphorylation of these
NMDA receptor subunits would therefore likely produce a suppression of NMDAreceptor mediated currents in the PrL cortex during early withdrawal from cocaine
SA, although this has yet to be shown.
Previous studies indicate that NMDA or glutamate stimulation in cultured
neurons leads to a rapid but transient NMDA receptor-dependent elevation in
ERK2 phosphorylation (Paul et al., 2003). The rapid rise in ERK2 phosphorylation
is GluN2A-dependent, whereas the subsequent dephosphorylation of ERK2 is
GluN2B-dependent (Paul and Connor, 2010). Finally, our lab has previously shown
that cocaine SA leads to STEP dephosphorylation in the PrL cortex during early
withdrawal, resulting in STEP activation (Sun et al., 2013).
Apart from its role in regulating glutamatergic neurotransmission, STEP
also plays a role in actin depolymerization following NMDA receptor stimulation in
vitro. Specifically, NMDA receptor activation in cultured neurons activates STEP
and leads to the STEP-dependent dephosphorylation of the actin binding protein,
SH3 protein interacting with NCK of 90 kD (SPIN90) (Cho et al., 2013). When
tyrosine is phosphorylated by Src family kinases (SFKs), SPIN90 acts as a potent
inhibitor of the actin-depolymerizing factor, cofilin, in dendritic spine heads.
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However, when dephosphorylated by STEP, SPIN90 translocates to the dendritic
shaft, allowing for cofilin-mediated actin depolymerization in dendritic spine heads.
Thus, it is possible that the activation of STEP during early withdrawal in the
PrL cortex may be accompanied by actin depolymerization, leading to shrinkage
of dendritic spine heads. Moreover, STEP dephosphorylates C-terminal tyrosine
residues of the GluA2 subunit of AMPA receptors, promoting endocytosis of
GluA2-containing AMPA receptors (Zhang et al., 2008). Collectively, these findings
indicate that STEP not only functions to limit excitatory neurotransmission via
dephosphorylation of key tyrosine residues on both AMPA and NMDA receptors,
but that STEP activation also facilitates actin depolymerization through interactions
with actin binding proteins. See Figure 1.2 for a diagram summarizing the
consequences of increased STEP activity on glutamate signaling. Such alterations
in actin polymerization may result in changes in the morphology of dendritic spines,
and presumably the activity state of neurons as discussed below.

9

Figure 1.2 Diagram summarizing consequences of STEP activation on glutamate
signaling. STEP activation suppresses ERK signaling and promotes endocytosis
of GluA2-containing AMPA receptors. STEP also interacts with the actin binding
protein substrate SPIN90 (not shown) to facilitate actin depolymerization leading
to shrinkage of dendritic spines.
Dendritic spine morphology as an index of neuronal physiology
Dendritic spines are small protrusions arising from dendrites that are enriched in factin, actin binding proteins, post-synaptic receptors, as well as scaffolding
proteins linking receptors to effectors and internal Ca2+ stores (Sala and Segal,
2014). For several decades, it has been suggested that actin polymerization plays
a critical role in mediating synaptic plasticity (Fifkova and Delay, 1982). Dendritic
spines exist in various morphological states and are generally classified into four
10

main categories; filopodia, thin, stubby, and mushroom, with the latter forming
stable and mature synapses (Bellot et al., 2014). In the adult cortex, filopodia,
which are generally thought to be immature protrusions but are required for initial
spinogenesis (formation of new spines), are low in density (Zuo et al., 2005).
Moreover, others have suggested that filopodia are indeed not dendritic spines due
to their overall lack of a defined spine head (Dailey and Smith, 1996).
Furthermore, the pruning and formation of new dendritic spines, as well as
the stabilization of existing spines (i.e. structural plasticity), is thought to underlie
several components of plasticity mediating learning and memory (Fu and Zuo,
2011). Indeed, several studies have demonstrated changes in the morphology of
dendritic spine heads following LTP induction, such as the enlargement of spine
heads and shortening/widening of the spine neck (Tonnesen et al., 2014), are
highly

correlated

with

the

potentiation

of

glutamatergic

excitatory

neurotransmission (Kasai et al., 2003). Thus, synaptic plasticity at excitatory
synapses mediating learning and memory in various brain regions is reflected in
alterations in dendritic spine morphology, and such changes may be an index of
the activity state of neurons.
Role of AMPA receptor subunit conformation and transmission in dendritic
spine morphology
Ionotropic

glutamate

neurotransmission

receptors

within

the

subserve

brain

the

(Hollmann

majority
and

of

excitatory

Heinemann,

1994).

Physiologically, NMDA receptor activation produces a rise in intracellular Ca 2+
which is important for enlargement of dendritic spine heads during the induction of
long-term potentiation. This series of events is dependent on calmodulin, actin
11

polymerization, and an increase in AMPA receptor-mediated glutamate currents
(Matsuzaki et al., 2004). Studies in vitro have shown that, in particular, the GluA2
subunit of AMPA receptors is important for dendritic spine head enlargement
(Passafaro et al., 2003).
The GluA1 subunit of AMPA receptors is critical for glutamatergic plasticity,
and phosphorylation of several key C-terminal residues of GluA1 potentiates
AMPA receptor-mediated excitatory transmission. Specifically, phosphorylation of
GluA1S845 through a cAMP-dependent protein kinase A (PKA)-mediated
mechanism enhances glutamate currents (Roche et al., 1996). Interestingly,
AMPA receptors are extremely abundant in mature, mushroom-type dendritic
spines, but display low abundance in thin and filopodia-type dendritic spines,
subtypes which are thought to be more malleable in response to differential
excitatory input and may be the site of so-called silent synapses (Matsuzaki et al.,
2001). Collectively, these findings indicate that AMPA receptor phosphorylation,
and trafficking to synapses, is a critical event mediating synaptic potentiation;
which requires actin polymerization and enlargement of dendritic spine heads.
Regarding the effect of short access cocaine SA on AMPA receptor
phosphorylation in the PrL cortex, our lab has found no such alterations during
early withdrawal. However, in contrast to early withdrawal, one week of abstinence
(i.e. early abstinence) results in profound alterations in AMPA receptor
phosphorylation due to elevated PKA activity.

12

Prelimbic cortex and early abstinence
As discussed above, the PrL cortex shows a state of diminished glutamatergic
neurotransmission during early withdrawal which is reversed by BDNF. However,
additional data collected in our laboratory suggest that plasticity occurring over one
week of abstinence renders the PrL cortex hypersensitive to inputs encoding
cocaine-conditioned stimuli. Specifically, following one week of forced abstinence
there is enhanced phosphorylation of CREB with no alteration in ERK2
phosphorylation. Furthermore, the PKA target GluA1S845 is also elevated after one
week of forced abstinence (Sun et al., 2014b). Importantly, an intra-PrL infusion of
the PKA inhibitor, Rp-cAMPS, prior to context-induced relapse after abstinence
normalizes the hyperphosphorylation of GluA1 and CREB, suppressing contextinduced relapse.
PKA phosphorylation of GluA1S845 has been shown to enhance plasma
membrane insertion of AMPA receptors, augmenting excitatory neurotransmission
(Banke et al., 2000; Oh et al., 2006). Apart from the upstream kinase ERK2, PKA
is also an important regulator of CREB phosphorylation and CREB-mediated gene
transcription in the cortex (Kelly, 2018). Several experiments have implicated
dopamine receptor D1-PKA signaling in both the PrL cortex (Boudreau et al., 2009)
as well as the NAc core (Hope et al., 2005) in neuroplasticity following chronic
cocaine administration. In a cocaine SA paradigm, infusion of dopamine into the
NAc core or the PrL cortex is sufficient to induce reinstatement following extinction
(Cornish and Kalivas, 2000; McFarland and Kalivas, 2001).
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The finding that the PrL cortex shows a hyperphosphorylation of PKA
targets, GluA1 and CREB, indicates the potential for hyperactivity within the PrL
cortex following one week of abstinence. This is not without precedent, as a recent
experiment showed elevated AMPA:NMDA ratio, an index of synaptic potentiation,
following withdrawal from cocaine-induced conditioned place preference (Otis and
Mueller, 2017). Noncontingent cocaine administration has also been shown to
increase excitability of PrL neurons by inhibiting G protein-gated inwardly rectifying
K+ (GIRK) channels (Dong et al., 2005; Hearing et al., 2013). Interestingly, a
deletion of GIRK channel-encoding genes in forebrain neurons of knockout mice
is sufficient to augment cocaine-induced locomotion, which is associated with
increased PrL-NAc core glutamate transmission (Marron Fernandez de Velasco et
al., 2017). Finally, a cocaine-induced behavioral sensitization paradigm augments
extracellular glutamate levels in the PrL cortex after 7 days of withdrawal,
suggesting elevated glutamate tone on PrL pyramidal neurons (Williams and
Steketee, 2004).
A recent study found that after extinction from cocaine SA, there is an
increase in intrinsic excitability of PrL neurons (Sepulveda-Orengo et al., 2017).
This induction of PrL hyperexcitability is likely not an epiphenomenon, as drugs
that impair cocaine reinstatement show a normalization of this hyperexcitability
(Sepulveda-Orengo et al., 2017). Recent evidence also indicates a role for
sensitized PrL D1-PKA signaling following chronic cocaine injections in decreasing
the threshold for the induction of spike-timing-dependent LTP in layer V pyramidal
neurons, perhaps priming synapses for potentiation following subsequent cue
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exposure (Ruan and Yao, 2017). Moreover, elevated BDNF expression in the PrL
cortex following 8 days of cocaine withdrawal facilitates LTP induction in layer V
pyramidal neurons, which mediates locomotor sensitization (Lu et al., 2010).
Taken together, these findings indicate that the PrL cortex likely transitions
from a state of glutamatergic hypoactivity to one of glutamatergic hypersensitivity
as a function of abstinence duration. This hypersensitive state may be dependent
on elevated sensitivity to dopaminergic inputs, perhaps priming synapses for an
augmented response to incoming glutamatergic inputs. This is supported by the
finding that there is increased activation of prefrontal cortical regions following
presentation

of

cocaine-conditioned

cues

in

human

cocaine

abusers

(Pulipparacharuvil et al., 2008) as well as increased immediate early gene
expression, a proxy for elevated neuronal activity (Dragunow and Faull, 1989),
during presentation of cocaine-conditioned cues (James et al., 2018) or contexts
(Hearing et al., 2008) in rodents. Although it is unclear whether cocaine SA alters
the electrophysiological properties of PrL neurons after one week of abstinence,
ex vivo and in vivo electrophysiology have been used to address cocaine-induced
alterations in such properties of neurons in the PrL cortex and the NAc core at
other timepoints.
Cocaine-induced alterations in physiology and structural plasticity in
cortico-accumbens circuitry
Although several studies have investigated how chronic cocaine exposure alters
excitatory neurotransmission within the NAc core, fewer experiments have
investigated alterations in physiology induced by chronic cocaine exposure in the
PrL cortex. In the NAc core, basal AMPA:NMDA ratio is elevated following
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extinction from cocaine SA, which is augmented by 15 minutes of cue-induced
reinstatement, representing a period of transient synaptic potentiation (tSP). The
elevated AMPA:NMDA ratio is associated with increased dendritic spine head
diameters following extinction that undergo further potentiation during cue-induced
reinstatement (Gipson et al., 2013; Smith et al., 2014). Importantly, these transient
adaptations rely on glutamate release arising from the PrL cortex (Stefanik et al.,
2016). Further, it has been shown that chronic cocaine SA and withdrawal produce
a marked inability to induce LTP or LTD in NAc core neurons following stimulation
of the prefrontal cortex in vivo (Moussawi et al., 2009). Moreover, animals
undergoing 30 days of abstinence from cocaine SA show a higher proportion of
‘phasically active’ NAc core neurons during resumption of cocaine SA relative to
one day of abstinence, suggesting prolonged abstinence elevates cocaine-cue
encoding and responsiveness in NAc core neurons (Hollander and Carelli, 2005).
Thus, cocaine SA induces dysfunctional glutamatergic transmission in PrL
afferents within the NAc core, which are likely important for craving and relapse to
cocaine seeking following re-exposure to cocaine-conditioned stimuli.
As discussed above, few experiments have investigated cocaine-induced
alterations in physiology or structural plasticity within the PrL cortex, which is
surprising given its critical role in behavioral activation and subsequent relapse. A
key study found that, relative to baseline, the firing rate of mPFC neurons is
suppressed following cocaine infusions in a SA paradigm. However, this effect was
normalized after 10 days of SA. Interestingly, this was associated with decreased
basal firing rate following the first cocaine infusion during each day of SA (Sun and
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Rebec, 2006). Furthermore, the authors found enhanced burst firing and numbers
of spikes per burst relative to baseline in cocaine-experienced animals. The
authors conclude that although cocaine dampens basal PFC firing rates, the
encoding of cocaine-conditioned stimuli is enhanced following chronic cocaine SA.
Data from our lab indicate that daily cocaine experience produces a dampening of
PrL firing rates, with subsequent daily sessions recruiting a larger percentage of
suppressed neurons (Dennis et al., 2018). Moreover, it has been shown that 30
days of abstinence from cocaine SA increases the percentage of ‘phasically active’
PrL, but not IL, cortical neurons during extinction day 1, relative to one day of
abstinence (West et al., 2014). A similar effect was shown following resumption of
cocaine SA after one month of abstinence.
Following long-access cocaine SA and extinction training, a subset of rats
who show compulsive cocaine-seeking behavior have decreased intrinsic
excitability in deep-layer pyramidal neurons of the PrL cortex (Chen et al., 2013).
Rescuing this hypoexcitability with optogenetic stimulation reduced compulsive
cocaine seeking (Chen et al., 2013). In concert, these findings indicate that, in
general, cocaine experience increases the encoding of cocaine-associated stimuli
by PrL neurons. However, this may be associated with suppressed activity of these
neurons at baseline.
Cocaine-induced alterations in PrL structural plasticity
Although well-documented adaptations in dendritic spine morphology or density
have been demonstrated in the NAc core, fewer experiments have been done
investigating such adaptations in the PrL cortex. The few studies that have been
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performed have provided mixed results regarding the effect of cocaine SA and
various lengths of abstinence on PrL structural adaptations. This discrepancy
appears to be due to different techniques to label dendritic spines, different
abstinence timepoints, different pyramidal neurons (i.e. layer II/III versus V), as
well as different regions of the dendrite analyzed (basal versus apical). Using Golgi
staining, experiments have generally reported increased spine density on apical
dendrites after one month of abstinence (Robinson et al., 2001) and basal
dendrites after one week of abstinence (Rasakham et al., 2014). This agrees with
the finding that MDMA behavioral sensitization produces increases in spine density
of distal apical dendrites of layer V PrL neurons (Ball et al., 2009). However, Golgi
staining typically uses 2D photomicrographs to trace dendrites, neglecting
dendritic spines that protrude axially. Additionally, relative to labeling of neurons
with the lipophilic dye DiI, Golgi staining severely underestimates the number of
spines, particularly thin spines (Shen et al., 2008). In contrast, more recent
experiments using advanced techniques have found reduced layer II/III apical
spine density after two weeks of abstinence (Radley et al., 2015) and reduced layer
V apical spine density specifically in neurons innervating D1-, but not D2,expressing MSN’s in the NAc core after 14 days of withdrawal from daily
noncontingent cocaine injections (Barrientos et al., 2018).
Although these experiments have provided valuable insight into how
cocaine SA alters the structure and function of PrL neurons, only recently have
they revealed pathway-specific structural adaptations. This is important given the
heterogeneity of PrL efferents. For example, layer II/III pyramidal neurons project
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to several downstream structures including the BLA (Gabbott et al., 2005; Little
and Carter, 2013). This well-defined projection likely contributes to prefrontal
cortical modulation of cognition as well as emotional drive. However, layer II/III
pyramidal neurons also project to the contralateral mPFC (Little and Carter, 2013),
as well as dorsal striatal regions regulating motor control (Gabbott et al., 2005). In
contrast, layer V pyramidal neurons provide robust innervation of the NAc core
(Gabbott et al., 2005), a pathway that has been shown to be a key projection in
cocaine-induced plasticity underlying relapse (discussed in detail above). Layer V
pyramidal neurons also innervate the dorsomedial striatum, as well as the BLA.
Additionally, these neurons project to other subcortical structures implicated in
prefrontal cortical regulation of motivation, such as the lateral hypothalamus
(Gabbott et al., 2005).
Thus, experiments investigating PrL structural adaptations resulting from
cocaine SA should provide additional information regarding how these adaptations
might occur in a pathway-specific manner. These observations would provide
critical information regarding projection-defined adaptations. Importantly, no
studies to date have investigated not only how cocaine SA alters PrL structural
plasticity during early withdrawal, but also whether this occurs in neurons
projecting from the PrL cortex to the NAc core. Assuming cocaine-induced
plasticity is altered in a pathway-specific manner, it is therefore imperative to
possess tools to interrogate the effect of pathway-specific manipulations of PrL
neurons on subsequent behavioral responses to cocaine-conditioned stimuli.
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Designer Receptors Exclusively Activated by Designer Drugs (DREADDs): A
chemogenetic toolkit for altering neuronal activity in a pathway-specific
manner
DREADDs are mutated human muscarinic receptors that lack the binding site for
the endogenous ligand, acetylcholine, but have gained affinity for the exogenous
ligand clozapine-N-oxide (CNO) (Pei et al., 2008). Specifically, DREADDs take
advantage of endogenous signaling cascades coupled to Gα i (hM4Di), Gαq
(hM3Dq), and Gαs (rM3Ds) signaling which decrease, increase, and modulate
neuronal excitability, respectively (Rogan and Roth, 2011). DREADDs are typically
introduced into neuronal populations through adeno-associated viral vectors
containing DNA encoding for DREADD receptors (Smith et al., 2016). Initially,
DREADD expression was exclusively driven by a cell-type specific promoter (i.e.
CaMKIIα) or a pan-neuronal promoter (i.e. Synapsin). More recently, the advent of
intersectional viral approaches has allowed for the manipulation of specific
neuronal pathways using DREADDs. This requires the use of viral vectors injected
in terminal regions of interest which show preferential retrograde transport and
express Cre-recombinase in all neurons projecting to said region (Junyent and
Kremer, 2015; Tervo et al., 2016). This is combined with infusions of viral vectors
containing Cre-dependent DNA in given brain regions innervating the area where
retrograde viruses were infused. Ultimately, this allows for Cre-dependent
DREADD expression in a defined pathway of interest (Garcia et al., 2017).
In the last several years, the use of pathway-specific DREADDs has been
applied to the interrogation of prefrontal cortical efferents implicated in relapse to
cocaine seeking. For example, Augur and colleagues recently found that
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chemogenetic activation of the ventromedial prefrontal cortex (vmPFC), including
the IL cortex, immediately prior to cue-induced reinstatement was sufficient to
suppress relapse. Moreover, they found that preferentially activating vmPFC
projections to the NAc shell was sufficient to reproduce this effect (Augur et al.,
2016). This finding suggests that the primary mechanism of action of hM3Dq
activation of this pathway was to reactivate IL cortical neurons projecting to the
NAc shell encoding the updated contingency of cocaine availability inherent in
extinction training.
Using Gi-coupled DREADDs, Kerstetter and colleagues found that inhibition
of PrL projections to the NAc core during daily cocaine SA sessions resulted in
enhanced responding on the formerly active lever during extinction, and increased
responding on the active lever during cocaine prime-induced reinstatement.
However, inhibiting this pathway immediately prior to reinstatement was sufficient
to suppress cocaine prime-induced reinstatement (Kerstetter et al., 2016). This
finding is consistent with a role for elevated PrL glutamate release in the NAc core
mediating cocaine prime-induced reinstatement (McFarland et al., 2003).
Data from our lab indicate that Gi-DREADD inhibition of all PrL outputs
using a CaMKIIα promoter immediately after the final SA session suppresses
relapse to contexts, cues, as well as a priming injection of cocaine. Specifically
inhibiting the PrL projection the NAc core at the same timepoint was without effect
on relapse behavior. However, the suppressive effect of global PrL Gi-DREADD
inhibition on relapse behavior was recapitulated when specifically inhibiting the PrL
projection to the paraventricular nucleus of the thalamus (PVT). One interpretation
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of these data is that there exist parallel, dichotomous glutamatergic pathways
arising from the PrL cortex during early withdrawal from cocaine SA. Thus, PrLNAc core may exist in a hypoactive state, whereas PrL-PVT may exist in a
hyperactive state following cocaine SA. This is not without precedent, as a recent
study found that these two pathways differentially encode reward-predictive cues
(Otis et al., 2017).
Collectively, these findings indicate that pathway-specific DREADD
modulation of PrL outputs can differentially affect various aspects of relapse to
cocaine seeking depending on the specific pathway being manipulated.
Purpose of studies and overall hypothesis
The data collected in our lab and others clearly show that the PrL cortex undergoes
profound alterations in glutamatergic plasticity during early withdrawal which, in
some instances, is opposite relative to one week of abstinence. This chain of
events has been shown to be critical for subsequent relapse. Because early
withdrawal represents a critical timepoint for relapse prevention due to the
dephosphorylation events that occur in the PrL cortex, it was imperative to examine
whether preventing these dephosphorylation events from occurring through
targeting STEP activity is sufficient to suppress relapse

(Aim1). Moreover,

because the dephosphorylation events occurring in the PrL cortex during early
withdrawal are reflective of a hypoactive glutamatergic state, it is reasonable that
artificially increasing glutamatergic neuronal activity in the PrL cortex during early
withdrawal would be sufficient to suppress relapse after abstinence (Aim 2).
Further, the dephosphorylation events occurring in the PrL during early withdrawal,
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as well as the hyperphosphorylation of PKA targets after one week of abstinence,
have previously been shown to be associated with altered AMPA receptor
transmission and spine morphology. Thus, we hypothesized that spine
morphology and AMPA receptor immunoreactivity in dendritic spines might also
be altered in an analogous manner at these various timepoints (Aim 3). Finally,
because the PrL projection to the NAc core is involved in the suppressive effect of
BDNF on relapse when infused into the PrL cortex immediately after SA, it is likely
that elevating neuronal activity preferentially in this pathway is sufficient to
suppress relapse after abstinence. Additionally, cocaine-induced alterations in
structural plasticity might be occurring in this pathway, which we hypothesized to
be bidirectionally regulated during early withdrawal and one week of abstinence.
Therefore, we investigated whether 1) cocaine SA-induced alterations in the
PrL cortex during early withdrawal are mediated by the activation of STEP,
resulting in dysfunctional glutamate transmission in the PrL to NAc core pathway,
2) artificially elevating corticostriatal glutamatergic transmission during early
withdrawal

would

suppress

relapse

after

abstinence,

and

3)

these

dephosphorylation events during withdrawal and the hyperphosphorylation of PKA
targets following one week of abstinence are associated with changes in the
activation state of PrL-NAc neurons and altered dendritic spine morphology
associated with AMPA receptor immunoreactivity in dendritic spines (Figure 1.2).
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Figure 1.3. Hypothesized alterations in glutamate signaling, gene transcription
regulators, and structural plasticity during early withdrawal and after one week of
abstinence from cocaine SA.
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Chapter 2. STEP activation in the PrL cortex mediates
cocaine-induced ERK dephosphorylation during early
withdrawal and plays a role in relapse after abstinence
Data presented in Chapter 2 have been published in Addiction Biology (23(1):219229, 2018). Minor changes to the original article have been made for appropriate
integration into this dissertation.
Introduction
Cocaine SA causes a transient dephosphorylation of critical neuronal plasticityrelated proteins in the PrL cortex of rats that leads to subsequent relapse to
cocaine seeking, as discussed in detail in Chapter one. The dephosphorylation of
ERK is a critical component of the cocaine-induced alterations in PrL plasticity
occurring during early withdrawal. BDNF-mediated inhibition of cocaine seeking
after abstinence when infused into the PrL cortex immediately after SA is blocked
by a prior infusion of the mitogen-activated extracellular signal-regulated kinase
inhibitor U0126 (Whitfield et al., 2011). Thus, the suppressive effect of BDNF on
relapse is dependent on normalizing ERK dephosphorylation in the PrL cortex
during early withdrawal.
A major question is how cocaine SA causes ERK dephosphorylation in the
PrL cortex. Of several phosphatases that dephosphorylate ERK, STEP has
emerged as a fundamental regulator of the ERK cascade in response to dopamine
and glutamate interactions in the striatum triggered by psychostimulants
(Lombroso et al., 1993; Valjent et al., 2005). STEP is a CNS-specific tyrosine
phosphatase localized to dopaminoceptive neurons with high expression in the
striatum (Lombroso et al., 1993) and moderate expression in the medial prefrontal
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cortex (Boulanger et al., 1995). Canonically, STEP is activated by Ca2+ influx
through GluN2B-containing NMDA receptors (Paul et al., 2003), leading to a
calcineurin-dependent

phosphatase

cascade

that

culminates

in

the

dephosphorylation and activation of STEP (Boulanger et al., 1995; Paul et al.,
2003; Goebel-Goody et al., 2012). Following activation, STEP dephosphorylates
regulatory tyrosine residues on various substrates implicated in neuronal plasticity,
including ERK (Paul et al., 2003; Paul and Connor, 2010), the Src family kinase,
Fyn (Nguyen et al., 2002), GluN2A (Tian et al., 2016), and GluN2B (Braithwaite et
al., 2006).
STEP

activity

is

augmented

in

several

neuropsychiatric

and

neurodegenerative disorders. For example, STEP activity is elevated in human
postmortem samples and in animal models of Alzheimer’s Disease (AD) (Snyder
et al., 2005; Kurup et al., 2010), Parkinson’s Disease (Kurup et al., 2015), and
schizophrenia (Xu et al., 2018). Moreover, inhibition of STEP with systemic
injections of the novel, relatively selective inhibitor, TC-2153, significantly improves
memory deficits in a mouse model of AD (Xu et al., 2014) as well as PCP-induced
hyperlocomotion in mice (Xu et al., 2016). TC-2153 treatment reverses the
biochemical, electrophysiological, and cognitive deficits in mouse models of
schizophrenia and in glutamatergic neurons derived from human-induced
pluripotent stem cells from schizophrenic patients (Xu et al., 2018). As expected,
TC-2153 acutely increases ERK phosphorylation in vivo (Xu et al., 2016; Xu et al.,
2018).
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Regarding preclinical models of addiction, dephosphorylation events within
the PrL cortex during early withdrawal from cocaine SA are accompanied by
decreased phosphorylation, and thus increased activation, of STEP (Sun et al.,
2013), suggesting STEP is a likely mediator of the ERK dephosphorylation in the
PrL cortex during early withdrawal from cocaine SA. Therefore, we investigated
whether inhibition of STEP with an intra-PrL microinfusion of TC-2153 immediately
following the final SA session would prevent ERK dephosphorylation in the PrL
cortex during early withdrawal and decrease relapse to cocaine seeking. We also
tested whether systemic injections of TC-2153 at the same time point would reduce
relapse. Our results indicate that intra-PrL administration of TC-2153 immediately
following the final SA session suppressed context-induced relapse and cue-, but
not cocaine prime-, induced reinstatement. Intra-PrL TC-2153 also prevented the
cocaine-induced ERK dephosphorylation within the PrL cortex during early
withdrawal. However, systemic TC-2153 injections at the same time point had the
opposite effects on cocaine-seeking. Overall, our results indicate that the cocaineinduced activation of STEP is an important regulator of neuroadaptations occurring
within the PrL cortex during early withdrawal that lead to subsequent cocaine
seeking.
Materials and Methods
Animal subjects and surgery
Adult male Sprague Dawley rats (n=166) Charles Rivers Laboratories; Wilmington,
MA) were individually housed on a twelve-hour reverse light/dark cycle (lights on
at 6AM). Upon arrival, rats were allowed at least 3 days of acclimation to the
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vivarium. During this time, they were provided standard rat chow (Harlan;
Indianapolis, IN) and water ad libitum. All animal use protocols were approved by
the Institutional Animal Care and Use Committee of the Medical University of South
Carolina and were performed according to the National Institutes of Health Guide
for the Care and Use of Laboratory Animals (8th ed., 2011). All rats weighed 275325g at the time of surgery. On the day of surgery, rats were injected i.p. with a
ketamine (66 mg/kg) and xylazine (1.33 mg/kg) mixture for anesthesia and
ketorolac (2.0 mg/kg) for analgesia. Rats that underwent SA were implanted in the
right jugular vein with chronic indwelling i.v. silastic catheters (Fisher Scientific;
Hampton, NH). Catheters were attached by subcutaneous tubing to a backmount
which exited from an incision in the back. Following catheterization, rats were
either secured in a stereotaxic apparatus (Kopf Instruments, Tujunga, CA) or
underwent post-operative recovery care (specified below). Following securement
in the stereotaxic apparatus, 26-gauge bilateral stainless-steel guide cannulae
(Plastics One, Roanoke, VA) were aimed 1 mm above the PrL cortex (+2.8mm
anteroposterior, +/- 0.6mm mediolateral, -3.0mm dorsoventral relative to bregma).
Guide cannulae were fixed to the skull with cranioplastic cement and anchored
with steel screws. Following surgery, a bilateral 10 mm stylet was inserted into the
guide cannula to prevent blockage, and rats were infused i.v. with 0.1 ml of
cefazolin and 0.05 ml of Taurolidine-Citrate Solution (TCS; Access Technologies,
Skokie, IL). Post-operative care was conducted for 5 days, during which rats were
inspected for abnormalities, and catheters were flushed with 0.05 ml TCS.
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Self-administration
Rats were trained to self-administer cocaine on a fixed-ratio 1 schedule of
reinforcement for 12-14 days (2 hr/day; criterion of ≥ 10 infusions/day), during
which rats were food restricted to 20g of chow to motivate learning. SA was
conducted in standard MedPC operant chambers which contained two retractable
levers (Fairfax, VT), and were housed within sound-attenuating cubicles fitted with
a fan for airflow and masking noise. Active lever presses elicited a light and tone
cue complex followed by a 0.2 mg/50 μl infusion of cocaine hydrochloride (NIDA,
Research Triangle Park, NC), followed by a 20 second timeout period. Yokedsaline controls received a non-contingent infusion of 0.9% saline (with light and
tone cues) when their cocaine partner received a contingent cocaine infusion. For
all experiments, inactive lever presses had no programmed consequence.
Sucrose SA was conducted in the same manner as cocaine SA experiments,
except active lever presses were reinforced with a single 45 mg chocolate flavored
sucrose pellet (BioServe-F07256; Flemington, NJ).
Intracranial microinfusions
Prior to intracranial microinfusions, rats were habituated to a different behavioral
room equipped with an infusion pump (Harvard Apparatus) containing two gastight Hamilton syringes for at least 2 days immediately following their SA sessions.
The day prior to their microinfusions, a stylet extending 1 mm past the tip of the
guide cannula was inserted. Immediately following their final SA session, rats were
infused (0.5 μl/hemisphere, 0.25 μl/minute) with either vehicle (0.01% DMSO in
filtered 0.1M PBS) or a 1 μM concentration of TC-2153. Injectors (33 gauge) were
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left in place for 1 minute after infusions to facilitate diffusion. Following
microinfusions, rats were either returned to the vivarium for 6 days of homecage
abstinence or were rapidly decapitated two hours later for phospho-protein
analysis.
Systemic injections
TC-2153 (2.0 mg/ml) was dissolved in 18% DMSO/2% Tween-20 in filtered 0.1M
PBS, and rats were injected (i.p.) 2.5X body weight to achieve a final dose of 5
mg/kg, immediately after the final SA session. Six and 10 mg/kg have been shown
to increase p-ERK in mice in vivo (Xu et al., 2014; Xu et al., 2016). However, due
to solubility restrictions (4 mg/ml did not stay in solution in our hands), we tested
only 5 mg/kg. Following injections, rats were returned to the vivarium for 6 days of
homecage abstinence.
Post-abstinence relapse test, extinction, cue- and cocaine prime-induced
reinstatement
Following abstinence, rats underwent a post-abstinence (PA) relapse test under
extinction conditions (active lever presses had no programmed consequence).
After at least 6 days (no more than 21 days) of further extinction training to a
criterion of an average of ≤15 presses on the active lever over the last 3 days, rats
underwent a 2-hour cue-induced reinstatement test. During this test, active lever
presses elicited the cocaine-associated cue complex, but no infusion. Following
further extinction, rats underwent a 2-hour cocaine prime-induced reinstatement
test (10 mg/kg, i.p.) under extinction conditions. Following the cocaine prime test,
rats were decapitated with anesthesia to confirm accuracy of cannula placements.
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Histology
Following decapitation, brains were extracted, rapidly frozen in isopentane, and
stored at -80°C. Brains were either coronally sectioned (40 μM) with a cryostat and
Nissl-stained to confirm cannula placements, or a single 3mm wide X 2mm deep
tissue punch through the dorsomedial PFC (AP +~4.68–2.76) was taken using a
modified biopsy punch (Braintree Scientific; Braintree, MA), and stored at -80°C
until processing. Cannula placements were confirmed during dissection.
Tissue processing
Tissue processing was performed as previously described (Sun et al. 2013).
Briefly, 115 μl of ice-cold RIPA buffer (in mM: 50 Tris-HCL, pH 7.4, 150 NaCl, 2
EDTA, pH 7.4, and 10% Glycerol, 1% Triton X, 1% NP-40, and 1% Sodium
Deoxycholate) with a complete set of protease and phosphatase inhibitors, was
added to each punch. Punches were briefly sonicated, incubated in ice-cold buffer
for 30 minutes, centrifuged at 10,000 x g for 20 minutes at 4°C, and the supernatant
was used for all analyses. Protein concentrations were determined using a
standard BCA assay. Lysates were then diluted to 2 μg/μl in 0.1X Sample Buffer
(Protein Simple; San Jose, CA) and individually aliquoted.
Wes™ immunoassay
The Wes™ capillary electrophoresis system (Protein Simple, Bio-Techne, San
Jose, CA) was used for protein quantification. Aliquots of lysates (2 μg/μl) were
thawed and further diluted in 0.1X Sample Buffer to 0.8 μg/μl for analysis of p-ERK
and 0.4 μg/μl for analysis of t-ERK using a combination of ¾ 0.1x Sample Buffer
and ¼ 4X Master Mix (1:1 mix of 40 mM DTT and 10X Sample Buffer, Protein
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Simple, San Jose, CA) according to the manufacturer’s instructions. Samples were
denatured at 95°C for 5 minutes. A rabbit primary antibody against p-ERK1/2 (1:50,
Cell Signaling Technology-9101S RRID:AB_331646) was multiplexed with a
primary

antibody

against

calnexin

(Enzo

life

sciences-ADI-SPA-860-F

RRID:AB_11178981) at a concentration of 1:2000. A rabbit primary antibody
against t-ERK1/2 (1:100, Cell Signaling Technology-9102S RRID:AB_10695746)
was multiplexed with 1:1000 calnexin. Supplier anti-rabbit secondary antibodies
were used as instructed (Protein Simple, San Jose, CA).
Each plate contained samples from all experimental groups, and both pERK2 and t-ERK2 were analyzed for each sample from the same aliquot. Analysis
of electropherogram peaks was performed using Compass™ software (Protein
Simple) using the Gaussian distribution of the Area Under the Curve (AUC) of the
peak luminol-peroxidase signal in the capillaries. Analysis was done by dividing
the AUC of p-ERK2 by t-ERK2. Data are expressed as a fold change relative to
the respective controls.
Experimental design
Figure 2.1 shows the timeline for all experimental procedures conducted.
Experiment 1 was conducted to determine the optimum concentration of TC-2153
that increased p-ERK when microinfused into the PrL cortex. Rats received a
single intra-PrL microinfusion of vehicle or TC-2153 (0.5, 1, or 5 μM) and were
rapidly decapitated two hours later. These concentrations were chosen based on
previous work showing that treatment of cortical cultures with concentrations of
TC-2153 ranging from 1-5 μM increased p-ERK (Xu et al., 2014). The time point
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was chosen because the cocaine-induced dephosphorylation of ERK in the PrL
cortex occurring two hours after the end of SA is necessary for subsequent cocaine
seeking because normalizing ERK dephosphorylation with a single intra-PrL BDNF
infusion suppresses cocaine seeking (Whitfield et al., 2011).
Experiment 2 was designed to determine whether an intra-PrL
microinfusion of TC-2153 immediately following the final SA session would
suppress relapse after abstinence and extinction. Rats were either microinfused
with vehicle or the optimal concentration of TC-2153 (1 μM) from Experiment 1
immediately following the final of 12-14 cocaine SA sessions. Following 6 days of
forced abstinence, rats underwent a PA context-induced relapse test, further
extinction, a cue-induced reinstatement test, further extinction, and a cocaine
prime-induced reinstatement test. In Experiment 3, rats either underwent cocaine
SA or received yoked-saline infusions and received either an intra-PrL
microinfusion of TC-2153 (1 μM) or vehicle immediately after the final SA session.
Rats were rapidly decapitated two hours later to determine the effect of TC-2153
on the cocaine-induced ERK dephosphorylation within the PrL cortex during early
withdrawal. Experiment 4 was conducted in the same manner as Experiment 2,
except active lever presses were reinforced with chocolate sucrose pellets instead
of cocaine infusions and there was no sucrose-primed test. The design of
Experiment 5 was similar to Experiment 2, except rats received a systemic
injection of TC-2153 (5 mg/kg, ip) or vehicle immediately following the final cocaine
SA session.
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Figure 2.1. Schematic of the experimental timelines for all experiments. Final
sample sizes: Experiment 1-(0 μM: n=5, 0.5 μM: n=7, 1 μM: n=6, 5 μM: n=7);
Experiment 2- (TC-2153 (1μM): n=9, vehicle: n=13); Experiment 3(Saline+Vehicle: n=10, Saline+TC-2153: n=7, Cocaine+Vehicle: n=8,
Cocaine+TC-2153: n=9); Experiment 4- (TC-2153 (1 μM): n=7, Vehicle: n=4);
Experiment 5- (TC-2153 (5 mg/kg): n=10, Vehicle: n=11).
Statistical analysis
All analyses were performed using GraphPad Prism 7 software (La Jolla, CA). All
behavioral data were analyzed with a mixed-model ANOVA with time
(SA/extinction versus PA/Cue/cocaine prime test) as the within-subject variable
and treatment (TC-2153 versus Vehicle) as the between-subject variable. If
significant main effects or an interaction was observed, Bonferroni-corrected
pairwise comparisons were used to compare groups during and across time points.
Grubbs’ test was used to determine statistical outliers and these were removed
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from final analyses (n=4). Data in Experiment 1 were analyzed with a one-way
ANOVA followed by Dunnett’s multiple comparison test to compare all TC-2153
concentrations to the vehicle control group. Data in Experiment 3 were analyzed
with a two-way ANOVA followed by Student-Neuman-Keuls pairwise comparison
tests. All data are expressed as the mean +/- SEM, and statistically significant
differences were determined at p<0.05.
Results
Histology
Cannula placements for experiments 2 and 4 are shown in Figure 2.2. Circles
indicate the region of the PrL cortex dissected for subsequent phospho-protein
analyses in experiments 1 and 3. Cannula placements were deemed suitable if the
tip of the cannula was located within the ventral tier of the anterior cingulate cortex
or within the PrL cortex, but not in the infralimbic cortex. Additionally, the most
ventral portion of the cannula had to be between AP +4.20 – AP +2.76 mm from
Bregma. As shown in Figure 2.2, most cannula placements were tightly focused
around AP +3.00 – AP +3.24 mm from Bregma.
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Figure 2.2. Map of coronal sections through the PFC showing all cannula
placements for experiments 2 and 4. The circled regions correspond to areas
where tissue punches were taken for experiments 1 and 3 (AP ~+4.68mm+2.76mm relative to bregma).
Experiment 1. Intra-PrL microinfusion of TC-2153 increased p-ERK in naïve
rats
Naïve rats (n=32; n=8/group) received a bilateral intra-PrL microinfusion of vehicle
or one of three concentrations of TC-2153 (0.5, 1, or 5 μM). Rats were rapidly
decapitated two hours after the infusion to determine the optimal concentration of
TC-2153 that increased p-ERK in the PrL cortex in vivo. Of the 32 rats initially
used, 2 died after surgery and 4 brain samples were incorrectly punched. One
sample was not analyzed due to lysate discoloration.
A one-way ANOVA indicated a significant effect of intra-PrL TC-2153 on pERK (F(3,21)=3.21, p<0.05). Dunnett’s multiple comparison test indicated that only
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the 1 μM concentration of TC-2153 significantly increased p-ERK relative to vehicle
controls (p=0.04; Fig. 2.3A,C). There was no effect of TC-2153 on t-ERK
normalized to calnexin (F(3,21)=0.08, p>0.05; Fig. 2.3B,D). Thus, for all future
microinfusion experiments, we used a 1 μM concentration of TC-2153.

Figure 2.3. A single intra-PrL microinfusion of TC-2153 (1 μM) increased p-ERK
in naïve rats. Rats were infused with vehicle (0) or 0.5, 1, or 5 μM of TC-2153 and
rapidly decapitated two hours later to determine the optimal concentration of TC2153 that increased p-ERK when microinfused into the PrL cortex. A. Only 1 μM
TC-2153 increased p-ERK relative to vehicle-infused rats (*p<0.05). B. There was
no difference in t-ERK/calnexin. Representative chemiluminescent peaks for pERK (C) and t-ERK multiplexed with calnexin (D) for groups in experiment 1.
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Experiment 2. Intra-PrL microinfusion of TC-2153 suppressed contextinduced relapse and cue-, but not cocaine prime-, induced reinstatement.
We next investigated the effect of a bilateral intra-PrL microinfusion of TC-2153 (1
μM) immediately following SA on context-induced relapse following abstinence,
cue-, and cocaine prime-, induced reinstatement following extinction. Two rats died
during surgery, 5 rats died before finishing SA, 11 rats were removed from the final
analysis due to cannula placements outside of the PrL cortex, and 2 rats were
outliers according to Grubbs’ test during the cue and cocaine prime test in the TC2153 and vehicle group, respectively. Final group sizes were: n=13 (vehicle) and
n=9 (TC-2153). Figure 2.4A shows SA data for both groups. When analyzing active
lever presses during the final 10 days of SA, results revealed a significant main
effect of time (F(9,180)=2.37, p<0.05). However, there was no significant main effect
of treatment (F(1,20)=0.46, p>0.05) nor a significant treatment by time interaction
(F(9,180)=0.74, p>0.05). When analyzing inactive lever presses, results revealed
there was no significant main effect of time (F(9,180)=0.69, p>0.05), treatment
(F(1,20)=0.00008, p>0.05), nor a significant treatment by time interaction
(F(9,180)=1.35, p>0.05). When analyzing infusions, results revealed a significant
main effect of time (F(9,180)=4.48 p<0.0001), but no significant main effect of
treatment (F(9,180)=2.78, p>0.05), nor a significant treatment by time interaction
(F(9,180)=0.39, p>0.05). Thus, there was no difference between groups regarding
active lever presses, inactive lever presses, or infusions during the final 10 days
of SA. However, both groups showed elevated responding on the active, but not
inactive, lever as well as increased infusions earned over the course of SA.
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After their respective intracranial infusions, rats were exposed to 6 days of
abstinence followed by a PA test. Results revealed a significant main effect of time
(F(1,20)=6.09, p<0.05) and treatment (F(1,20)=8.53, p<0.01), but no treatment by time
interaction (F(1,20)=3.30, p>0.05) for active lever presses. Bonferroni-corrected
pairwise comparisons indicated that active lever presses were similar between
groups during the last 3 days of SA before microinfusions (p>0.05). Rats infused
with vehicle (p<0.01), but not TC-2153 (p>0.05), pressed the active lever
significantly more during the PA test than during the last 3 days of SA and rats
infused with TC-2153 pressed the active lever during the PA test significantly less
than vehicle-infused controls (p<0.01; Fig. 2.4B). For inactive lever presses, there
was a significant main effect of time (F(1,20)=23.17, p<0.0001), but no significant
main effect of treatment (F(1,20)=3.62, p>0.05), nor a significant treatment by time
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interaction (F(1,20)=1.77, p>0.05). Thus, both groups showed elevated inactive lever
pressing during the PA test relative to the last 3 days of SA.

Figure 2.4. A single intra-PrL TC-2153 microinfusion immediately following the
final SA session suppressed cocaine seeking following abstinence and extinction
training. Rats were either infused in the PrL cortex with TC-2153 (1 μM) or vehicle
immediately following the final SA session. A. SA data for rats in experiment 2. BD. TC-2153 suppressed active lever pressing during (B) the PA test following
abstinence as well as (C) during the cue-induced reinstatement test after
extinction, but not (D) the cocaine prime-induced reinstatement test (++p<0.01,
++++p<0.0001 compared to the last 3 days of SA/extinction; **p<0.01, ***p<0.001
compared to vehicle).
After completion of extinction, rats underwent a cue-induced reinstatement
test. For active lever presses, there was a significant main effect of time
(F(1,20)=88.67, p<0.0001) and treatment (F(1,20)=8.82, p<0.01), as well as a
significant treatment by time interaction (F(1,20)=9.80, p<0.01; Fig. 2.4C).
Bonferroni-corrected pairwise comparisons indicated that active lever pressing
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over the last 3 days of extinction did not differ between groups (p>0.05). Both
vehicle- (p<0.0001) and TC-2153- (p<0.01) infused rats pressed the active lever
significantly more during the cue test than during the last 3 days of extinction and
rats infused with TC -2153 pressed the active lever significantly less than vehicleinfused rats (p<0.001). For inactive lever presses, there was no significant main
effect of treatment (F(1,20)=1.56, p>0.05), time (F(1,20)=1.47, p>0.05), not a
significant treatment by time interaction (F(1,20)=0.007, p>0.05).
Following re-extinction to criterion, rats underwent a cocaine prime-induced
reinstatement test (Fig. 2.4D). One rat removed its headcap prior to the cocaine
prime test and was excluded from the analysis. For active lever presses, there was
a significant main effect of time (F(1,19)=54.86, p<0.0001), indicating that both
groups had increased active lever pressing during the cocaine prime-induced
reinstatement test relative to the last 3 days of extinction. However there was no
significant main effect of treatment (F(1,19)=1.857, p>0.05) or a significant treatment
by time interaction (F(1,19)=0.33, p>0.05). For inactive lever presses, there was no
significant main effect of treatment (F(1,19)=2.20, p>0.05), time (F(1,19)=0.51,
p>0.05), nor a significant treatment by time interaction (F(1,19)=0.16, p>0.05). These
results show that a single intra-PrL microinfusion of TC-2153 immediately following
SA suppresses cocaine seeking in the PA and cue-, but not cocaine prime-,
induced reinstatement tests.

41

Experiment 3. Intra-PrL microinfusion of TC-2153 prevented the cocaineinduced ERK dephosphorylation within the PrL cortex during early
withdrawal
To determine the effect of STEP inhibition on the cocaine-induced ERK
dephosphorylation within the PrL cortex during early withdrawal, rats (n=48) were
randomly assigned to either cocaine SA or yoked-saline groups following surgery.
One rat was removed prior to the end of SA after a catheter failure. Immediately
following the final of 12-14 cocaine/yoked saline SA sessions, the PrL cortex of
rats was microinfused bilaterally with TC-2153 or vehicle and rapidly decapitated
two hours after the infusion. Of the remaining 47 rats, 13 were excluded from
analyses for the following reasons: cannula placements that were outside of the
PrL cortex (n=6), catheter failure on the final day of SA (n=1), or tissue samples
were punched incorrectly (n=6). Following exclusion, final group sizes were as
follows: Saline+Vehicle (n=10), Saline+TC-2153 (n=7), Cocaine+Vehicle (n=8),
Cocaine+TC-2153 (n=9).
Figure 2.5A shows the SA data for cocaine self-administering rats and
yoked saline controls. A two-way repeated measures ANOVA revealed a
significant main effect of SA (cocaine versus yoked saline) for active lever presses
(F(1,32)=92.34, p<0.05). Bonferroni-corrected pairwise comparison test indicates
that cocaine self-administering animals pressed the active lever significantly more
than yoked saline controls during sessions 1-10 (p<0.0001). Moreover, cocaine
SA rats receiving vehicle microinfusions were not significantly different than
cocaine SA rats receiving TC-2153 microinfusions when analyzing average active
lever presses during the last 3 days of SA (t(15)=0.006, p>0.05) or average infusions
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earned over the last 3 days of SA (t(15)=0.11, p>0.05; Fig. 2.5B). A two-way ANOVA
revealed a significant main effect of treatment (TC-2153 versus vehicle) as well as
SA (cocaine versus saline) on p-ERK (Treatment: F(1,30)=14.84, p<0.001, SA:
F(1,30)=10.28, p<0.01), but no significant treatment by SA interaction (F (1,30)=0.08,
p>0.05). Student-Neuman-Keuls tests revealed that p-ERK levels were
significantly lower in the cocaine + vehicle group versus the yoked-saline + vehicle
group. TC-2153 significantly increased p-ERK in yoked-saline rats (p<0.05; Fig.
2.5C,E) and prevented the cocaine SA-induced decrease. There was no effect of
treatment, SA, or a significant treatment by SA interaction on t-ERK/calnexin
(Treatment: F(1,30)=2.28, p>0.05, SA: F(1,30)=2.43, p>0.05, treatment by SA:
F(1,30)=3.12, p>0.05; Fig. 2.5D,F). These results indicate that intra-PrL TC-2153
infused immediately following the final SA session prevented the cocaine-induced
ERK dephosphorylation within the PrL cortex during early withdrawal.
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Figure 2.5. Intra-PrL TC-2153 normalizes the cocaine-induced decrease in pERK2 within the PrL cortex during early withdrawal. A. SA data for cocaine (n=17)
and yoked saline (n=17) rats. Cocaine SA rats pressed the active lever significantly
more than yoked saline controls (^^^^p<0.0001) B. Cocaine self-administering rats
infused with vehicle or TC-2153 were equal regarding active lever presses over
the last 3 days of SA as well as average infusions earned. C. Rats microinfused
with vehicle immediately following the final cocaine SA session show decreased
p-ERK relative to yoked-saline rats infused with vehicle. This decrease is
prevented in rats that received a TC-2153 microinfusion immediately following
cocaine SA. Additionally, yoked-saline rats microinfused with TC-2153 showed
augmented p-ERK compared to saline-vehicle rats (*p<0.05 compared to SalineVehicle, +p<0.05 compared to Cocaine-Vehicle). D. There were no differences
between groups in t-ERK/calnexin. E-F. Representative chemiluminescent peaks
for p-ERK (E) and t-ERK multiplexed with calnexin (F) for groups in experiment 3.
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Experiment 4. Intra-PrL microinfusion of TC-2153 did not affect contextinduced relapse or cue-induced reinstatement of sucrose seeking
To determine whether the suppressive effect of intra-PrL infusion of TC-2153 on
relapse was cocaine-specific, rats (n=16) underwent 12-14 days of sucrose SA
and were microinfused with either TC-2153 or vehicle immediately following the
final SA session. One rat died after surgery and 3 rats removed their headcaps
prior to the PA test. Of the remaining 12 rats, one was removed from analysis
because its cannula placement was outside of the PrL cortex. Figure 2.6A shows
sucrose SA data for all final rats included in this experiment. When active lever
presses were analyzed, a two-way repeated-measures ANOVA revealed a
significant main effect of time (F(9,81)=4.26, p<0.0001), but no significant main effect
of treatment (F(1,9)=0.63, p>0.05), nor a significant treatment by time interaction
(F(9,81)=0.89, p>0.05). For pellets earned, a two-way repeated-measures ANOVA
indicated a significant main effect of time (F(9,81)=6.24, p<0.05), but no significant
main effect of treatment (F(1,9)=0.99, p>0.05) nor a significant treatment by time
interaction (F(9,81)=0.89, p>0.05). Following infusions, rats underwent 6 days of
forced abstinence followed by a PA test. For active lever presses, a two-way
ANOVA revealed a significant main effect of time (F(1,9)=35.69, p<0.001; Fig. 2.6B),
but no main effect of treatment (F(1,9)=0.00005, p>0.05) or a significant treatment
by time interaction (F(1,9)=0.01, p>0.05), indicating that both groups had reduced
active lever pressing during the PA test relative to the last 3 days of sucrose SA.
For inactive lever presses, there was no significant main effect of treatment
(F(1,9)=1.09, p>0.05), time (F(1,9)=1.14, p>0.05), nor a significant treatment by time
interaction (F(1,9)=2.44, p>0.05). Following further extinction to criterion, rats
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underwent a cue-induced reinstatement test. When analyzing active lever presses,
results indicated a significant main effect of time (F(1,9)=37.79, p<0.001; Fig. 2.6C),
but not treatment (F(1,9)=0.31, p>0.05) or a significant treatment by time interaction
(F(1,9)=1.08, p>0.05). For inactive lever presses, there was no significant main
effect of treatment (F(1,9)=0.79, p>0.05), time (F(1,9)=0.51, p>0.05), nor a significant
treatment by time interaction (F(1,9)=0.47, p>0.05). These data indicate that both
groups had increased active lever pressing during the cue-induced reinstatement
test relative to the last 3 days of extinction, which was not altered by a prior TC2153 microinfusion.

Figure 2.6. A single intra-PrL microinfusion of TC-2153 fails to suppress sucrose
seeking after abstinence and extinction. A. Sucrose SA data for all rats in
experiment 4. B-C, Animals microinfused with TC-2153 or vehicle show equal
responding on the active lever during the PA test (B) as well as (C) during the cueinduced reinstatement test, but both groups had reduced responding during the
PA test relative to the last 3 days of SA and increased responding during the cue
test relative to the last 3 days of extinction (***p<0.001 compared to the last 3 days
of SA or extinction, two-way ANOVA).
Experiment 5. A systemic injection of TC-2153 preferentially suppressed
cocaine prime-induced reinstatement
Previous findings indicate systemic TC-2153 is able to alter ERK2 phosphorylation
in the mPFC in vivo (Xu et al., 2014). To test the ability of TC-2153 to induce pERK2 in the PrL cortex two hours after injection, naïve rats were either injected
with vehicle or TC-2153 (5 mg/kg, i.p., n=4/group) and rapidly decapitated two
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hours later. A two-tailed t-test showed that rats injected with TC-2153 had
significantly higher p-ERK2 relative to tERK2 in the PrL cortex two hours after
injection (t(6)=2.81, p<0.05, Fig. 2.7A). There was no difference in tERK2
normalized to Calnexin between groups (t(6)=0.62, p>0.05, Fig. 2.7B).

To

determine the effect of systemic administration of TC-2153 on relapse, rats (n=28)
underwent cocaine SA for 12-14 days as above. Three rats became ill and were
euthanized prior to the end of SA. Two rats were removed for catheter failure prior
to finishing SA. One rat per group was an outlier according to Grubbs’ test in the
cocaine prime test and was removed from all analyses. The remaining rats were
injected i.p. with TC-2153 (5 mg/kg, n=10) or vehicle (n=11) immediately following
the last of 12-14 cocaine SA sessions. Figure 2.7C shows SA data for all rats in
this experiment. When comparing active lever presses between vehicle versus TC2153 injected rats, a two-way repeated-measures ANOVA indicated there was no
significant main effect of time (F(9,171)=1.27, p>0.05), treatment (F(1,19)=0.33,
p>0.05), nor a significant treatment by time interaction (F(9,171)=1.61, p>0.05). For
inactive lever presses, there was no significant main effect of time (F (9,171)=0.92,
p>0.05), treatment (F(1,19)=3.75, p>0.05), nor a significant treatment by time
interaction (F(9,171)=0.82, p>0.05). For infusions, there was a significant main effect
of time (F(9,171)=7.64, p<0.0001), but not treatment (F(1,19)=0.13, p>0.05), nor a
significant treatment by time interaction (F(9,11)=1.41, p>0.05). Thus, there was no
difference between groups for active lever presses, inactive lever presses, nor
infusions earned during SA. However, both groups had increased infusions as a
function of SA time. Following 6 days of abstinence, rats were returned to their SA
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chambers for the PA test. For active lever presses, a two-way ANOVA revealed a
significant main effect of time (F(1,19)=23.10, p<0.001; Fig. 2.7D), indicating that
both groups had increased active lever pressing in the PA test relative to the last
3 days of SA, but there was no significant main effect of treatment (F(1,19)=0.18,
p>0.05) or a significant treatment by time interaction (F(1,19)=0.003, p>0.05). There
was a significant main effect of time (F(1,19)=51.78, p<0.05), but no significant main
effect of treatment (F(1,19)=3.82, p>0.05), nor a significant treatment by time
interaction (F(1,19)=2.15, p>0.05) when analyzing inactive lever presses.
Following completion of extinction, rats underwent a cue-induced
reinstatement test. For active lever presses, results showed a significant main
effect of time (F(1,19)=110.50, p<0.0001; Fig. 2.7E), indicating that both groups
pressed the active lever significantly more during the cue-induced reinstatement
test compared to the last 3 days of extinction, but there was no main effect of
treatment (F(1,19)=2.50, p=0.13) or a treatment by time interaction (F(1,19)=2.38,
p>0.05). When analyzing inactive lever presses, there was no significant main
effect of treatment (F(1,19)=2.21, p>0.05), time (F(1,19)=1.59, p>0.05), nor a
significant treatment by time interaction (F(1,19)=0.11, p>0.05).
Following re-extinction to criterion, rats underwent a cocaine prime-induced
reinstatement test. When analyzing active lever presses, there were significant
main effects of time (F(1,19)=42.66, p<0.0001), treatment (F(1,19)=7.065, p<0.05), as
well as a significant treatment by time interaction (F(1,19)=8.26, p<0.01; Fig. 2.7F).
Bonferroni-corrected pairwise comparisons indicated that active lever presses
were equal between groups over the last 3 days of extinction (p>0.05), but rats
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injected with TC-2153 pressed the active lever significantly less than vehicleinjected rats during the cocaine prime test (p<0.001). For inactive lever presses,
there was no significant main effect of time (F(1,19)=0.0005, p>0.05), treatment
(F(1,19)=0.74, p>0.05), nor a significant treatment by time interaction (F (1,19)=3.22,
p>0.05). Collectively, these data indicate that injections of TC-2153 immediately
following SA preferentially suppress cocaine prime-induced reinstatement.

Figure 2.7. Systemic injection of TC-2153 suppressed cocaine prime-induced
reinstatement but not post-abstinence context-induced relapse or cue-induced
reinstatement. A-B. A single systemic injection of TC-2153 (5 mg/kg, i.p.)
increased PrL cortical p-ERK2 (A) two hours after injection in naïve rats, without
affecting tERK2 (B) (n=4/group). C. SA data for all rats in experiment 5. D-F. Rats
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were either injected with TC-2153 (5 mg/kg, i.p.) or vehicle immediately following
the final cocaine SA session. Both groups had increased active lever pressing
during (D) the PA test following 6 days of forced abstinence as well as (E) during
the cue-induced reinstatement test following extinction. There was no effect of TC2153 on active lever pressing in either test. However, TC-2153 injections
suppressed (F) cocaine prime-induced reinstatement (++++p<0.0001,
+++p<0.001, +p<0.05 compared to the last 3 days of SA/extinction, *p<0.05,
***p<0.001 compared to vehicle).
Discussion
Summary of findings
The results of the current experiments are the first to show that the cocaineinduced activation of STEP in the PrL cortex during early withdrawal from cocaine
SA (Sun et al., 2013) plays a significant role in relapse. Interestingly, we found that
an intra-PrL TC-2153 microinfusion immediately after SA suppressed contextinduced relapse and cue-, but not cocaine prime-, induced reinstatement.
However, systemic TC-2153 injections had the opposite effect. Additionally, intraPrL TC-2153 prevented the cocaine-induced ERK dephosphorylation in the PrL
cortex during early withdrawal. These results corroborate previous findings that
early withdrawal from cocaine SA is a critical time point whereby an intervention,
like an infusion of BDNF or TC-2153, that normalizes ERK and/or GluN2 signaling
in the PrL cortex produces an enduring suppression of relapse (Whitfield et al.,
2011; Go et al., 2016). This finding coupled with the finding that BDNF does not
alter food seeking (Berglind et al., 2007), and TC-2153 does not alter sucrose
seeking, indicates that intra-PrL interventions during early withdrawal selectively
attenuate cocaine seeking without affecting the motivation to seek natural rewards.

50

Differential effect of systemic vs. intra-PrL TC-2153 on cocaine seeking
Recent studies indicate that systemic delivery of TC-2153 normalizes
cognitive/behavioral dysfunction in animal models of disorders with augmented
STEP activity (Xu et al., 2014; Xu et al., 2016; Xu et al., 2018). However, our
experiments are the first to microinfuse TC-2153 and we found that systemic
versus intra-PrL TC-2153 differentially suppressed cocaine seeking. Several
potential explanations exist for these observed differences.
The lack of effect of systemic TC-2153 on context-induced relapse and cueinduced reinstatement could be due to the inability of 5 mg/kg TC-2153 to prevent
the dephosphorylation of ERK within the PrL cortex during early withdrawal from
cocaine SA. However, this is unlikely because 5 mg/kg TC-2153 increased p-ERK
within the PrL cortex two hours after an injection in naïve rats. STEP is heavilyenriched in other regions, such as the striatum and hippocampus (Boulanger et
al., 1995) thus it is likely that systemic TC-2153 also increases p-ERK in these
regions, as previously reported for the hippocampus (Xu et al., 2014). Furthermore,
intra-PrL TC-2153 also increased p-ERK acutely in naïve rats, but, unlike systemic
TC-2153, prevented context-induced relapse as well as cue-induced reinstatement
after extinction when infused immediately after SA. Thus, we hypothesize that the
inability of systemic TC-2153 to suppress context- and cue-induced cocaine
seeking is likely due to the inhibition of STEP in other brain regions, in addition to
the PrL cortex, during early withdrawal, and that one or more of these regions may
underlie the preferential inhibition of cocaine prime-induced reinstatement.
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The striatum, including the NAc core, is heavily-enriched in both major
isoforms of STEP, STEP46 and STEP61 (Lombroso et al., 1993; Sharma et al.,
1995). However, only STEP61 is expressed in the PFC. Furthermore, STEP46 has
greater enzymatic activity than STEP61 (Boulanger et al., 1995), and TC-2153 has
~1.75 higher affinity for STEP46 than STEP61 (Xu et al., 2014). Acute cocaine has
been shown to increase p-ERK in the NAc core by inactivating STEP46, which
requires concomitant activation of dopamine D1 and NMDA receptors (Paul et al.,
2000; Valjent et al., 2005; Girault et al., 2007). By extension, cocaine primeinduced reinstatement is thought to require the integration of dopamine and
glutamate inputs in the NAc core from the VTA and PrL cortex, respectively (Shen
et al., 2014a), and is associated with increased extracellular dopamine and
glutamate in the NAc core (McFarland et al., 2003), suggesting that a priming
injection of cocaine likely increases p-ERK by inactivating STEP46 in the NAc core.
The differential expression pattern and function of STEP46 and STEP61 in the PrL
cortex and NAc core, and the role of dopamine and glutamate interactions in the
NAc core in regulating STEP and cocaine prime-induced reinstatement, suggest
that systemic TC-2153 may preferentially suppress cocaine prime-induced
reinstatement by inhibiting STEP in the NAc core during early withdrawal, which
future experiments should investigate.
Intra-PrL TC-2153 prevented the cocaine-induced ERK dephosphorylation
during early withdrawal
The results of the current study agree with previous studies indicating that cocaine
SA decreases p-ERK in the PrL cortex during early withdrawal (Whitfield et al.,
2011; Go et al., 2016). Consistent with our hypothesis, we show here that this
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effect was prevented by intra-PrL microinfusions of TC-2153. ERK is central to
neuroadaptations occurring within neural circuits that mediate drug seeking (Lu et
al., 2006; Zhai et al., 2008). Therefore, it is not surprising that time-course
experiments indicate that p-ERK changes dynamically within the PFC during
various stages of abstinence from cocaine SA (Whitfield et al., 2011; Miszkiel et
al., 2014). For example, cocaine-mediated decreases in p-ERK in the PrL cortex
two hours after SA normalize by 22 hours and remain unaltered after six days of
abstinence (Whitfield et al., 2011). Importantly, intra-PrL infusion of BDNF is
unable to suppress relapse when microinfused after six days of forced abstinence
(Berglind et al., 2007). However, the suppressive effect of BDNF on cocaine
seeking when it is microinfused immediately after SA depends on normalizing pERK during early withdrawal (Whitfield et al., 2011).
Potential mechanism of STEP activation during early withdrawal
STEP has been shown to be dephosphorylated and activated by Ca 2+ influx
through GluN2B-containing NMDA receptors via a PP2B-PP1 dependent
mechanism in corticostriatal cultures (Paul et al., 2003). Moreover, extrasynaptic
NMDA receptor stimulation inactivates ERK in cultured hippocampal and cortical
neurons (Kim et al., 2005; Ivanov et al., 2006; Leveille et al., 2008) whereas
synaptic NMDA receptor stimulation leads to STEP ubiquitination, facilitating
sustained ERK activation (Hardingham et al., 2001; Hardingham et al., 2002; Xu
et al., 2009). Thus, an attractive hypothesis is that a hyperglutamatergic tone
arises in the PrL cortex after chronic SA which facilitates extrasynaptic NMDA
receptor stimulation, and subsequent activation of STEP, inhibiting NMDA function
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and associated ERK signaling during early withdrawal. In support, not only does
cocaine SA lead to the dephosphorylation of ERK and CREB, but also GluN2AY1325
and GluN2BY1472 (Go et al., 2016), and STEP dephosphorylates GluN2BY1472
(Braithwaite et al., 2006).
TC-2153

also

enhances

GluN2A

pan-tyrosine

phosphorylation

in

hippocampal cultures. Interestingly, STEP-/- mice have increased GluN2A pantyrosine, but not GluN2AY1325, phosphorylation (Tian et al., 2016) suggesting a
different tyrosine site in GluN2A may be dephosphorylated by STEP. However,
STEP may indirectly dephosphorylate GluN2AY1325 via dephosphorylation and
inactivation of Fyn as demonstrated in vitro (Nguyen et al., 2002). Thus, future
experiments should investigate whether TC-2153 prevents the cocaine-induced
GluN2A/B dephosphorylation. Furthermore, an intra-PrL microinfusion of Ro-256981, a selective GluN2B antagonist, immediately after SA does not reduce
relapse (Go et al., 2016). However, treatment of cortical cultures with memantine,
a non-selective NMDA antagonist, preferentially blocks extrasynaptic NMDA
receptors (Leveille et al., 2008), suggesting that preferential inhibition of
extrasynaptic GluN2B-containing NMDA receptors may prevent the cocaine-

54

induced activation of STEP, ERK dephosphorylation, and subsequent cocaine
seeking (Figure 2.8).

Figure 2.8 Cocaine SA-induced activation of STEP in the PrL cortex during early
withdrawal may rely on increased activation of extrasynaptic NMDA receptors due
to glutamate overflow.
Conclusions
ERK dephosphorylation in the PrL cortex during early withdrawal represents a
critical neuroadaptation that promotes relapse. Normalizing p-ERK with a single
intra-PrL BDNF (Whitfield et al., 2011) or TC-2153 microinfusion immediately after
cocaine SA suppresses cocaine seeking. Although BDNF and TC-2153 have a
similar effect on cocaine seeking, they are likely producing this effect in different
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ways. Intra-PrL BDNF immediately after SA is likely acting upstream of STEP by
directly increasing activity of MEK signaling during early withdrawal (Whitfield et
al., 2011), as well as potentially inducing the degradation of STEP (Saavedra et
al., 2016). However, TC-2153 acts only at the level of STEP to prevent the catalytic
activity of STEP following activation (Xu et al., 2014). Both interventions culminate
in normalized p-ERK, highlighting the importance of ERK dephosphorylation as a
neuroadaptation occurring in the PrL cortex during early withdrawal that leads to
cocaine seeking. In conclusion, our results reveal a key role of STEP activation in
the PrL cortex in regulating cocaine seeking, as well as associated adaptations in
p-ERK that occur during early withdrawal from cocaine SA.
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Chapter 3: The effect of chemogenetic activation of the
PrL cortex and PrL-NAc core pathway on relapse to
cocaine seeking after abstinence
Introduction
Relapse is thought to arise from dysfunctional medial prefrontal cortex-dependent
regulation of subcortical basal ganglia structures (Quintero, 2013). Specifically,
cocaine-induced alterations in the glutamatergic projection arising from the PrL
cortex innervating the NAc core has been implicated in the initiation of drug
seeking following presentation of cocaine-conditioned contexts, cues, or a priming
injection after abstinence or extinction (Kalivas, 2009). Moreover, the development
of cocaine addiction is thought to occur through distinct stages of altered
neuroplasticity, which are differentially regulated by drug-taking, abstinence, and
re-exposure to cocaine-conditioned stimuli (Kalivas and O'Brien, 2008). Thus,
pharmacological agents targeting specific adaptations mediating relapse may be
beneficial at one stage of addiction relative to other stages.
Previous work from our lab indicates that the suppressive effect of PrL
cortical BDNF on cocaine seeking when infused immediately after SA can be
blocked by antagonizing GluN2A/B-containing NMDA receptors prior to BDNF.
Thus,

preventing

BDNF-TrkB

signaling

from

elevating

glutamatergic

neurotransmission by antagonizing NMDA receptors prior to BDNF during early
withdrawal prevents the long-term suppressive effect of BDNF on cocaine seeking
(Go et al., 2016). These findings indicate that BDNF is likely augmenting glutamate
transmission in the PrL-NAc core pathway during early withdrawal. Although intraPrL BDNF likely exerts its effects by normalizing corticostriatal glutamate
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transmission through increased synaptic activity during early withdrawal, it is
unknown whether simply elevating synaptic activity in the PrL cortex during early
withdrawal is sufficient to suppress cocaine seeking after abstinence and extinction
training.
A plethora of literature indicates that the PrL-NAc core pathway is the
primary glutamatergic projection mediating the initiation of cocaine seeking
(McFarland et al., 2003; Reissner et al., 2015; McGlinchey et al., 2016). However,
recent data indicate that divergent pathways arising from the PrL cortex
differentially encode reward-predictive cues. PrL-NAc, relative to PrL-PVT,
neurons differentially encode cue-elicited reinforcement learning of appetitive
behaviors, and their coordinated activity permits plasticity relevant for cueencoding (Otis et al., 2017). Moreover, during the acquisition of cocaine SA, some
PrL cortical neurons show decreased activity relative to baseline (i.e. prior to
beginning daily SA sessions), with a larger percentage showing hypoactivity on the
last day of SA relative to the first. However, a certain percentage of pyramidal
neurons show elevated firing rates relative to baseline, although the percentage
does not change from the first to the last day of SA (Dennis et al., 2018). Therefore,
it could be postulated that these neurons may differentially encode cocaine cue
salience through divergent outputs during the critical early withdrawal period. With
the advent of optogenetics and chemogenetics, it has only recently been possible
to definitively show the relationship between the PrL cortex and its downstream
targets in drug seeking following various periods of abstinence.
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Apart from transiently elevating the firing rates of neurons, Gq-coupled
DREADDs also engage cell-signaling pathways associated with Gq-signaling,
including the MAPK pathway (Bellocchio et al., 2016). In the last decade,
DREADDs have been used extensively to probe the role of the medial prefrontal
cortex in working memory (Liu et al., 2014), fear memory prediction (Yau and
McNally, 2015), as well as behavioral activation elicited by cocaine conditioned
cue exposure (Augur et al., 2016), among other prefrontal-dependent behaviors.
Apart from being utilized as a tool to potentiate, or inhibit, general populations of
neurons in various brain regions, DREADDs have also been combined with
intersectional viral approaches which allow for modulation of specific PrL cortical
projections (Garcia et al., 2017). These experiments rely on injections of
retrograde-transported viruses, such as canine-adeno virus type 2 (CAV2) or
AAVrg, which express Cre-recombinase (Junyent and Kremer, 2015; Tervo et al.,
2016) in combination with Cre-dependent viral vectors expressing DREADDs.
Using this intersectional viral approach, Kerstetter and colleagues found
that suppressing PrL-NAc core neurons during progressive ratio (PR) cocaine SA
augments responding on the formerly active lever during the first extinction
session, as well as cocaine prime-induced reinstatement. However, inhibition of
PrL-NAc core neurons immediately prior to drug-prime reinstatement suppressed
drug seeking (Kerstetter et al., 2016). This is consistent with optogenetic evidence
that inhibiting PrL-NAc core neurons prior to reinstatement prevented cocaine
seeking (Stefanik et al., 2013). Thus, PrL-NAc core manipulations have opposing
effects depending on the timepoint of intervention. Moreover, augmenting activity
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in the IL-NAc shell pathway prior to reinstatement following extinction training
suppresses cocaine seeking (Augur et al., 2016). Thus, intersectional viral
approaches can be utilized to gain a better understanding of corticostriatal
pathways that mediate, or suppress, cocaine seeking. However, to date, no studies
have applied this technique to alter PrL cortical activity, specifically that of NAc
core efferents, immediately after cocaine SA.
The data discussed above suggest that BDNF elevates synaptic activity in
the PrL cortex during early withdrawal, which may provide a long-term
normalization of corticostriatal glutamate transmission. We therefore hypothesized
that chemogenetic-mediated activation of the PrL cortex immediately after the final
SA session would suppress relapse after abstinence, an effect mediated by PrLNAc core activation. To investigate this hypothesis, we used either CaMKIIα-driven
hM3Dq, or hSyn-DIO-hM3Dq, DREADDs in combination with NAc core CAV2-CreeGFP or rgAAV-pmSyn1-Cre-eBFP viral vectors to activate PrL cortical
glutamatergic neurons, or preferentially activate the PrL-NAc core output,
respectively. Although we did not find any effects that persisted during an entire
two-hour relapse test in either experiment, we did see trends in some of the relapse
tests as well as specific timepoints during relapse wherein hM3Dq activation was
effective. Thus, global chemogenetic activation of the PrL cortex as well as the
PrL-NAc core pathway is insufficient to suppress relapse to the same degree as
BDNF during early withdrawal. This difference may be due to the transient nature
of hM3Dq activation as opposed to the more-sustained nature of BDNF-TrkB
signaling.
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Materials and Methods
Animal subjects
Sixty-seven adult male Sprague Dawley rats were used for this study (Charles
Rivers Laboratories, Wilmington, MA). Rats were maintained in the vivarium under
the same conditions as experiments described in Chapter two.
Surgery
Rats were anesthetized, and chronic indwelling catheters were implanted into the
jugular vein as described in Chapter two. All viral procedures and constructs used
in this study were approved by the Medical University of South Carolina
Institutional Biosafety Committee. For intra-cranial viral microinjections, rats were
fixed into a stereotaxic apparatus and glass micropipettes were used to inject
either an AAV5-CaMKIIα-hM3Dq-mCherry (UNC vector core, Chapel Hill, NC or
Addgene, Cambridge, MA), AAV5-CaMKIIα-mCherry (UNC vector core, Chapel
Hill, NC or Addgene, Cambridge, MA), AAV5-CaMKIIα-eGFP (UNC vector core),
AAV5-hSyn-DIO-hM3Dq-mCherry

(Addgene),

or

AAV5-hSyn-DIO-mCherry

(Addgene) into the PrL cortex (AP +2.8 mm, ML +/- 0.6 mm, DV -3.8mm from
bregma). All viruses injected into the PrL cortex had a titer of ~3 X 10 12 viral
genomes/ml and 0.75 μl/hemisphere was injected. In Experiment 3, rats also
received microinjections of either CAV2 vector expressing a Cre-eGFP fusion
protein under control of a CMV promoter (CAV2-Cre-eGFP; 3.6 X 1012 viral
genomes/ml, Montpellier vector core, 0.75 ul/hem) or AAVrg pmSyn1-EBFP-Cre
(~3 X 1012 viral genomes/ml Addgene, 0.75 ul/hem) into the NAc core (+ 1.6 mm
AP, +/- 2.8 mm ML, - 7.1 mm DV from bregma, 10º angle). These viruses are
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retrogradely transported, expressing Cre-recombinase in neurons expressing Credependent viral vectors that innervate the injected brain region (Junyent and
Kremer, 2015; Tervo et al., 2016). All microinjections were delivered over a course
of 5 minutes and glass micropipettes were left in place for 10 minutes to facilitate
diffusion away from the injection site.
Behavior
Cocaine SA was performed identical to that which was used in Chapter two. Rats
received 10-14 days of SA. Immediately following the final cocaine SA session,
all rats were injected with CNO (3 mg/kg i.p., NIDA chemical synthesis and drug
supply program). Subsequent forced abstinence (i.e. 6 days), post-abstinence
context-induced relapse, extinction, cue-induced reinstatement, extinction, and
cocaine prime-induced reinstatement were performed identical to Chapter two.
Approximately one week following the cocaine prime test, rats received
another injection of CNO (3 mg/kg, i.p.), were anesthetized (ketamine/xylazine),
then transcardially perfused with 150 ml of 0.1M phosphate-buffered saline (PBS)
followed by 200 ml of 4% paraformaldehyde (PFA, pH 7.4) two hours after the
injection because this timepoint has been shown to be when maximal Fos
induction occurs following acute cocaine (Graybiel et al., 1990). Brains were
immersed in the same fixative for 1 hour and were then processed for
immunohistochemical detection of the mCherry or eGFP tag/reporter and the
activity protein, Fos.
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Immunohistochemistry
Fifty μm sections containing the medial prefrontal cortex (mPFC) and NAc core
were sliced on a cryostat (Leica Biosystems, Mannheim, Germany). The collected
sections were stored in 0.1 M PBS containing 0.2% sodium azide and stored at
4oC until immunohistochemical processing.
Three to four sections from AP +2.76 to AP +4.2 mm from bregma were
used for mCherry and Fos detection. First, sections were blocked in PBS with 0.3%
Triton X-100 (PBST) and 2% normal goat serum (NGS) for two hours. Next, tissue
was incubated at 4oC in PBST containing primary antisera with NGS (2%)
overnight. Primary antisera consisted of a chicken anti-mCherry (1:2000; LS
Biosciences #LS-C204825, Seattle, WA RRID:AB_2716246), chicken anti-GFP
(1:1000; Abcam #ab13970, Cambridge, MA RRID:AB_300798) and either rabbit
anti-cFos (1:250, Santa Cruz Biotechnology, sc-52 RRID:AB_2106783) or mouse
anti-cFos (1:100, Santa Cruz Biotechnology, sc-166940). Sections were then
rinsed in PBST (3 X 10 minutes), then incubated in species-specific secondary
antisera conjugated to either Alexa Fluor®594 (1:1,000; Abcam #ab150172) for
mCherry detection or Alexa Fluor®647 (1:1,000; Abcam #ab150115) for detection
of Fos. In experiment 2, mCherry/eGFP and Fos colocalization was not performed
due to diffuse virus expression when hM3Dq was driven by a CaMKIIα promoter.
Thus, sections were immunoprocessed for only Fos (1:250, Santa Cruz
Biotechnology, sc-52 RRID:AB_2106783) followed by Alexa Fluor®594conjugated secondary antisera (1:1,000; Cell-signaling technologies, #8889).
Sections were incubated in secondary antisera for two hours at room temperature
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protected from light. Sections were then rinsed in PBST (3 X 10 minutes), then
mounted on superfrost-plus glass slides using ProLong gold anti-fade (Thermo
Fisher Scientific; Waltham, MA). Slides were stored at 4ºC until imaging was
performed.
Epifluorescent and confocal imaging
Epifluorescent photomicrographs of mCherry and eGFP expression in the PrL
cortex and NAc core, respectively, were acquired using a 2.5X air objective with
an Olympus brightfield microscope equipped with appropriate wavelength filters.
These images were used for verification of virus placement in the PrL cortex and
NAc core. Animals were excluded from analyses if significant virus expression was
observed in the infralimbic cortex (see results) or if virus expression was
significantly different between hemispheres. ImageJ was used to manually draw
regions of interest for Cg1, IL, and PrL cortex on each photomicrograph. The
percent of total integrated density in each region was calculated for each section.
Three to four sections were analyzed per animal, and then averaged to obtain a
single integrated density data point for each region for each animal. In Experiment
2, Fos immunoreactivity was detected using a Leica SP5 laser-scanning confocal
microscope. Images were acquired with a He-Ne 543 laser line, 10X air objective,
a 1024x1024 frame size, and a 1 μm Z-step size. In experiment 3, a Leica SP5
laser-scanning confocal microscope was used. Images were acquired with a 20X
air objective with 1024x1024 frame size and a 1 μm Z-step size. Alexa Fluor® 594
(mCherry) was detected using a He-Ne 543 laser line and Alexa Fluor® 647 (Fos)
was detected using a He-NE 633 laser line. In some instances, a Leica SP8 laser-
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scanning confocal microscope was used, but imaging parameters were similar.
Laser power, pinhole size, and gain was initially optimized and then held constant
for the remainder of the experiment.
In Experiment 2, FIJI (NIH) was used to quantify the extent of Fos
expression in acquired images. Un-deconvolved Z-stacks were exported to FIJI
and automatic thresholds were applied. In experiment 3, un-deconvolved confocal
Z-stacks (~35 μm) were exported to Imaris software (Bitplane, Zurich, Switzerland)
for analysis. First, background was subtracted from images. Next, the spots
module was used to identify mCherry+ soma and Fos+ nuclei. Spot-detection size
was held constant throughout the experiment. However, in instances where Imaris
did not detect clear mCherry+ soma or Fos+ nuclei, these were manually added.
Finally, the number of mCherry+ somas expressing Fos+ nuclei was normalized to
the total number of mCherry+ soma and compared between mCherry- and hM3Dqexpressing rats.
Tissue processing and Wes™ immunoassay
Tissue processing and the Wes™ immunoassay were performed in an identical
manner as in Chapter 2. However, in this experiment we observed subtle, albeit
significant, differences in the AUC of calnexin multi-plexed with p-ERK2 between
groups. Thus, p-ERK2 AUC was normalized to calnexin, which was then
normalized to the ratio of the AUC of tERK2/calnexin. Like Chapter 2, samples
were normalized to control.
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Statistical Analyses
All behavioral data were analyzed with a mixed-model two-way ANOVA utilizing
Bonferroni-corrected pairwise comparison tests when comparing two or more
timepoints between groups. When comparing several bins to the first bin for each
virus group independently, Dunnett’s multiple comparison test was used. Fos data
and neurochemical data were analyzed with a two-tailed t-test with or without
Welch’s correction when appropriate. Statistical outliers were detected using
Grubbs’ test (extreme studentized deviate method) and were excluded from all
analyses. All data are expressed as the mean +/- standard error of the mean
(SEM).
Results
Experiment 1. CNO increased p-ERK2 two hours after injection in naïve rats
Figure 3.1A shows the timeline for Experiment 1. Experiment 1 was designed to
determine whether acute activation of CaMKIIα-hM3Dq with CNO (3 mg/kg, i.p.)
increased ERK2 phosphorylation (p-ERK2) in the PrL cortex two hours after
injection, similar to the effect of BDNF (Whitfield et al., 2011) or STEP inhibition
(Chapter 2). Naïve rats (n=9) were either injected with CNO (n=5, 3 mg/kg, i.p.) or
vehicle (n=4, 5% DMSO in sterile saline) and rapidly decapitated two hours after
the injection. Using a Wes™-based immunoassay, results showed a significant
elevation in p-ERK2/tERK2 in hM3Dq rats injected with CNO relative to vehicle
(t(7)=2.38, p<0.05, Fig. 3.1B). There was no difference in tERK2/calnexin (t(7)=0.51,
p>0.05, Fig. 3.1C). Representative chemiluminescent peaks of p-ERK2 for CNO-
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injected animals (blue) and vehicle-injected animals (green) are shown in Figure
3.1D.

Figure 3.1. CNO (3 mg/kg, i.p.) acutely elevates p-ERK2 in CaMKIIα-hM3Dqexpressing rats. A. Experimental timeline. B. Naïve rats infused with AAV5CaMKIIα-hM3Dq injected with CNO (3 mg/kg, i.p.) show elevated ERK2
phosphorylation in the PrL cortex two hours after the injection relative to vehicleinjected controls. C. There was no difference in ERK2 between groups. D.
Representative chemiluminescent peaks for CNO-injected rats (blue) and vehicleinjected rats (green) *p<0.05 compared to vehicle.
Experiment 2. The effect of hM3Dq activation of the PrL cortex immediately
after SA on post-abstinence context-induced relapse, cue-, and cocaine
prime-, induced reinstatement after extinction
Of the initial 13 rats infused with the eGFP control virus, 3 were removed. One rat
was removed for significant virus expression in the IL cortex. One rat was removed
for lack of reinstatement in all three tests, and one rat never acquired SA. Of the
13 rats initially infused with hM3Dq virus, 3 were removed. One rat never acquired
SA, and two rats were removed for having significant virus expression in the IL
cortex. Figure 3.2A shows the experimental timeline for experiment 2.
Representative virus expression for CaMKIIα-hM3Dq-expressing rats is shown in
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Figure 3.2B. The quantitation of virus expression in three regions of the mPFC is
shown in Figure 3.2C. Figure 3.2D shows the last 10 days of SA for eGFP (blue)
and hM3Dq (black) rats. Active lever presses (ALP), inactive lever presses (ILP),
and infusions were analyzed with a mixed-model two-way ANOVA with virus as
the between-subjects factor and SA session as the within-subjects factor. For
active lever presses, analyses revealed there was no significant virus by SA
session interaction (F(9,162)=0.36, p>0.5), main effect of virus (F(1,18)=0.08, p>0.05),
nor a significant main effect of SA session (F(9,162)=0.58, p>0.05). Thus, there was
no difference between groups in active lever presses over the last 10 days of SA
and both groups showed stable responding on the active lever during this time.
For inactive lever presses, there was no significant virus by SA session interaction
(F(9,162)=0.58, p>0.05), main effect of virus (F(1,18)=0.74, p>0.05), or main effect of
SA session (F(9,162)=1.24, p>0.05). Thus, there was no difference between groups
regarding inactive lever presses. For infusions, there was no significant virus by
SA session interaction (F(9,162)=0.23, p>0.05), nor a main effect of virus
(F(1,18)=0.33, p>0.05). However, there was a main effect of SA session
(F(9,162)=4.98, p<0.0001). Thus, there was no difference between groups for
infusions earned over the last 10 days of SA, but both groups increased infusions
over time.

68

Figure 3.2. PrL cortical CaMKIIα-hM3Dq-mCherry virus expression quantitation
and SA data. A. Experimental timeline. B. Representative virus expression for
hM3Dq-expressing rats. C. Quantitation of the extent of virus expression in eGFP
(left) and hM3Dq (right) rats. The percentage of total virus expression (as shown
by fluorescent integrated density) is shown for Cg1 (grey), IL (red), and PrL (black)
cortex. D. SA data comparing active lever presses (ALP), inactive lever presses
(ILP), and infusions between groups over the last 10 days of SA.
hM3Dq activation of the PrL cortex immediately after SA did not suppress
context-induced relapse after abstinence
Immediately following the final SA session, all rats were injected with CNO (3
mg/kg, i.p.) and returned to the vivarium for one week of forced home-cage
abstinence. Rats then underwent a single two-hour post-abstinence contextinduced relapse test under extinction conditions. Figure 3.3A shows the results of
the post-abstinence relapse test. A mixed-model two-way ANOVA revealed there
was no significant virus by timepoint interaction (F(1,18)=2.70, p>0.05), nor a
significant main effect of virus (F(1,18)=3.99, p>0.05), but there was a significant
main effect of timepoint (F(1,18)=47.33, p<0.0001). Thus, there was no difference
between groups regarding active lever presses during both the last 3 days of SA
and the PA test. However, both groups showed elevated responding on the
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formerly active lever during the PA test relative to the last 3 days of SA. For inactive
lever presses, there was no significant virus by timepoint interaction (F (1,18)=0.17,
p>0.05), nor a significant main effect of virus (F(1,18)=0.22, p>0.05), but there was
a significant main effect of time (F(1,18)=35.81, p<0.0001). Thus, there was no
difference between groups regarding inactive lever presses during the last 3 days
of SA or during the PA test. However, both groups showed elevated responding
on the formerly inactive lever during the PA test relative to the last 3 days of SA.
Because the results revealed a trend towards reduced active lever pressing
in hM3Dq-expressing rats when the entire two-hour PA test data set was analyzed,
we performed a follow-up analysis investigating individual timepoints during the PA
test in 10-minute bins using a two-way RM ANOVA (Fig. 3.3B). There was no
significant virus by time point interaction (F(11,198)=1.49, p>0.05) nor a significant
main effect of virus (F(1,18)=3.67, p>0.05). However, there was a significant main
effect of time (F(11,198)=9.54, p<0.0001). Thus, akin to the entire two-hour test, there
was no significant difference between groups when examining individual
timepoints within the PA test, but both groups reduced their responding during the
PA test.
hM3Dq activation of the PrL cortex immediately after SA reduced active lever
pressing only during the first 10 minutes of cue-induced reinstatement
Following the PA test, rats underwent further extinction training until they reached
criterion, then underwent a cue-induced reinstatement test. Figure 3.3C shows the
results of the entire two hours of cue-induced reinstatement. For active lever
presses, a two-way mixed model ANOVA revealed that there was no significant
virus by time point interaction (F(1,18)=1.53, p>0.05), nor a significant main effect of
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virus (F(1,18)=1.58, p>0.05). However, there was a significant main effect of time
(F(1,18)=78.14, p<0.0001). Thus, there was no overall effect of hM3Dq activation of
the PrL cortex immediately after SA on cue-induced reinstatement. However, both
groups increased their responding on the formerly active lever during cue-induced
reinstatement relative to the last 3 days of SA, as expected. For inactive lever
presses, there was no significant virus by timepoint interaction (F(1,18)=0.1, p>0.05)
nor a significant main effect of virus (F(1,18)=0.01, p>0.05). However, there was a
significant main effect of time (F(1,18)=6.09, p<0.05). Thus, there was no difference
between groups during the last 3 days of extinction or during the entire two-hour
duration of the cue-induced reinstatement test. However, both groups showed
elevated active and inactive lever pressing during reinstatement relative to the last
3 days of extinction.
As in the PA test, we also analyzed individual 10-minute bins during the
cue-induced reinstatement test using a two-way RM ANOVA, as shown in Figure
3.3D. In contrast to the PA test, a two-way ANOVA revealed a significant virus by
timepoint interaction (F(11,198)=2.01, p<0.05). There was also a significant main
effect of timepoint (F(11,198)=3.86, p<0.0001), but no significant main effect of virus
(F(1,18)=0.57, p>0.05). Bonferroni-corrected pairwise comparison tests indicated
that hM3Dq rats had significantly lower active lever presses during the first 10
minutes of cue-induced reinstatement relative to eGFP rats (p<0.05). Moreover,
when comparing each 10-minute bin to the first 10-minute bin in eGFP rats with a
Dunnett’s multiple comparison test, each timepoint was significantly lower than the
first 10 minutes (all p<0.05), except when comparing 20-30 minutes to 0-10
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minutes (p>0.05). However, when comparing each 10-minute bin to the first 10minute bin in hM3Dq rats, there was no timepoint that was significantly different
from the first 10-minute bin. Thus, there was no significant difference between
groups when analyzing active or inactive lever presses during the entire two-hour
reinstatement test. However, hM3Dq activation of the PrL cortex immediately after
SA suppressed active lever pressing during the first 10 minutes of reinstatement,
when lever pressing was highest in eGFP rats.
hM3Dq activation of the PrL cortex immediately after SA did not suppress
cocaine prime-induced reinstatement after extinction
Following the cue-induced reinstatement test, rats were re-extinguished until
criterion. Rats then underwent a two-hour cocaine prime-induced reinstatement
test under extinction conditions (Fig. 3.3E). When analyzing active lever presses,
a two-way mixed model ANOVA revealed that there was no significant virus by
timepoint interaction (F(1,18)=0.54, p>0.05), nor a significant main effect of virus
(F(1,18)=1.39, p>0.05). However, there was a significant main effect of time
(F(1,18)=103.8, p<0.0001). For inactive lever presses, there was no significant virus
by timepoint interaction (F(1,18)=0.21, p>0.05), main effect of virus (F(1,18)=2.08,
p>0.05), or main effect of time (F(1,18)=0.02, p>0.05). Thus, there was no effect of
hM3Dq activation of the PrL cortex immediately after SA on active or inactive lever
presses during the entire two-hour cocaine prime-induced reinstatement following
extinction.
As for the PA test and cue-induced reinstatement test, we also extended
this analysis to the individual 10-minute bins within the cocaine prime-induced
reinstatement test (Fig. 3.3F). A two-way RM ANOVA revealed that there was no
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significant virus by timepoint interaction (F(11,198)=0.57, p>0.05), nor a significant
main effect of virus (F(1,18)=1.0, p>0.05). However, there was a significant main
effect of time (F(11,198)=15.74, p<0.0001). Thus, there was no difference between
groups regarding active lever pressing during individual timepoints within the
cocaine prime-induced reinstatement test, and both groups showed reduced active
lever pressing during cocaine prime-induced reinstatement.
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Figure 3.3. Global chemogenetic activation of PrL cortical neurons immediately
after SA is without an overall effect on post-abstinence context-induced relapse
and cue- and cocaine prime- induced reinstatement after extinction during the twohour tests but did selectively reduce lever pressing during the first 10 minutes of
cue-induced reinstatement. A. hM3Dq-mediated activation of the PrL cortex
immediately after SA failed to suppress post-abstinence context-induced relapse
after abstinence. B. There was no effect of hM3Dq activation immediately after SA
at any timepoint analyzed during the PA test. C. There was also no effect of hM3Dq
activation of the PrL cortex on cue-induced reinstatement after extinction when
analyzing the entire two-hour session. D. There was a specific reduction in lever
pressing during the first 10 minutes of cue-induced reinstatement when lever
pressing was highest in eGFP control rats. E. There was no effect of hM3Dq
activation on cocaine prime-induced reinstatement. F. There was no effect of
hM3Dq activation immediately after SA at any timepoint analyzed during the
cocaine prime-induced reinstatement test. White bars indicate inactive lever
presses, and colored bars indicate active lever presses. ****p<0.0001 compared
to last 3 days of SA (ALP), +p<0.05, ++++p<0.0001 compared to last 3 days of SA
(ILP), ^p<0.05 compared to eGFP, @p<0.05 compared to first 10-minute bin.
CNO increased Fos expression in the PrL cortex of hM3Dq rats
Following the cocaine prime-induced reinstatement test, all rats were returned to
the vivarium for ~one week. A subset of rats was then given a challenge injection
of CNO (3 mg/kg, i.p.) and transcardially perfused two hours later for Fos analysis
(Fig. 3.4). A Welch’s-corrected t-test showed that hM3Dq-expressing rats showed
robust Fos activation relative to eGFP controls (t(6.05)=2.92, p<0.05, Fig. 3.4A).
Representative Fos induction is shown for eGFP- (Fig. 3.4B), and hM3Dqexpressing (Fig. 3.4C) rats.
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Figure 3.4. Post-experiment CNO challenge increased Fos immunoreactivity in
hM3Dq-expressing rats. A. Fos+ cells were significantly higher in hM3Dq rats
relative to eGFP controls two hours after CNO injection. B. Representative Fos
(red) immunoreactivity in eGFP rats. C. Representative Fos immunoreactivity in
hM3Dq rats. *p<0.05 compared to eGFP.
Experiment 3. The effect of hM3Dq activation of PrL cortical neurons
projecting to the NAc core immediately after SA on post-abstinence contextinduced relapse, cue-, and cocaine prime-, induced reinstatement after
extinction
Of the 16 mCherry rats, 4 were removed. One rat was removed for lack of SA
acquisition, one rat was removed as a statistical outlier during cue-induced
reinstatement, and two rats were removed for virus expression outside of the PrL
cortex. Of the 16 hM3Dq rats, 5 were removed. Three rats were removed for
significant virus expression outside of the PrL cortex. One rat never acquired SA,
and one rat became ill and was removed from the study. Figure 3.5A shows the
experimental timeline including surgery, behavioral experiments, time of CNO
injections as well as post-experiment CNO-induced Fos quantitation in mCherryand hM3Dq-expressing rats. Figure 3.5B shows a schematic for dual-viral
injections which result in preferential infection of PrL cortical neurons projecting to
the NAc core. Figure 3.5C shows representative Cre-dependent expression of the
mCherry tag in the hM3Dq construct. Note that virus expression was largely
confined to the PrL cortex, particularly layer V. Figure 3.5D shows representative
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CAV2-Cre-eGFP expression in the NAc core. Figure 3.5E shows SA data for
mCherry and hM3Dq rats. For statistical purposes, only the last 10 days of SA are
shown. However, all rats received a minimum of 10 days and a maximum of 14
days of SA.
For active lever presses, a two-way RM ANOVA showed no significant virus
by SA session interaction (F(9,189) = 0.8266, p>0.05) nor significant main effects of
SA session (F(9,189)=0.8858, p>0.05) or virus (F(1,21)=1.51, p>0.05). For inactive
lever presses, there was no significant virus by SA session interaction
(F(9,189)=1.35, p>0.05) or main effect of virus (F(1,21)=1.78, p>0.05). However, there
was a significant main effect of time (F(9,189)=2.58, p<0.05). For infusions earned,
a two-way RM ANOVA showed no significant virus by SA session interaction
(F(9,189)=1.47, p>0.05) nor a significant main effect of SA session (F(9,189)=1.40,
p>0.05) or virus (F(1,21)=1.08, p>0.05). Collectively, these results indicate that there
was no difference between mCherry and hM3Dq rats regarding active lever
presses, inactive lever presses, or infusions over the last 10 days of SA.
Immediately following the last SA session, all rats received a single injection of
CNO (3 mg/kg, i.p.) and were then returned to the vivarium for one week of forced
abstinence.
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Figure 3.5. Experimental timeline, virus expression, and SA data for experiment
3. A. Experimental timeline. B. Schematic illustrating use of intersectional viral
approach for preferential infection of PrL-NAc core neurons. C. Representative
AAV5-hSyn-DIO-hM3Dq-mCherry expression in the PrL cortex. Note the majority
of virus expression is contained within the PrL cortex, specifically in layer V
neurons. D. Representative CAV2-Cre-eGFP expression in the NAc core. Circled
region denotes anterior commissure (ac), and dotted line indicates NAc core. Inset
corresponds to high-magnification view of boxed region. E. SA data for experiment
3 showing active lever presses (ALP), inactive lever presses (ILP), and infusions
for both groups over the last 10 days of SA.
hM3Dq activation of PrL-NAc core neurons reduced lever pressing only
during the first 10 minutes of post abstinence relapse testing
Figure 3.6A shows the average active lever presses for the last 3 days of SA (left)
for mCherry (blue) and hM3Dq-expressing (black) rats. A two-way mixed model
ANOVA indicated a non-significant virus by timepoint interaction (F(1,21)=0.58,
p>0.05), but significant main effects of virus (F(1,21)=4.78, p<0.05) and time
(F(1,21)=16.15, p<0.001). There was no significant virus by timepoint interaction
(F(1,21)=1.88, p>0.05) nor main effect of virus (F(1,21)=1.78, p>0.05) on inactive lever
presses. However, there was a main effect of time (F(1,21)=27.39, p<0.0001). Thus,
both groups showed elevated active and inactive lever pressing following one
week of forced abstinence, and hM3Dq rats showed reduced active lever pressing
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relative to mCherry controls. Bonferroni-corrected pairwise comparison tests
indicated that there was no difference between groups over the last 3 days of SA
(p>0.05), but there was a strong trend towards reduced active lever pressing
during the PA test in hM3Dq rats (p=0.08).
Because we found a strong trend towards reduced active lever pressing in
the overall two-hour PA test, we investigated individual timepoints within the PA
test by analyzing lever pressing during 10-minute bins. Figure 3.6B shows the
effect of hM3Dq activation immediately after SA on active lever pressing during
10-minute bins. A two-way RM ANOVA showed a significant virus by time
interaction (F(11,231)=2.03, p<0.05) as well as a significant main effect of time
(F(11,231)=11.55, p<0.0001), but not virus (F(1,21)=2.06, p>0.05). Bonferronicorrected multiple comparison tests indicated that hM3Dq rats showed reduced
active lever pressing during the first 10 minutes of the PA test (p<0.001) relative to
mCherry controls. Additional analyses comparing each timepoint to this first 10minute bin only in mCherry control rats indicated that the first 10 minutes of active
lever pressing were significantly higher relative to every other 10-minute bin
(p<0.01 0-10 vs. 10-20, p<0.001 0-10 vs. 20-30, p<0.0001 0-10 vs. 30-40 and
above). Interestingly, only 90-100 minutes was different than 0-10 minutes in
hM3Dq rats (p<0.05). Thus, hM3Dq activation of PrL-NAc core neurons
immediately after SA suppresses relapse during the first 10 minutes of testing,
when lever pressing is most-elevated in mCherry control rats.

78

hM3Dq activation of PrL-NAc core neurons failed to suppress cue-induced
reinstatement after extinction
Figure 3.6C shows the average last 3 days of extinction active lever pressing for
mCherry and hM3Dq rats as well as active and inactive lever pressing during cueinduced reinstatement. A two-way mixed model ANOVA indicated a non-significant
virus by time point interaction (F(1,21)=2.92, p>0.05) as well as a non-significant
main effect of virus (F(1,21)=3.14, p>0.05). However, there was a significant main
effect of timepoint (F(1,21)=102.9, p<0.0001). There was a no virus by time point
interaction (F(1,21)=0.23, p>0.05), main effect of treatment (F(1,21)=0.27, p>0.05), or
main effect of time (F(1,21)=1.54, p>0.05) on inactive lever presses. Thus, both
groups showed elevated active, but not inactive, lever pressing during cue-induced
reinstatement relative to the last 3 days of extinction but there was no difference
between groups on active lever presses during extinction or cue-induced
reinstatement.
When analyzing 10-minute bins (Fig. 3.6D), a two-way RM ANOVA
indicated no virus by time interaction (F(11,31)=1.054, p>0.05) or a main effect of
virus (F(1,21)=3.065, p>0.05). However, there was a significant main effect of time
(F(1,21)=3.283, p<0.001). Thus, both groups showed reduced active lever pressing
as a function of time during cue-induced reinstatement but there was no effect of
hM3Dq activation on any timepoint.
hM3Dq activation of PrL-NAc neurons after SA failed to suppress cocaine
prime-induced reinstatement after extinction
Figure 3.6E shows the average last 3 days of extinction (left) for mCherry and
hM3Dq rats. When analyzing active lever presses, a two-way mixed-model
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ANOVA revealed there was no significant virus by timepoint interaction
(F(1,21)=2.68, p>0.05), nor main effect of virus (F(1,21)=2.86, p>0.05). However, there
was a significant main effect of time (F(1,21)=37.86, p<0.0001). There was no
significant virus by timepoint interaction (F(1,21)=2.65, p>0.05), main effect of virus
(F(1,21)=0.91, p>0.05), or a main effect of time (F(1,21)=3.40, p>0.05) on inactive
lever presses. Thus, both groups showed elevated active, but not inactive, lever
pressing during cocaine prime-induced reinstatement relative to the last 3 days of
extinction, and hM3Dq activation was without an effect on cocaine prime-induced
reinstatement during the 2-hour test. Further analysis of individual 10-minute
binned data with a two-way RM ANOVA indicated that there was no significant
virus by time interaction (F(11,231)=0.849, p>0.05) or main effect of virus
(F(1,21)=2.893, p>0.05) but there was a significant main effect of time (F(11,231)=6.57,
p<0.0001). In this analysis, both hM3Dq-activated and control groups showed
reduced active lever pressing as a function of time during cocaine prime-induced
reinstatement but there was no effect of hM3Dq activation per se on active lever
pressing (Fig. 3.6F).
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Figure 3.6. Activation of PrL-NAc core neurons immediately after SA failed to
suppress post-abstinence context-induced relapse or cue- and cocaine primeinduced reinstatement after extinction during two-hour tests but did reduce lever
pressing selectively during the first 10 minutes of post-abstinence context-induced
relapse. A. PrL-NAc core activation immediately after SA had no effect on lever
pressing during two-hour post-abstinence relapse testing. B. PrL-NAc core
activation suppresses active lever pressing during the first 10 minutes of relapse
testing, when mCherry lever pressing was highest. C. PrL-NAc core activation was
without an effect during two-hour cue-induced reinstatement testing. D. There was
no effect of PrL-NAc core activation during any timepoint during cue-induced
reinstatement. E. There was no effect of PrL-NAc core activation on cocaine primeinduced reinstatement. F. There was no effect of PrL-NAc core activation during
any timepoint during cocaine prime-induced reinstatement. *** p<0.001, ****
p<0.0001 compared to last 3 days of SA or extinction (ALP), ++++ p<0.0001
compared to last 3 days of SA (ILP), ^^^ p<0.001 compared to mCherry, @ p<0.05,
@@ p<0.01, @@@ p<0.001, @@@@ p<0.0001 compared to first 10-minute bin.
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Post-experimental CNO challenge induced robust Fos expression in
mCherry neurons preferentially in hM3Dq rats
Approximately one week following the cocaine prime-induced reinstatement test,
a subset of rats received another single injection of CNO (3 mg/kg, i.p.) and were
perfused two hours later for Fos immunohistochemistry. Figure 3.7A shows that
CNO induced robust Fos activation in mCherry neurons in hM3Dq rats relative to
mCherry as shown by Welch’s-corrected t-test (t(10.69)=13.83, p<0.0001).
Representative Fos immunoreactivity in mCherry rats is shown in Figure 3.7B.
Representative Fos immunoreactivity in hM3Dq rats is shown in Figure 3.7C.

Figure 3.7. Post-experiment CNO challenge increased Fos immunoreactivity in
mCherry+ neurons preferentially in hM3Dq-rats. A. Approximately 75% of
mCherry+ neurons showed robust Fos immunoreactivity in hM3Dq-expressing rats
compared to mCherry controls. B. Representative Fos immunoreactivity in
mCherry control rats. C. Representative Fos immunoreactivity in hM3Dqexpressing rats. Blue arrow: Fos+mCherry- soma. White arrow: Fos+mCherry+
soma. ****p<0.0001 compared to mCherry.
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Discussion
Summary of findings
Here we provide data showing an overall lack of support for the hypothesis that
augmenting PrL cortical, and specifically PrL-NAc core, neuronal activity during
early withdrawal is sufficient to suppress relapse after abstinence. Although we
found that hM3Dq activation increased p-ERK2 two hours after injection in naïve
rats (Experiment 1), we did not find an overall behavioral effect of hM3Dq activation
of the PrL cortex (Experiment 2), or PrL-NAc core neurons (Experiment 3),
immediately after SA. However, we did observe several trends when overall twohour testing was analyzed. Subsequent analyses of the within-session
timecourses indicated that activation of all PrL cortical outputs immediately after
SA transiently suppressed cue-induced reinstatement after extinction (i.e. first 10
minutes) when control lever pressing was highest. However, we did not see such
an effect during post-abstinence context-induced relapse or cocaine primeinduced reinstatement after extinction. Moreover, when specifically activating PrLNAc core neurons immediately after SA, there was a transient inhibition of cocaine
seeking during the post-abstinence context-induced relapse test, but not during
cue- or cocaine prime-induced reinstatement after extinction, again, when control
lever pressing was invigorated.
Relevance of early timepoints in relapse testing
Although our previous experiments have typically examined data during the entire
two-hour test (Whitfield et al., 2011; Barry and McGinty, 2017), there is precedent
for examining early portions of relapse testing. Although context-induced
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reinstatement after extinction and context-induced relapse after abstinence are
mediated by distinct brain regions (Fuchs et al., 2006), the cocaine-conditioned
context represents a shared stimulus which elicits cocaine seeking. Context
(Stankeviciute et al., 2014)- and cue (Gipson et al., 2013)-induced reinstatement
potentiate dendritic spine head diameter, which tightly correlates with lever
pressing behavior, in NAc core medium spiny neurons (MSNs) during the first 15
minutes of reinstatement. During cue-induced reinstatement, this transient
synaptic potentiation is associated with an augmented AMPA:NMDA ratio and is
dependent on glutamate release from the PrL cortex, which likely holds true for
context-induced reinstatement. Moreover, after 45 minutes of reinstatement, spine
head size and AMPA:NMDA ratios normalize. At this time lever pressing is
diminished, presumably due to within-session extinction learning.
Although we did not see any significant differences when examining overall
lever pressing during the two-hour session, the finding that lever pressing was
suppressed during early parts of post-abstinence context-induced relapse
(Experiment 3) and cue-induced reinstatement (Experiment 2) is likely an
important, albeit subtle, effect of hM3Dq activation of PrL cortex, and PrL-NAc
core, immediately after SA. Moreover, the overall lack of effect suggests that there
are distinct mechanisms in the suppressive effect of BDNF relative to hM3Dq,
which could be due to differential signaling and duration of effects induced by these
two interventions.
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BDNF-TrkB signaling vs. Gq-DREADD signaling: Similarities and differences
Previous data indicate that intra-PrL BDNF suppresses cocaine seeking by
normalizing glutamate transmission in the PrL cortex during early withdrawal,
leading to a long-term stabilization of glutamate release in the NAc core (Berglind
et al., 2007; Berglind et al., 2009; Go et al., 2016). Moreover, there is evidence
that intra-PrL BDNF alters neuronal signaling in the NAc core as early as two hours
after the infusion (Berglind et al., 2007; Sun et al., 2014a). BDNF is typically
recognized as a neurotrophic factor that induces neuronal activity by linking TrkB
activation with NMDA receptor tyrosine phosphorylation and glutamate release
(Huang and McNamara, 2010; Zhang et al., 2013). Ultimately, this facilitates
CREB-mediated gene transcription (Mao et al., 2015) via ERK-MAPK signaling
(Tao et al., 1998).
However, there is also a clear role for BDNF acting in a homeostatic manner
depending on the activity state of neurons (Rutherford et al., 1998). At the synaptic
level, it has been suggested that BDNF may preferentially alter transmission
differentially at individual synapses depending on the state of potentiation or
depression at these synapses (Nagappan and Lu, 2005). This may be critical for
the sustained induction of ERK activity. For example, sequential stimulation of only
seven spatially-dispersed dendritic spines by glutamate uncaging in vitro is
sufficient to induce sustained ERK, and ultimately CREB, activation in the nucleus,
effects largely due to NMDA receptor-mediated elevations in intracellular Ca2+
(Zhai et al., 2013).

In contrast, DREADDs are thought to integrate with

endogenous Gq-coupled signaling cascades (Alexander et al., 2009), presumably
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lacking specificity regarding the spatial location of their mode of action, specifically
at sites of internal Ca2+ stores. This is important considering the functional
heterogeneity that exits between various internal Ca2+ stores (Blaustein and
Golovina, 2001). Thus, DREADDs are likely promiscuous regarding their
engagement of Gq-coupled signaling cascades to induce neuronal firing.
Interestingly, muscarinic type-1 acetylcholine receptor activation facilitates
the activation of STEP through the release of Ca2+ from intracellular stores (Tian
et al., 2016), opposing the Src-mediated phosphorylation of GluN2A-containing
NMDA receptors. Thus, the activation of Gq-coupled DREADDs with CNO may
induce STEP activation, which would likely be dependent on the dose of CNO
used. However, because we found elevated p-ERK2 two hours after CNO (3
mg/kg, i.p.) injection in naïve rats, and because STEP is a major regulator of the
magnitude of ERK signaling (Paul et al., 2003), it is unlikely that the dose of CNO
used in our experiments activates STEP two hours after injection.
Furthermore, BDNF super-activates (i.e. above and beyond baseline) ERK
signaling in the PrL cortex during early withdrawal (Whitfield et al., 2011; Barry and
McGinty, 2017), driving CREB phosphorylation and presumably CREB-mediated
gene transcription of plasticity-regulating genes (Whitfield et al., 2011). Although
we did not test whether hM3Dq activation is able to normalize the cocaine-induced
dephosphorylation of ERK2 or CREB in the PrL cortex during early withdrawal, we
hypothesize that hM3Dq activation likely does not elevate ERK2 or CREB
phosphorylation to the same degree as BDNF. Moreover, BDNF leads to sustained
ERK2 phosphorylation with maximal effects seen at two hours, returning to
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baseline by six hours, but CREB phosphorylation remains elevated six hours after
a single BDNF infusion in naïve rats (Whitfield et al., 2011). Previous experiments
have shown that treatment of striatal cultures with high concentrations of CNO (50
μM) only transiently activates ERK2 phosphorylation, which returns to baseline
levels two hours after treatment (Bellocchio et al., 2016). Moreover, activation of
striatal projection neurons in mice with CNO (1 mg/kg, i.p.) elevates pERK within
30 minutes which returns to baseline by 140 minutes (Alcacer et al., 2017). One
caveat of the latter finding was that this experiment was performed in dopamine
denervated mice. These findings are consistent with the hypothesis that hM3Dq
activation may not elevate ERK2 and CREB phosphorylation in the PrL cortex for
the entire two hours after the end of cocaine SA due to the transient effects of
CNO.
BDNF-TrkB signaling elevates ERK-MAPK signaling not only through
autophosphorylation of TrkB (Atwal et al., 2000), but also by BDNF-TrkB-GluN2Bmediated activation of ERK (Krapivinsky et al., 2003). Moreover, blockade of
NMDA receptors prior to BDNF prevents the suppressive effect of BDNF as well
as BDNF-mediated elevations in ERK2 phosphorylation in the PrL cortex during
early withdrawal (Go et al., 2016). These findings suggest that the activation of
ERK by BDNF is dependent on the source of Ras-MAPK activity (i.e. downstream
of TrkB or directly at the level of TrkB). Such fine-tuned regulation of ERK signaling
likely does not occur with hM3Dq activation, as previous findings indicate that GqDREADDs activate ERK exclusively through a PKC-dependent mechanism, at
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least in vitro (Kaufmann et al., 2013), and there is no evidence for NMDA-induced
elevations in Ca2+ following hM3Dq activation.
Considerations for experimental approach
Recent evidence indicates that CNO is back-metabolized to clozapine, which is
the direct agonist for DREADD receptors (Gomez et al., 2017). Clozapine shows
high-affinity for dopamine D2 receptors, α adrenergic receptors, as well as several
serotonin receptor subtypes. Specifically, acute treatment with clozapine (10
mg/kg, i.p.) reduces binding affinity of the 5-HT2A serotonin receptor (Wilmot and
Szczepanik, 1989). Moreover, a subthreshold dose of clozapine (0.1 mg/kg, i.p.)
alters striatal-dependent locomotor activity in hM4Di-expressing mice, which is
comparable in magnitude to 10 mg/kg, i.p. CNO (Gomez et al., 2017). Thus, we
cannot exclude the effects of clozapine in our experiments. However, because all
animals were injected with CNO at a relatively low dose (3 mg/kg, i.p.), which did
not affect the ability of control animals to reinstate, we suggest that off-target
effects of clozapine are likely not present. Thus, any effect (or lack thereof) is likely
due to clozapine binding to DREADD receptors as opposed to the welldocumented actions of clozapine at various other receptors when delivered acutely
(Wilmot and Szczepanik, 1989). Moreover, others have suggested that 10 mg/kg,
i.p. CNO may be required for sustained activity of DREADD receptors over a twohour window (Mahler and Aston-Jones, 2018). Because 0.1 mg/kg clozapine is a
subthreshold dose for altering behavior in animals that do not express DREADDs,
and is equivalent, at least behaviorally, to 10 mg/kg CNO in animals expressing
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DREADDs, a 10 mg/kg dose of CNO or 0.1 mg/kg dose of clozapine may provide
a more pronounced effect of DREADD receptor activation in our paradigm.
Summary, conclusions, and future directions
In conclusion, the results presented herein do not support the hypothesis that
augmented PrL cortical or PrL-NAc core neuronal activity during early withdrawal
is sufficient to suppress cocaine seeking after abstinence. However, we found
discrete timepoints in the post-abstinence context-induced relapse test as well as
cue-induced reinstatement when hM3Dq was effective, particularly when control
lever pressing was elevated. Although it is unknown at exactly what point PrL
cortical ERK2 phosphorylation normalizes in cocaine self-administering animals, it
is likely that BDNF provides an enduring normalization during the critical early
withdrawal period. However, we hypothesize that hM3Dq activation transiently
elevates neuronal activity in the PrL-NAc core pathway during early withdrawal,
culminating in a transient reversal of ERK2 dephosphorylation which is not
sustained during the entire timecourse of early withdrawal from cocaine SA. This
normalization is likely more transient and not as strong as BDNF, and does not
prevent STEP activation as is the case of TC-2153 according to data presented in
Chapter two (Fig. 3.8A). We propose that this ultimately leads to a transient
attenuation of stimulus-induced drug seeking relative to BDNF or STEP inhibition
with TC-2153 (Fig. 3.8B), which is differentially regulated by activating the PrL
cortex or specifically activating the PrL-NAc core pathway. Accordingly, future
experiments should determine whether hM3Dq activation is sufficient to normalize
the cocaine-induced dephosphorylation of ERK2 in the PrL cortex during early
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withdrawal, as well as glutamate release in the NAc core after extinction, as
previously found for BDNF (Berglind et al., 2009; Whitfield et al., 2011).
Additionally, future studies should examine dose-dependent effects of clozapine
or CNO on relapse to cocaine seeking.

Figure 3.8. Comparison between hM3Dq activation, STEP inhibition, and BDNF
on ERK activation during early withdrawal and subsequent lever pressing during
relapse testing. A. Schematic illustrating the hypothesized temporal difference in
modulation of the cocaine-induced ERK dephosphorylation in the PrL cortex during
early withdrawal between BDNF, TC-2153, and hM3Dq activation. The horizontal
dotted line indicates baseline ERK activity, whereas the vertical dotted lines
indicates timepoint of maximal or minimal ERK activity. B. Schematic illustrating
the hypothesized behavioral consequences of BDNF, TC-2153, and hM3Dq during
early withdrawal on relapse testing after abstinence or extinction.
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Chapter 4: Biphasic effect of abstinence duration
following cocaine SA on corticostriatal structural
plasticity and AMPA receptor expression in dendritic
spines
Introduction
In contrast to depressed glutamatergic neurotransmission in the PrL cortex during
early withdrawal, after one week of abstinence from cocaine SA, hyperphosphorylation of the PKA targets, CREBS133 and GluA1S845, in the PrL cortex
and synapsin-1S9 in the NAc core emerge (Sun et al., 2014b; Sun et al., 2014a).
Inhibition

of

PKA

with

intra-PrL

Rp-cAMPs

normalizes

these

hyper-

phosphorylation events and prevents context-induced relapse to cocaine seeking
under extinction conditions (Sun et al., 2014b). GluA1S845 phosphorylation by PKA
enhances glutamate currents by promoting membrane insertion of AMPA
receptors (Banke et al., 2000). Further, learning promotes incorporation of GluA1containing AMPA receptors in large, mushroom-type dendritic spines (Matsuo et
al., 2008). In addition, mushroom-type spines, relative to smaller, less stable
spines, show an augmented AMPA receptor-mediated excitatory current in
response to glutamate uncaging (Matsuzaki et al., 2001). Thus, cocaine-induced
adaptations in glutamate transmission are likely associated with altered dendritic
spine morphology and AMPA receptor expression. However, it is unknown how
the signaling events occurring in the PrL cortex during these stages of early
withdrawal and abstinence translate into alterations in spine morphology and/or
density, changes that have been linked to relapse propensity (Russo et al., 2010;
Gipson et al., 2013).
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Although cocaine-induced alterations in structural plasticity within the NAc
core are well-documented (Gipson et al., 2013; Stefanik et al., 2016), conflicting
reports have appeared about modifications in structural plasticity in PrL pyramidal
neurons after the end of cocaine SA. The earliest report, based on Golgi staining,
indicated that cocaine SA followed by one month of abstinence increased layer V
apical spine density (Robinson et al., 2001). More recently, it was reported (also
with Golgi staining) that synaptic density was significantly reduced, but the density
of thin dendritic spines was significantly increased, on layer V pyramidal neurons
in the PrL cortex after one week of abstinence (Rasakham et al., 2014). In contrast,
using intracellular dye filling, cocaine SA followed by two weeks of abstinence
reduced layer II/III distal apical spine density, but remaining spines showed
augmented volume (Radley et al., 2015). Thus, changes in structural plasticity in
the PrL cortex after cocaine SA may depend on the type of pyramidal neurons
analyzed, the duration of cocaine abstinence, and the technological strategy used
to reveal dendritic spine morphology.
Various techniques have been used to visualize dendritic spine morphology
including Golgi-Cox staining, lipophilic dye (i.e. DiI) labeling, intracellular dye filling
(i.e. lucifer yellow iontophoresis), or transgenic animals expressing YFP driven by
cell-type specific promoters (i.e. thy1 promoter-driven YFP transgenic mice).
Although Golgi staining provides sparse and complete labeling of deep-layer
pyramidal neuron dendritic arbors, it severely underestimates the density of thin
spines (Shen et al., 2008). In contrast, lipophilic dyes such as DiI provide sparse
and intense labeling of pyramidal neuronal somas but minimize visualization of the
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long apical dendrites of deep-layer pyramidal neurons (Trantham-Davidson et al.,
2017). Moreover, intracellular dye filling with fluorescent dyes such as Lucifer
Yellow allows for investigator-controlled labeling of neurons, but inconsistently
labels apical dendritic arbors of deep-layer pyramidal neurons in the PFC (Radley
et al., 2015). Finally, thy1-YFP transgenic mice have been used extensively for
dendritic spine morphometric analyses (Keifer et al., 2015; Swanson et al., 2017).
However, their utility is generally restricted to experiments involving mice because
only one study has described the use of thy1-YFP rats (Magill et al., 2010).
A recent experiment found that intersectional viral approaches using a cell
type-specific promoter expressing Cre recombinase in D1 receptor-expressing
MSNs in the striatum in conjunction with Cre-dependent fluorescent reporters can
be used to label dendritic spines (Dos Santos et al., 2017). In parallel, we recently
found that an intersectional viral approach can be used to fully label the dendritic
trees of deep-layer pyramidal neurons in the PrL cortex with pathway specificity.
Moreover, this approach can be combined with immunohistochemical detection of
various proteins of interest in different dendritic subcompartments, allowing for a
high-throughput analysis of dendritic spine morphology and associated protein
expression in spines of PrL cortical neurons projecting to the NAc core. In the
current experiment, we focused our attention specifically on the distal apical tuft of
layer V neurons in part because chronic stress produces a selective reduction in
distal apical tuft dendrite length as well as spine density in layer V PrL cortical
neurons (Liu and Aghajanian, 2008). Additionally, recent evidence indicates a
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relationship between abstinence from cocaine SA, stress, and prefrontal pyramidal
neuron apical tuft regressive structural plasticity (Radley et al., 2015).
Because PrL cortical glutamatergic transmission switches from a putatively
hypoactive to a hyperactive state as a function of abstinence duration from cocaine
(Sepulveda-Orengo et al., 2017; Dennis et al., 2018), we hypothesized that activity
markers and dendritic spine morphometric features would follow a similar trajectory
in PrL-NAc neurons because this pathway is highly implicated in pathological
adaptations that promote cocaine seeking (Kalivas et al., 2005). Here we show
that cocaine SA causes a biphasic alteration in nuclear markers of neuronal activity
(Fos, p-CREB), structural plasticity, as well as AMPA receptor immunoreactivity in
dendritic spines of PrL-NAc core neurons after two hours of withdrawal or one
week of abstinence, changes which are likely important for subsequent relapse to
cocaine seeking.
Materials and Methods
Animal subjects
Thirty-two adult male Sprague Dawley rats were used in this study (Charles Rivers
Laboratories; Wilmington, MA). Rats were acclimated to the vivarium and catheter
surgery was performed identical to methods in Chapters 2 and 3. Following
catheterization, rats were secured in a stereotaxic apparatus (Kopf Instruments,
Tujunga, CA) for intra-cranial virus microinjections.
Viral constructs and stereotaxic surgery
All viral procedures and constructs used in this study were approved by the
Medical University of South Carolina Institutional Biosafety Committee. All rats
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received a single microinjection (0.75 µl/hemisphere) of a canine adeno virus type
2 expressing a Cre-eGFP (CAV2-Cre-eGFP) fusion protein under the control of a
CMV promoter (3.6x1012 vg/ml) (gift of E. Kremer, Montpellier Molecular Genetic
Institute Vector Core, Montpellier, FR) within the NAc core (coordinates: +1.6 mm
AP from bregma, +/- 2.8 mm ML from bregma, -7.1 mm DV from skull, 10º angle).
Rats were then microinjected within the PrL cortex (coordinates: +2.8 mm AP from
bregma, +/- 0.6 mm from bregma, -3.8 DV from skull) with an AAV5-hSyn-DIOmCherry (~1.5X1012 vg/ml) obtained from Addgene (Cambridge, MA). Injections
were performed over a period of 5 minutes (0.15 µl/minute) using a Nanoject II
(Drummond scientific, Broomall, PA) and injectors were left in place for 10 minutes
to facilitate diffusion away from the injection site, then slowly retracted. Following
surgery, bore holes were sealed with dental acrylic, and the incision was sutured
closed. Rats were allowed at least 5 days of recovery, during which food and water
were available ad libitum prior to beginning behavioral training.
Self-administration
SA procedures, including use of yoked saline controls, were conducted in an
identical manner to those in Chapter 2.
Abstinence and perfusions
In Experiment 1, rats were returned to their homecage for two hours after the final
cocaine SA session, heavily anesthetized with equithesin (~0.5 ml, i.v.), and
transcardially perfused with 150 ml of ice-cold 0.1M phosphate buffer (PB) at 60
ml/minute followed by 200 ml of ice-cold 4% paraformaldehyde (PFA, pH 7.4) in
0.1M PB. Brains were rapidly removed and immersed in the same fixative for 1
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hour, then transferred to a 20% sucrose solution prior to sectioning. In Experiment
2, rats were perfused one week after the final cocaine SA session following forced
homecage abstinence where food and water were provided ad libitum, and brains
were post-fixed for 24 hours. To match virus expression duration between
experiments, rats in Experiment 1 were given an extra week of recovery after
surgery prior to beginning SA.
Immunohistochemistry
Coronal sections (AP +2.52-4.2 mm from bregma) were sliced at 80 µm using a
Leica cryostat and collected in 0.1M PBS containing 0.01% sodium azide. Sections
were stored at 4ºC until immunohistochemical processing. Immunohistochemistry
was performed according to previously published protocols (Scofield et al., 2016b).
Briefly, sections were blocked with 0.1M phosphate-buffered saline containing 2%
Triton X-100 (PBST) and 2% normal goat serum (NGS) for two hours at RT
protected from light. Sections were then incubated in chicken anti-mCherry
(1:2000; LS Biosciences #LS-C204825, Seattle, WA RRID:AB_2716246), mouse
anti-GluR2 (2.13 ug/ml; Millipore #MAB397, Billerica, MA RRID:AB_2113875),
rabbit anti-GluA1 (1:500; Cell Signaling Technology #13185, Danvers, MA), rabbit
anti-cFos

(1:1000,

Santa

Cruz

Biotechnology

#sc-52,

Dallas,

TX

RRID:AB_2106783), or mouse anti-p-CREB (1:200, Cell Signaling Technology,
#9196, Danvers, MA RRID:AB_331275) at 4ºC overnight. Sections were washed
3 X 10 minutes in PBST, and then incubated with species-appropriate Alexa
Fluor®594 (mCherry), Alexa Fluor®488 (Fos, p-CREB), or Alexa Fluor®647 (GluA1,
GluA2)-conjugated secondary antisera (1:1000, Abcam, Cambridge, UK) diluted
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in 2% PBST with 2% NGS for 5 hours at room temperature (RT) protected from
light. Sections were washed 3 X 10 minutes and then mounted on superfrost plus
slides using ProLong® gold Antifade (Thermo Fisher Scientific; Waltham, MA).
Slides were stored at 4ºC until imaging.
Confocal microscopy
Fos/p-CREB quantitation. Confocal Z-stack (50 µm) images were captured with
a Leica SP8 confocal microscope. Fos or p-CREB immunoreactivity (IR) was
excited using an Optically Pumped Semiconductor Laser (OPSL) 488 nm line
using a 20X air objective. mCherry IR was excited using an OPSL 552 nm laser
line. Z-stacks were then imported to Imaris. The spot tool in Imaris was used and
detection threshold and spot size were empirically determined and maintained
constant for each measurement. The number of p-CREB-IR or Fos-IR cells was
counted automatically for each hemisphere and averaged across 1 section per rat.
The spots colocalization extension in Imaris was used to determine coregistry
between mCherry+ and Fos/p-CREB+ somas. The number of mCherry-IR neurons
that were p-CREB or Fos-IR was normalized to the number of total mCherry-IR
neurons.
Dendritic Spine Imaging. Confocal Z-series data sets were acquired using a
Leica SP8 laser-scanning confocal microscope. Dendrites selected for imaging
had the following characteristics: the apical dendritic segment was 1) visually
connected to the cell body of origin, 2) after the third branch point, 3) >15 μm below
the surface of the tissue, and 4) located within 10 µm of the end of the dendrite
(i.e. approaching the pial surface). Overall imaging parameters including laser
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power, gain, pinhole, and optical section thickness were set empirically prior to
imaging and were held constant for the remainder of the experiment. mCherry was
excited using an OPSL 552 nm laser line, and GluA1/2 were excited using a Diode
638 nm laser line. Emitted photons were collected using high-sensitivity hybrid
detectors (HyD). Images were acquired with a 1024x512 frame size, 3.5X digital
zoom, and 0.1 um step size generating a voxel size of 52nm X 52nm X 100nm.
Images were acquired using sub-airy unit pinhole sizes. These parameters were
selected to obtain optimal deconvolution as recommended by Huygens essential
deconvolution software (Hilversum, NL). The resulting set of parameters allows for
a minimum resolution of 150nm XY by 300nm Z in our reconstructions. Four to
twelve dendritic spine segments were analyzed per animal, each with an
accompanying GluA1 or GluA2 channel collected.
Imaris 3D reconstruction, morphological analyses, and colocalization
Following deconvolution, Z-stacks were imported into BitPlane Imaris (version 9.0)
for morphological analyses. Z-stacks were cropped in 3D to isolate individual
dendrites, and a 3D space-filling model was generated to isolate voxels
corresponding to the mCherry-positive dendrite of interest. The filament module
was used to semi-manually trace identified dendritic spines as described
previously (Trantham-Davidson et al., 2017). Dendritic spine head diameter was
calculated using an automated threshold set by Imaris. To calculate dendritic spine
density, the number of spines was normalized to the length of the dendrite (in µm).
Segments were typically 40-50 μm in length.
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The “create channel” filament extension was used to generate a channel
defined by the filament built by Imaris, which was used for colocalization analyses.
To isolate GluA1/2-IR corresponding to dendritic spine heads relative to total
dendrite, the “filament analysis” extension was used to mask all GluA1/2-IR not
corresponding to Imaris-defined dendritic spine heads and shafts. Filament
analysis uses the predefined boundaries of the spine heads relative to the dendritic
shaft to isolate specific channels of interest in dendritic subcompartments.
For colocalization analyses, a region of interest (ROI) containing only the
mCherry dendrite was used. The colocalization module of Imaris was used to
perform standard intensity-based colocalization analyses between total mCherry
signal and total GluA1/2 signal (dendrite shaft and spine heads). The intensity
value at which a voxel could be considered coregistered was set empirically by a
blinded investigator for both channels as described previously (Scofield et al.,
2016b). We recorded the percent of signal above threshold to determine whether
differences in the intensity of signal impacted coregistry analyses for GluA1,
GluA2, and mCherry. Percent colocalization was calculated by normalizing the
total volume of GluA1/2-mCherry coregistry to the total volume of mCherry. The
total colocalization channel was then separated into Imaris-defined spine heads
and dendritic shaft using the “filament analysis” extension, and a 3D space-filling
model was generated corresponding to colocalized voxels for a) spine headspecific colocalization and b) dendritic shaft-specific colocalization. Electron
microscopy studies indicate that a significant amount of GluA2 expression is
present in both dendritic shafts and spine heads (Vissavajjhala et al., 1996) and in
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vitro experiments indicate similar patterns for GluA1 (Szepesi et al., 2014). Thus,
percent colocalization was determined for total GluA1/2, spine head-specific
GluA1/2, and dendritic shaft-specific GluA1/2 by normalizing the volume of
colocalized voxels in each compartment to the volume of the mCherry dendrite. To
determine specific spine head bins that may account for overall alterations in spine
head diameter, the number of spines within each bin was normalized to the total
number of spines and compared between groups. To determine spine head bins
that show more/less GluA1/2 coregistry in spine heads, the volume of coregistry
was manually counted in each spine, then averaged for each bin for each segment,
then across segments for each animal. All analyses were performed by an
individual blinded to experimental treatment groups.
Statistical analyses
Behavioral data were analyzed with a two-way repeated measures (RM) ANOVA
with treatment (cocaine versus saline) as a between-subjects factor and SA
session as a within-subjects factor followed by Bonferroni-corrected pairwise
comparison’s when a significant interaction was observed. A two-tailed t-test with
or without Welch’s correction was used when two groups were compared for a
single dependent variable. Binned dendritic spine head and GluA1/2 colocalization
volume data were analyzed with a two-way RM ANOVA with treatment (cocaine
versus saline) as a between-subjects factor and bin as a within-subjects factor
followed by a Bonferroni-corrected pairwise comparison test when a significant
interaction was observed, as previously performed (Ball et al., 2009). Each
animal’s dendritic spine or colocalization data points were derived from an average
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across the analyzed segments. Cumulative frequency distribution data were
analyzed to determine general shifts in spine head diameter for each group using
a Kolmogorov-Smirnov non-parametric test. When correlating spine head diameter
and density with p-CREB-IR, Pearson’s correlation test was used. Statistical
outliers were detected with Grubbs’ test and were excluded from all analyses as
discussed in the results. Data are expressed as the mean +/- SEM, and
significance was determined at p<0.05.
Results
Experimental design and cocaine SA
The timeline for Experiments 1 and 2 are shown in Figure 4.1A. Representative
CAV2-Cre-eGFP expression in the NAc core and an mCherry-expressing PrL-NAc
core neuron are shown in Figure 4.1B and C, respectively. Figure 4.1D shows a
representative PrL-NAc core neuron immunohistochemically processed for GluA2.
Figure 4.1E shows cocaine SA data. A two-way RM ANOVA revealed a significant
treatment (cocaine versus saline) by session interaction for active lever presses
(F(11,264)=2.01, p<0.05) as well as a significant main effect of treatment
(F(1,24)=38.88, p<0.0001), but not time (F(11,264)=1.69, p>0.05). Bonferronicorrected pairwise comparisons indicated a significant difference between cocaine
and saline on SA sessions 4-12 (all p<0.05). There was no significant treatment
by SA session interaction for inactive lever presses (F(11,264)=1.19, p>0.05), nor
was there a significant main effect of time (F(11,264)=0.60, p>0.05). However, there
was a significant main effect of treatment (F(1,24)=4.31, p<0.05). Thus, yoked saline
controls pressed the inactive lever more than cocaine SA rats. Additionally,
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cocaine SA rats showed lever discrimination, as evidenced by a significant main
effect of lever (active versus inactive) (F(1,24)=60.38, p<0.0001).

Figure 4.1. Experimental timeline, virus expression, and cocaine-induced
alterations in Fos-IR in PrL-NAc core neurons during early withdrawal A. Timeline
for Experiments 1 and 2. B. Representative CAV2-Cre-eGFP virus expression in
the NAc core. Dotted lines indicate lateral ventricle (top), anterior commissure (ac,
center) and border of NAc core and shell. C. Representative mCherry-labeled PrLNAc core layer V neuron. Inset corresponds to a representative dendritic spine
segment taken from the distal apical tuft. D. Representative mCherry-labeled spine
segment from distal apical tuft of a layer V PrL-NAc core neuron displaying GluA2IR (top). Bottom left – GluA2 IR corresponding only to mCherry signal within the
dendrite. Bottom right – GluA2-mCherry coregistered voxels in dendritic spine
heads (yellow) and dendritic shaft (white). E. SA data over the last 12 days of SA.
Sold lines and closed symbols indicate active lever presses and dotted lines with
open signals indicates inactive lever presses. F-G. Fos+ cells in layer V of the PrL
cortex (F) and mCherry+Fos+ normalized to total mCherry+ cells (G). H. Top representative images of Fos+ neurons in saline and cocaine SA rats. Bottom Representative Fos+ mCherry+ and Fos+ mCherry- neurons in saline and cocaine
102

SA rats. White arrows indicate Fos+ mCherry+ neurons, yellow arrows indicate Fos+
mCherry- neurons. Scale bars = 200 μm (B), 50 μm (C), 5 μm (Inset, C), 2 μm (D),
40 μm (H). ****p<0.0001 comparing cocaine to saline active lever presses. SA:
self-administration. dH: spine head diameter.
Effect of cocaine SA on PrL-NAc core structural plasticity, Fos-IR, p-CREBIR, and GluA1/2-IR during early withdrawal.
In Experiment 1, rats (N=16) underwent 12-14 days of cocaine SA or received
yoked-saline infusions and were then transcardially perfused two hours after the
final SA session. One yoked-saline rat was excluded due to a missed NAc core
placement. Two cocaine SA animals were excluded due to failed catheters. The
final sample sizes were n=6 for cocaine and n=7 for yoked saline. First, we
examined Fos-IR in layer V PrL cortex in a subset of yoked-saline and cocaine SA
rats (n=4 per group). One section at approximately the same coronal plane was
analyzed per rat. A two-tailed t-test indicated a non-significant effect of cocaine SA
on Fos-IR in layer V PrL neurons (t(6)=1.70, p>0.05, Fig. 4.1F). When limiting
analysis to mCherry+ neurons, a two-tailed t-test revealed a significant reduction in
the percent of mCherry+ neurons expressing Fos (t(6)=3.31, p<0.05, Fig. 4.1G).
Representative images of Fos+ mCherry- and Fos+ mCherry+ neurons for saline and
cocaine SA rats are shown in Figure 4.1H.
Next, a subset of animals was used to analyze p-CREB-IR in the PrL cortex
(n=5 per group due to limited number of sections available). One section, at
approximately the same coronal plane, was analyzed per rat. A two-tailed t-test
indicated a non-significant effect of cocaine SA on p-CREB-IR in layer V PrL
neurons (t(8)=1.16, p>0.05, Fig. 4.2A). However, when limiting analysis only to
mCherry+ PrL-NAc core neurons, a Welch’s-corrected two-tailed t-test showed a
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significant decrease in the percentage of mCherry+ neurons displaying p-CREBIR (t(4.7)=2.94, p<0.05, Fig. 4.2B). There was no difference between groups in the
average p-CREB signal intensity in all cells that were p-CREB+ (t(8)=0.87, p>0.05,
Fig. 4.2C) or mCherry+p-CREB+ neurons (t(8)=0.96, p>0.05, Fig. 4.2D).
Representative images of mCherry- p-CREB+ and mCherry+p-CREB+ neurons from
yoked-saline and cocaine SA rats are shown in Figure 4.2E.
We next asked whether the alteration in PrL-NAc core activity markers
during early withdrawal was associated with altered dendritic spine morphometry
and AMPA receptor expression. Adjacent sections from the same rats were
immunostained for mCherry and GluA1 or mCherry and GluA2 in two separate
runs. Dendritic spine morphometric data from distal tufts of layer V dendrites were
pooled from both runs. In a minority of instances when sections from individual
animals showed mCherry neurons labeled for GluA1, but not GluA2, and vice
versa, due to technical issues, the spine morphometry data for that animal
consisted of the run in which mCherry neurons were labeled, but the colocalization
data for that animal for the selected protein was not included. A two-tailed t-test
indicated that there was a significantly lower spine head diameter average
(t(11)=3.19, p<0.01, Fig. 4.2F) in cocaine SA rats than in yoked-saline rats but there
was no difference in spine density between groups (t(10)=1.83, p>0.05, Fig. 4.2G).
There was no difference between cocaine and saline groups in the average spine
head center intensity (t(11)=0.53, p>0.05, Fig. 4.2H), indicating that the mCherry
intensity in dendritic spine heads did not contribute to the observed effects.
Additional binned analyses revealed that cocaine SA altered the percent of total
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spines as a function of spine head diameter (in 0.1 µm bins) as evidenced by a
significant two-way RM ANOVA treatment by spine head diameter bin interaction
(F(5,55)=6.59, p<0.0001). Bonferroni-corrected pairwise comparisons indicated a
significant increase in the percent of total spines with head diameters between 0.30.4 µm (p<0.01) and a significant decrease in the percent of total spines with head
diameters between 0.6-0.7 µm (p<0.05) and above 0.7 µm (p<0.01, Fig. 4.2I) in
cocaine SA rats. These changes were associated with a general leftward shift in
spine head diameter after all spines in saline (n=1651) and cocaine SA (n=2159)
rats were analyzed as shown by a non-parametric Kolmogorov-Smirnov test (K-S
p<0.0001, Fig. 4.2J). Representative dendrites from yoked-saline and cocaine SA
rats are shown in Figure 4.2K. Interestingly, there was a positive correlation
between spine head diameter and p-CREB-IR (r2=0.64, p<0.01, Fig. 4.2L) whereas
there was a negative correlation between spine density and p-CREB-IR (r2=0.44,
p<0.05, Fig. 4.2M).
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Figure 4.2. Cocaine SA decreased PrL-NAc core p-CREB-IR and dendritic spine
head diameter during early withdrawal. A-B. p-CREB+ cells in layer V of the PrL
cortex (A) and mCherry+ p-CREB+ normalized to total mCherry+ cells (B). C-D.
There was no difference between groups in p-CREB signal intensity in all p-CREB+
neurons (C) or mCherry+ p-CREB+ neurons (D). E. Top-representative images of
p-CREB+ neurons in yoked-saline and cocaine SA rats. Bottom-representative
mCherry+ p-CREB+ and mCherry+ p-CREB- neurons in yoked-saline and cocaine
SA rats. White arrows indicate mCherry+p-CREB+ neurons, yellow arrows indicate
mCherry+ p-CREB- neurons. F. Cocaine SA decreased spine head diameter
compared to yoked-saline controls. G. There was no difference in spine density
between groups. H. The average mCherry signal intensity in the center of the spine
head was not different between groups. I-J. Cocaine SA rats show a general
leftward shift in percent of total spines as a function of spine head diameter (I) and
cumulative frequency (J). K. Representative dendrites from saline and cocaine SA
rats. L-M. The percentage of mCherry+ neurons that are also p-CREB+ positively
correlated with dendritic spine head diameter (L), but negatively correlated with
dendritic spine density (M). *p<0.05, **p<0.01 compared to saline. Scale bars = 40
μm (E), 5μm (K).
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Next, a subset of the sections was immunostained for mCherry and GluA1,
as described above. One saline rat showed no neurons labeled for mCherry in this
run and was not included in the analysis. Final sample sizes were n=6 for both
groups. Interestingly, analyses revealed a significant reduction in total GluA1-IR in
PrL-NAc core dendrites (t(10)=2.39, p<0.05, Fig. 4.3A). This was accounted for by
a decrease in shaft-specific GluA1-IR (t(10)=2.45, p<0.05, Fig. 4.3B) as well as a
decrease in spine head-specific GluA1-IR (t(10)=2.30, p<0.05, Fig. 4.3C). When
analyzing GluA1 volume in spine heads as a function of dendritic spine head
diameter, a two-way RM ANOVA revealed a significant treatment by spine head
diameter bin interaction (F(5,50)=4.18, p<0.01). Bonferroni-corrected pairwise
comparisons indicated that cocaine SA rats showed a specific decrease in GluA1IR in spine heads larger than 0.7 μm (p<0.0001, Fig. 4.3D). Importantly, these
effects are likely not due to differences in empirical thresholds set for GluA1
because the percent of signal above threshold was not different between cocaine
and saline groups (t(10)=1.10, p>0.05, Fig. 4.3E). The percent of mCherry signal
above threshold was also not different between groups (t (10)=0.73, p>0.05, Fig.
4.3F). Furthermore, reduced overall GluA1-IR was not accounted for by reduced
average signal intensity of GluA1 in the mCherry+ dendrites (t(10)=0.29, p>0.05,
Fig. 4.3G). Representative spine segments are shown in Figure 4.3H.
Next, sections from all animals were immunostained for GluA2. One yokedsaline rat was excluded from analysis due to immunohistochemical detection
issues leading to profound saturation in each image. Thus, final sample sizes were
n=6 per group. Unlike GluA1, total GluA2-IR was not altered by cocaine (t(10)=0.51,
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p>0.05, Fig. 4.3I). Moreover, there was no effect of cocaine on shaft-specific
GluA2-IR (t(10)=0.22, p>0.05, Fig. 4.3J) but there was a trend towards reduced
spine head-specific GluA2-IR (t(10)=1.74, p=0.11, Fig. 4.3K). However, like GluA1,
there was a treatment by spine head diameter bin interaction on GluA2-IR volume
as a function of spine head diameter (F(5,50)=4.89, p<0.01). A Bonferroni-corrected
pairwise comparison test indicated a specific reduction in GluA2-IR in spines larger
than 0.7 μm (p<0.0001, Fig. 4.3L) in the cocaine group. These effects are likely
not due to differences in the empirical thresholds set for GluA2 because the
percent of signal above threshold was not different between groups (GluA2:
t(10)=0.67, p>0.05, Fig. 4.3M; mCherry: t(10)=2.04, p>0.05, Fig. 4.3N). Moreover,
there was no difference between groups in the average GluA2-IR intensity in
mCherry+ dendrites (t(10)=0.30, p>0.05, Fig. 4.3O). Representative spine segments
are shown in Figure 4.3P.
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Figure 4.3. Cocaine SA reduced GluA1/2-IR in enlarged mushroom spines of PrLNAc core neurons during early withdrawal. A. Total GluA1-IR was decreased in
PrL-NAc core dendrites. B-C. The decreased total GluA1-IR was accounted for by
(B) decreased GluA1 in the dendritic shaft and (C) decreased GluA1 in dendritic
spine heads. D. The decreased GluA1-IR in spine heads was specific to spines
with head diameters larger than 0.7 μm. E-F. The signal above threshold for GluA1
(E) and mCherry (F) was not different between groups. G. The average GluA1
signal intensity in mCherry+ dendrites was not different between groups. H.
Representative dendrites from saline (left) and cocaine (right) showing mCherry
(top), mCherry + GluA1 (middle), and shaft-specific versus spine head-specific IR
(bottom). I. There was no difference between cocaine and saline in total GluA2-IR.
J-K. There was no difference between cocaine and saline in shaft-specific GluA2IR (J), but a strong trend towards decreased spine head-specific GluA2-IR (K). L.
Cocaine SA rats showed decreased GluA2-IR only in spines greater than 0.7 μm.
M-N. The signal above threshold for GluA2 (M) and mCherry (N) was not different
between groups. O. The average GluA2 signal intensity in the mCherry+ dendrites
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was not different between groups. P. Representative dendrites showing decreased
spine head-specific GluA2 (bottom) in cocaine (right) relative to saline controls
(left). Scale bars = 2 μm. *p<0.05, **p<0.01, ****p<0.0001 compared to saline.
Effect of cocaine SA on PrL-NAc core activity markers, structural plasticity,
and GluA1/2-IR after one week of abstinence
In Experiment 2, rats (N=16) underwent 12-14 days of cocaine SA or received
yoked-saline infusions. One yoked-saline rat never finished SA due to stress
reactions when handled. One yoked-saline rat was removed from analyses
because of insufficient virus expression and one cocaine SA rat was removed as
a statistical outlier in colocalization analyses. Final sample sizes were n=6 for
saline and n=7 for cocaine.
A subset of animals was used to analyze p-CREB-IR in the PrL cortex (n=3
per group). One section, at approximately the same coronal plane, was analyzed
per rat. A two-tailed t-test indicated a non-significant effect of cocaine SA on pCREB-IR, although there was a trend towards elevated p-CREB-IR in cocaine SA
rats (t(4)=2.04, p=0.11, Fig. 4.4A). However, when limiting analysis only to mCherry+
PrL-NAc core neurons, a two-tailed t-test showed a significant increase in the
percentage of mCherry+ neurons displaying p-CREB-IR (t(4)=3.41, p<0.05, Fig.
4.4B). There was no difference between groups in the average p-CREB signal
intensity in all cells that were p-CREB+ (t(4)=1.02, p>0.05, Fig. 4.4C) or in cells
that were mCherry+ p-CREB+ (t(4)=1.18, p>0.05, Fig. 4.4D). Representative
images of mCherry- p-CREB+ and mCherry+ p-CREB+ neurons in yoked-saline and
cocaine SA rats are shown in Figure 4.4E.
Next, we asked whether this increase in p-CREB-IR in PrL-NAc core
neurons after one week of abstinence was associated with altered spine head
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diameter of PrL-NAc core neurons. In contrast to early withdrawal, cocaine SA
followed by one week of abstinence produced a profound increase in spine head
diameter of PrL-NAc core distal apical tuft dendrites (t(11)=7.44, p<0.0001, Fig.
4.4F), but an overall reduction in spine density, in cocaine SA compared to yokedsaline rats (t(11)=4.32, p<0.01, Fig. 4.4G). Akin to Experiment 1, there was no
difference in the average spine head center intensity between cocaine and saline
groups (t(11)=1.80, p>0.05, Fig. 4.4H), indicating that the mCherry intensity in
dendritic spine heads did not contribute to the observed effects. These effects were
associated with a significant treatment by spine head diameter bin interaction
(F(5,55)=18.86, p<0.0001). Bonferroni-corrected pairwise comparisons indicated
that cocaine SA rats showed a reduction in the percent of total spines with head
diameters between 0.3-0.4 µm (p<0.001), and 0.4-0.5 µm (p<0.01), but an
increase in the percent of total spines with head diameter above 0.7 µm (p<0.0001,
Fig. 4.4I). Moreover, these changes were associated with a general rightward shift
in spine head diameter when analyzing all spines in yoked-saline (n=1907) and
cocaine SA (n=1642) rats as shown by a Kolmogorov-Smirnov test (K-S p<0.0001,
Fig. 4.4J). Representative dendrites from a yoked-saline and cocaine SA rat are
shown to the right in Figure 4.4K. Like early withdrawal, we found that spine head
diameter and p-CREB-IR showed a positive correlation (r2=0.82, p<0.01, Fig.
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4.4L), whereas spine density and p-CREB-IR showed a non-significant trend
towards a negative correlation (r2=0.58, p=0.07, Fig. 4.4M).

Figure 4.4. Cocaine SA increased PrL-NAc core p-CREB-IR and dendritic spine
head diameter following one week of abstinence. A-B. p-CREB+ cells in layer V of
the PrL cortex (A) and mCherry+ p-CREB+ normalized to total mCherry+ cells (B).
C-D. There was no difference between groups in p-CREB signal intensity in all pCREB+ neurons (C) or mCherry+ p-CREB+ neurons (D). E. Top-representative
images of p-CREB+ neurons in yoked-saline and cocaine SA rats. Bottomrepresentative mCherry+ p-CREB+ and mCherry+ p-CREB- neurons in yoked-saline
and cocaine SA rats. White arrows indicate mCherry+ p-CREB+ neurons, yellow
arrows indicate mCherry+ p-CREB- neurons. F-G. Cocaine SA increased spine
head diameter (F), but decreased spine density (G) compared to yoked-saline
controls. H. The average mCherry signal intensity in the center of the spine head
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was not different between groups. I-J. Cocaine SA rats showed a general rightward
shift in percent of total spines as a function of spine head diameter (I) and
cumulative frequency (J). K. Representative dendrites from saline and cocaine SA
rats. L-M. The percentage of mCherry+ neurons that are also p-CREB+ positively
correlated with dendritic spine head diameter (L) and showed a trend toward
negatively correlating with dendritic spine density (M). *p<0.05, **p<0.01,
***p<0.001, ****p<0.0001 compared to saline. Scale bars = 40 μm (E), 5μm (K).
To determine whether this hypertrophic structural alteration in spine head
diameter and elevated p-CREB-IR were associated with altered GluA1-IR, we
performed the same colocalization analyses as described above. However,
sections from one cocaine animal did not show virus expression in the run
processed for GluA1 but was included in GluA2 measurements (see below).
Interestingly, the elevated spine head diameter was associated with an overall
reduction in total GluA1 coregistry with mCherry in the cocaine group (t (10)=2.79,
p<0.05, Fig. 4.5A). This effect was associated with reduced dendritic shaft-specific
GluA1-IR (t(10)=3.55, p<0.01, Fig. 4.5B), but increased spine head-specific GluA1IR (t(10)=2.50, p<0.05, Fig. 4.5C). A two-way RM ANOVA revealed a significant
treatment by spine head diameter bin interaction of GluA1 volume as a function of
spine head diameter (F(5,50)=11.87, p<0.0001). Bonferroni-corrected pairwise
comparison tests indicated an increase in GluA1-IR in spines larger than 0.7 μm
(p<0.0001, Fig. 4.5D) in cocaine SA rats. It is unlikely that differences in empirical
thresholds set for GluA1 or mCherry accounted for these differences because the
percent of signal above threshold was not different between cocaine and saline
groups (GluA1: t(10)=0.53, p>0.05, Fig. 4.5E; mCherry: t(10)=1.13, p>0.05, Fig.
4.5F). There was also no difference in the average intensity of GluA1-IR in
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mCherry+ dendrites between groups (t(10)=1.54, p>0.05, Fig. 4.5G). Representative
spine segments are shown in Figure 4.5H.
Next, sections were immunostained for GluA2 and mCherry and
colocalization analyses were performed as described above. All 13 animals
showed labeled neurons and thus sample sizes for this experiment were n=6
(saline) and n=7 (cocaine). Interestingly, in contrast to GluA1, total GluA2-IR was
unaffected after one week of abstinence from cocaine SA (t (11)=0.97, p>0.05, Fig.
4.5I). There was no difference between groups in dendritic shaft-specific GluA2-IR
(t(11)=0.08, p<0.05, Fig. 4.5J), but cocaine SA rats showed elevated spine headspecific GluA2-IR (t(11)=3.47, p<0.01, Fig. 4.5K). A two-way RM ANOVA revealed
a significant treatment by spine head diameter bin interaction (F(5,55)=5.58,
p<0.001). Bonferroni-corrected pairwise comparison tests indicated that the
elevated spine head-specific GluA2-IR was specific to spines greater than 0.7 μm
(p<0.0001, Fig. 4.5L). Consistent with our previous findings, these effects were not
due to differences in thresholds for GluA2 or mCherry because the percent of
signal above threshold was not different between groups (GluA2: t (11)=0.63,
p>0.05, Fig. 4.5M; mCherry: t(11)=1.02, p>0.05, Fig. 4.5N). Moreover, the average
GluA2 signal intensity in mCherry dendrites was not different between groups
(t(11)=0.59, p>0.05, Fig. 4.5O). Representative spine segments are shown in Figure
4.5P.
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Figure 4.5. Cocaine SA increased GluA1/2-IR in enlarged mushroom spines of
PrL-NAc core neurons after one week of abstinence. A. Total GluA1-IR was
decreased in PrL-NAc core dendrites. B-C. This was accounted for by decreased
GluA1 in dendritic shafts (B), but increased GluA1 in dendritic spine heads (C). D.
The increased GluA1-IR in spine heads was specific to spines with head diameters
larger than 0.7 μm. E-F. The signal above threshold for GluA1 (E) and mCherry
(F) was not different between groups. G. The average GluA1 signal intensity in the
mCherry-labeled dendrite was not different between groups. H. Representative
dendrites from saline (left) and cocaine (right) showing mCherry (top), mCherry +
GluA1 (middle), and shaft-specific versus spine head-specific IR (bottom). I. There
was no difference between cocaine and saline in total GluA2 IR. J-K. There was
no difference between cocaine and saline in shaft-specific GluA2-IR (J), but a
significant increase in spine head-specific GluA2-IR (K). L. Cocaine SA rats
showed increased GluA2-IR only in spines greater than 0.7 μm. M-N. The signal
above threshold for GluA2 (M) and mCherry (N) was not different between groups.
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O. The average GluA2 signal intensity in the mCherry-labeled dendrite was not
different between groups. P. Representative dendrites showing decreased spine
head-specific GluA2 (bottom) in cocaine SA (right) relative to yoked-saline controls
(left). Scale bars = 2 μm. *p<0.05, **p<0.01, ****p<0.0001 compared to saline.
Discussion
Summary of findings
Here we show that cocaine SA biphasically alters nuclear activity markers,
structural plasticity, and AMPA receptor expression in dendritic spines of PrL-NAc
core neurons depending on the duration of abstinence. We found that two hours
after cocaine SA, PrL-NAc core neurons showed decreased Fos-IR and p-CREBIR, as well as spine head diameter, suggesting diminished neuronal activity in this
specific pathway. Further, total GluA1-IR was diminished in PrL-NAc core
dendrites, which was accounted for by reduced GluA1-IR in dendritic shafts and
spine heads. Interestingly, total GluA2-IR was unaffected by cocaine SA, although
both GluA1-IR and GluA2-IR were reduced in enlarged, putative mushroom-type
spines (i.e. head diameter greater than 0.7 μm), which make up a minority of
overall dendritic spines. In contrast, one week of abstinence was associated with
augmented spine head diameter and overall attrition of dendritic spines. Like early
withdrawal, one week of abstinence reduced overall GluA1-IR, but not GluA2-IR,
in PrL-NAc core neurons; however, both AMPA receptor subunits were elevated
in dendritic spine heads of PrL-NAc core neurons, an effect driven by increased IR
in enlarged, putative mushroom-type spines. At this timepoint, GluA1-IR was again
reduced in the dendritic shaft. Overall, these findings suggest that the PrL-NAc
core pathway may be in a hypoactive state during early withdrawal from cocaine
and potentiated following one week of abstinence.
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Cocaine SA reduced nuclear activity markers in PrL-NAc core neurons
during early withdrawal
A previous report indicates that a single session of cocaine SA enhances Fos
expression in the PrL cortex, which is normalized after six daily sessions of cocaine
SA (Zahm et al., 2010). However, others have found that 10 daily sessions of
cocaine SA increased c-fos gene expression in the medial prefrontal cortex
(including PrL and IL cortices), effects which are maintained following 60 days of
cocaine SA (Gao et al., 2017). Previously, we found decreased p-CREB-IR in the
PrL cortex during early withdrawal (Whitfield et al., 2011). In our study, we found
no effect of cocaine SA on global Fos-IR or p-CREB-IR in layer V PrL cortex. Layer
V predominantly contains cortical efferents innervating subcortical structures
implicated in motivation, cognition, and motor activation (Gabbott et al., 2005), one
of these pathways being the PrL-NAc core pathway, which is well-documented to
be involved in drug seeking after abstinence (Kalivas, 2009; Jasinska et al., 2015).
Interestingly, when analyzing Fos-IR and p-CREB-IR in this specific pathway
during early withdrawal, we found a significant decrease in both markers. Thus,
cocaine SA likely leads to a dampening of PrL-NAc core activity during early
withdrawal as evidenced by decreased IR of the activity markers, Fos and pCREB.
Cocaine SA reduced dendritic spine head diameter and GluA1/2 spine head
localization in PrL-NAc core neurons
PrL-NAc core apical spine head diameter was decreased during early withdrawal
from cocaine SA. This finding positively correlates with reduced global
dephosphorylation of GluN2A/B-containing NMDA receptors, ERK, and CREB and
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the activation of STEP (Whitfield et al., 2011; Sun et al., 2013; Go et al., 2016;
Barry and McGinty, 2017), as well as reduced nuclear Fos-IR and p-CREB-IR, and
GluA1/2-IR in dendritic spines of PrL-NAc core neurons in this study. Supporting
these observations, a recent study found that following a single injection of
cocaine, Fos+ neurons relative to random NAc core neurons in cocaine and
vehicle-injected controls showed elevated dendritic spine density and spine head
volume (Dos Santos et al., 2017). Thus, Fos expression positively correlates with
spine morphometric features. Here we found that p-CREB-IR positively correlated
with spine head diameter, but negatively correlated with spine density. Thus,
animals that showed higher p-CREB-IR in PrL-NAc core neurons tended to have
higher average spine head diameter, but lower spine density. In contrast, following
CREB overexpression in the amygdala, there is an increase in dendritic spine
density (Sargin et al., 2013). This dichotomy likely reflects the difference between
CREB overexpression and detection of endogenous p-CREB, as well as different
brain regions investigated, and the effects of cocaine SA.
Interestingly, we found distinct and overlapping alterations in AMPA
receptor subunit expression in PrL-NAc core dendritic spines. Total GluA1-IR was
suppressed in PrL-NAc core neurons but GluA2-IR was only reduced in a specific
subset of dendritic spines (i.e. enlarged, mushroom-type spines). GluA1 and
GluA2 differentially regulate spine morphology (Prithviraj et al., 2008), with GluA2
playing a key role in spine morphogenesis in vitro (Passafaro et al., 2003; Saglietti
et al., 2007). Moreover, β3 integrins, which play a critical role in regulating spine
morphology (Shi and Ethell, 2006), interact strongly with GluA2-, but not GluA1, -
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containing AMPA receptors (Pozo et al., 2012). Although the trafficking of AMPA
receptors involves multiple complex interactions with AMPA receptor-interacting
proteins through the C-terminal domains of AMPA receptor subunits (Shepherd
and Huganir, 2007), there is general consensus that GluA1 and GluA2 differentially
undergo trafficking and recycling (reviewed in (Anggono and Huganir, 2012).
Previous data from our lab indicate that short-access cocaine SA has no
effect on total GluA1 or GluA2 expression in the PrL cortex two hours after the final
SA session (Sun et al., 2013). Others have shown that 16 hours of withdrawal
reduces GluA2/3, but not GluA1, protein expression in the mPFC (Hemby et al.,
2005). These apparently contrasting findings are likely due to the different
timepoints analyzed in the two studies. Moreover, phospho-deficient mutations of
p-CREBS133 leading to CREB inactivation preferentially alter GluA1 synaptic
incorporation in a basal state, without affecting synaptic levels of GluA2/3, in the
hippocampus (Middei et al., 2013). Although our findings indicate that cocaine SA
differentially regulates total GluA1-IR and GluA2-IR specifically in PrL-NAc core
neurons during early withdrawal, the finding that both subunits were reduced in
enlarged dendritic spines, which constitute the majority of AMPA receptor
expression and function (Matsuzaki et al., 2001), suggests that mature spines
undergo AMPA receptor removal during early withdrawal from cocaine. Future
studies will address what molecular mechanisms may be responsible for the
observed spine morphometric and accompanying GluA1/2 effects.
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One week of abstinence from cocaine SA increased the head diameter, but
decreased the density, of PrL-NAc core neuron dendritic spines while
augmenting GluA1/2 IR in spine heads
Chronic cocaine SA followed by abstinence alters dendritic spine structural
plasticity within the PrL cortex (Robinson et al., 2001; Rasakham et al., 2014;
Radley et al., 2015). However, the precise induction of PrL cortical structural
plasticity is controversial, with some showing hypertrophic spine changes (i.e.
increased spine density), whereas others have shown hypotrophic spine
alterations (i.e. decreased spine density).
We found that cocaine SA followed by one week of abstinence decreased
the density of PrL-NAc core neuron apical dendritic spines but increased the
average head diameter. To the best of our knowledge, the only other study
investigating layer V PrL cortical structural plasticity after one week of abstinence
from cocaine SA found increased layer V basal thin spine density, but decreased
synapse number as well as overall dendritic complexity (Rasakham et al., 2014).
Our results should not be viewed as contradictory to these findings, rather these
differences underline the importance of investigating pathway-specific structural
modifications as well as the region of dendrite investigated as inputs to the apical
tuft (Liu and Aghajanian, 2008) and basal dendrites (Liu et al., 2015) differ in their
origin.
One week of abstinence from cocaine SA leads to increased PKA-mediated
phosphorylation of CREBS133 as well as GluA1S845 in the PrL cortex. Inhibiting PKA
activity with an intra-PrL microinfusion of the PKA inhibitor, Rp-cAMPs, suppresses
relapse to cocaine seeking when tested in the absence of conditioned cues (i.e.
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context-induced relapse) (Sun et al., 2014b). Here we extend these findings by
showing that elevated p-CREBS133 and GluA1 occurs in PrL-NAc core nuclei and
spines, respectively. Although it has not been confirmed that this PKA-mediated
induction of AMPA receptor phosphorylation results in a physiological
enhancement of PrL cortical glutamate currents, this is not without precedent as it
has been recently shown that cocaine conditioned place preference (CPP) training
increases evoked AMPA receptor excitatory transmission in layer V PrL cortical
neurons (Otis and Mueller, 2017).
Interestingly, we found decreased total GluA1-IR in PrL-NAc core neurons
after one week of abstinence which was largely accounted for by decreased
dendritic shaft-specific GluA1-IR. However, we found increased spine headspecific GluA1-IR. These findings infer that cocaine SA leads to compartmentspecific changes in GluA1-IR in PrL-NAc core neurons one week after abstinence
that are distinct from those which occur during early withdrawal. In contrast to early
withdrawal, GluA-1IR and GluA2-IR were upregulated in spine heads of PrL-NAc
core neurons after one week of abstinence. Although GluA2-lacking AMPA
receptors in the NAc play a key role in cocaine seeking after abstinence in longaccess SA paradigms (Conrad et al., 2008), we are likely not detecting such
receptors in our model because both AMPA receptor subunits were increased in
dendritic spines of PrL-NAc core neurons after one week of abstinence. However,
we cannot exclude the involvement of GluA3/4-containing AMPA receptors in the
effects of cocaine. Thus, it is possible that we are detecting elevated GluA1/3 as
well as GluA2/3-containing AMPA receptors in PrL-NAc core spine heads.
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Electrophysiological experiments would be needed to further discern the
involvement of specific AMPA receptor subunit conformation in the observed
effects. Regardless, it is likely that increased AMPA receptor expression in
enlarged dendritic spines disposes these dendritic compartments to be
hypersensitive to glutamate release because spines with enlarged volume show
greater AMPA receptor-mediated excitatory transmission (Matsuzaki et al., 2001;
Matsuzaki et al., 2004). Because we found an overall decrease in spine density,
but increased spine head diameter, it is intriguing to hypothesize that specific
inputs to the distal apical tuft of PrL-NAc core neurons may be potentiated whereas
others are depressed, but this remains to be tested. This is supported by previous
work showing that spines adjacent to active synapses have an accumulation of
AMPA receptors leading to a lack of lateral diffusion (i.e. functional trapping at
synapses), but AMPA receptors within spines adjacent to inactive synapses rapidly
diffuse away from synaptic sites (Ehlers et al., 2007).
Overexpression of the GluA2 subunit of AMPA receptors is sufficient to
increase dendritic spine density and size (Passafaro et al., 2003). Moreover,
following learning in a fear conditioning paradigm, newly synthesized GluA1containing AMPA receptors are incorporated into synapses preferentially in
mushroom-type spines (Matsuo et al., 2008). Further, GluA1S845 phosphorylation
by PKA is critical for the induction of synaptic plasticity governing learning and
memory (Huganir and Nicoll, 2013). Stimulation of the PKA-GluA1 pathway by
catecholamines lowers the threshold for LTP induction (Hu et al., 2007), indicating
that GluA1 phosphorylation by PKA primes AMPA receptors for synaptic
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incorporation, as shown previously with D1-PKA-GluA1 in cultured prefrontal
cortical neurons (Sun et al., 2005). Thus, the elevated PKA activity and
phosphorylation state of the PKA substrates described above that drive relapse
after abstinence (Sun et al., 2014b) in conjunction with the results described here
suggest that PrL-NAc core neurons likely exist in a hypersensitive glutamate state
after one week of abstinence which may be maintained by elevated dopamine
tone.
Technical considerations
Although confocal microscopy does not provide adequate resolution to infer
surface expression of AMPA receptors or trafficking of AMPA receptors, it does
provide the resolution to discern differences in compartmentalization of AMPA
receptors (i.e. dendritic shaft versus spine heads). This is important given that
previous

work

shows

activity-dependent

alterations

in

AMPA

receptor

compartmentalization in spines versus dendritic shafts in vitro (Shi et al., 1999;
Brown et al., 2007). Moreover, conventional techniques to measure receptor
surface expression (i.e. immunoblotting) in their current technological state
occlude the use of pathway-specific measurements. Interestingly, at both
timepoints, we observed differential expression of GluA1 and GluA2 in PrL-NAc
core dendrites. It is plausible that this could be due to differential regulation of
these AMPA receptor subunits by cocaine experience, which is supported by the
finding that at both time points total GluA1-IR was decreased whereas total GluA2IR was not. However, this interpretation should be viewed with caution because
the immunostaining for GluA1 and GluA2 in each experiment was done
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independently. Thus, this difference could be due to variations in the affinity of the
antibodies for their respective antigens, although both antibodies have been wellvalidated for the use of immunohistochemistry (Vissavajjhala et al., 1996; Yap et
al., 2017). Thus, directly comparing GluA1 and GluA2 findings may not be
warranted, whereas the comparison between timepoints for each protein target
may be more valid.
Moreover, it could be argued that several variables could account for altered
spine morphology and increased, or decreased, GluA1/2 expression in spine
heads, including signal intensity. This is extremely unlikely because a) the mCherry
intensity in spine heads did not differ between groups in either experiment, and b)
the percent of signal above threshold and the average signal intensity was not
different between groups for neither GluA1 or GluA2 in either experiment. Thus, it
is unlikely that differences in signal intensity contributed to our findings, but rather
that the observed effects are due to cocaine-induced adaptations in the
compartmentalization of AMPA receptors in these neurons.
Conclusions
The PrL cortex represents an important hub for the integration of sensory and
motivational computations and is a critical node in which encoded information
engages motor programs. Cocaine-induced structural plasticity in the PrL cortex
has not been heavily investigated, largely due to experimental obstacles in imaging
the full length of deep layer pyramidal neurons. The data described herein suggest
that the previously described biphasic alterations in glutamatergic signaling that
occur globally in the PrL cortex during early withdrawal and early abstinence are
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associated with adaptations in the PrL-NAc core pathway. These adaptations
occur not only at the level of the nucleus, but also at the level of individual dendritic
spines, leading to differential compartmentalization of AMPA receptors in spines.
Given that the two timepoints show remarkable dichotomy in PrL-NAc core
adaptations, it is plausible that the altered structure and presumably diminished
function of PrL-NAc core neurons during early withdrawal is likely required for the
subsequent enlargement of dendritic spines, induction of p-CREB, and
accumulation of AMPA receptors in enlarged spines after one week of abstinence.
Thus, the abstinence duration-dependent adaptations in PrL-NAc core neurons
provide a novel way of looking at corticostriatal dysfunction as it relates to relapse
vulnerability. Future studies should investigate the precise timescale of these
events as they occur over one week of abstinence. Furthermore, it is not clear
whether structural and synaptic adaptations in PrL-NAc neurons are required for
context-induced relapse. Future studies should address this question utilizing
chemogenetic-mediated silencing of the PrL-NAc core pathway prior to contextinduced relapse.
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Chapter 5: General discussion
Summary of findings
The data described in this dissertation show that the dephosphorylation of ERK2
in the PrL cortex during early withdrawal is mediated by cocaine-induced activation
of STEP that is critical to subsequent relapse to cocaine seeking after abstinence.
Moreover, stimulation of the PrL cortex or the PrL-NAc core pathway immediately
after SA leads to a transient suppression of cocaine seeking after abstinence, with
differential effects depending on the stimuli used to induce cocaine seeking,
suggesting that the ability to suppress subsequent cocaine seeking by intervening
during early withdrawal is more complex than merely stimulating PrL output to the
NAc core. Finally, cocaine SA decreases PrL-NAc core distal apical tuft dendritic
spine head diameter, nuclear p-CREB and Fos, as well as GluA1/2 AMPA receptor
expression in specific subsets of dendritic spines during early withdrawal.
However, one week of abstinence elevated dendritic spine head diameter, but
decreased density, and elevated GluA1/2 expression in dendritic spine heads and
p-CREB-IR in the nucleus. Thus, cocaine-induced adaptations in glutamatergic
transmission in the PrL-NAc core pathway emerge during early withdrawal, and
induce subsequent circuit remodeling during abstinence, ultimately facilitating
relapse to cocaine seeking.
Brain region-specific effects of drug-induced regulation of STEP function
Relative to several other neuropsychological and neurodegenerative disorders, far
less is known about the involvement of STEP in addiction-related disorders. The
little that is known clearly shows that STEP activation plays different roles in
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regulation of psychostimulant-induced synaptic transmission and glutamatergic
signaling depending on the brain region investigated, whether investigators
measure acute versus chronic effects of drugs of abuse, and whether drug
administration is contingent or non-contingent (Valjent et al., 2000).
Acute cocaine and amphetamine are well-documented to engage ERK2
phosphorylation in the ventral striatum, which is important for the expression of
behavioral sensitization, through concomitant activation of dopamine D1 and
NMDA receptors. The effect is complex, involving augmented dopamine
interactions with ambient glutamate, PKA-mediated phosphorylation of DARRP32, activation of PP1, dephosphorylation (inactivation) of STEP, elevations in
dendritic spine density, and Src Family Kinase (SFK)-mediated augmentation of
GluN2B-containing NMDA receptors (Zhang et al., 2001; Valjent et al., 2005;
Girault et al., 2007; Pascoli et al., 2011; Cahill et al., 2014; Dos Santos et al., 2017).
Although reinstatement/relapse following chronic cocaine SA and the
expression of locomotor sensitization to cocaine share some overlapping
characteristics (Kalivas et al., 1998), there are also clear differences between the
two paradigms pertaining to the operant conditioning nature of cocaine SA.
Remarkably, it is unknown how chronic cocaine SA alters STEP activity in the NAc
following cocaine SA. However, ERK phosphorylation is elevated in the NAc core
of cocaine SA animals following three weeks of withdrawal, which is not present
after one day of withdrawal, when reintroduced into the cocaine-paired context
(Edwards et al., 2011). This finding suggests that STEP activity in the NAc core
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may undergo abstinence duration-dependent inhibition of activity to drive relapse,
although other ERK phosphatases, such as MKP3, may be involved.
In the prefrontal cortex, a rather different picture emerges and, in general,
far less is known. In contrast to the NAc, acute cocaine-induced elevations in ERK
phosphorylation do not require PKA-mediated phosphorylation of DAARP-32
(Valjent et al., 2005), suggesting alternative pathways are involved. We have
previously found that cocaine SA leads to ERK, GluN2A/B-containing NMDA
receptor, and CREB dephosphorylation in the PrL cortex during early withdrawal
(Whitfield et al., 2011; Sun et al., 2013; Barry and McGinty, 2017). These changes
are associated with dephosphorylation and activation of STEP (Sun et al., 2013).
BDNF-mediated attenuation of cocaine seeking requires normalization of ERK
phosphorylation (Whitfield et al., 2011). The results presented herein posit that
STEP mediates the cocaine-induced dephosphorylation of ERK and plays a role
in relapse after abstinence and extinction training depending on whether STEP is
inhibited globally or specifically within the PrL cortex during early withdrawal. Thus,
STEP-mediated ERK dephosphorylation in the PrL cortex is a critical regulator of
cocaine-induced plasticity during early withdrawal that may ultimately facilitate
dysfuntional corticostriatal glutamate transmission that drives relapse, perhaps
through dysregulated gene expression.
Divergent prelimbic cortical pathways and their encoding of rewardpredictive stimuli
The PrL cortex is a highly organized structure that contains heterogenous
pyramidal neurons that project to multiple diverse subcortical targets. Layer II/III
pyramidal neurons are generally believed to be made up of projection neurons
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innervating the contralateral medial prefrontal cortex. In addition, a small number
of neurons project to subcortical structures implicated in assignment of stimulus
valence, such as the NAc and BLA (Gabbott et al., 2005; Little and Carter, 2013).
A few layer V projection neurons also project to contralateral mPFC, but the
majority of layer V neurons project to subcortical structures implicated in
reinforcement learning and conditioned reward seeking, including the NAc core
(Gabbott et al., 2005). Finally layer VI neurons encompass corticothalamic neurons
innervating the mediodorsal nucleus of the thalamus as well as midline thalamic
nuclei, such as the PVT (Otis et al., 2017). These glutamatergic projection neurons
are fundamentally regulated by an array of GABAergic inhibitory interneurons and
disruptions in this regulation have been implicated in numerous neuropsychiatric
disorders (Lodge et al., 2009; Hervig et al., 2016).
Recent evidence indicates that layer V corticostriatal neurons (including the
PrL-NAc core pathway) and layer VI neurons projecting to the midline thalamus,
particularly the PVT, produce dichotomous encoding of reward-related information
following learning (Otis et al., 2017). Moreover, recent data from our lab indicate
that chemogenetic-mediated inhibition of the PrL cortex immediately following SA
provides an enduring reduction in cocaine-seeking after abstinence or extinction
training. Specifically, selectively inhibiting the PrL-NAc core pathway during early
withdrawal had no effect on relapse to cocaine seeking whereas selective inhibition
of the PrL-PVT pathway replicated the suppression of cocaine seeking following
global PrL output inhibition (Giannotti et al., submitted).
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STEP mRNA is expressed in all layers of the PrL cortex (Lein et al., 2007).
Thus it is likely that intra-PrL STEP inhibition during early withdrawal from cocaine
SA inhibits STEP activity in the majority of pyramidal neurons in the PrL cortex.
However, it is unknown to what degree STEP is expressed in a pathway-specific
manner. It would be interesting to examine whether the effect of intra-PrL STEP
inhibition during early withdrawal is dependent on inhibiting STEP activity
specifically in the PrL efferents projecting to the NAc core.
In the experiments presented herein, we found that global chemogenetic
activation of the PrL cortex during early withdrawal transiently suppressed cueinduced reinstatement after extinction. In contrast, selective activation of the PrLNAc core pathway transiently suppressed post-abstinence context-induced
relapse but not cue-, or cocaine prime-, induced reinstatement. The relatively low
dose of CNO used may account for the transient suppression in each case
although alternative explanations, as discussed in Chapter 3, are possible.
However, the differential, transient, suppression of relapse depending on the
stimulus used to induce cocaine seeking after non-selective vs. pathway-specific
activation of PrL cortex may be because global chemogenetic activation of the PrL
cortex activates pyramidal neurons in all layers of the PrL cortex whereas selective
activation of the PrL-NAc core pathway is preferentially infecting layer V PrL
neurons projecting to the NAc core. Although PrL cortical STEP inhibition and GqDREADD activation showed vastly different behavioral effects, it can be postulated
that the two interventions combined may provide a more enduring normalization of
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ERK phosphorylation in the PrL cortex during early withdrawal more akin to BDNF,
allowing hM3Dq to provide a sustained suppression of relapse (Fig. 5.1).

Figure 5.1. TC-2153 and Gq-DREADD interact at the level of ERK. The cocaineinduced dephosphorylation of ERK by STEP represents a critical adaptation that
facilitates relapse. The synergistic action of the two to drive ERK phosphorylation
may provide a more enduring suppression of relapse behavior in cocaine SA
animals.
Cyotoarchitecture of layer V pyramidal neurons: Implications for activitydependent structural remodeling
Pyramidal neurons make up the majority of glutamatergic projection neurons and
are characterized by two distinct dendritic domains: basal and apical dendrites.
Layer V-VI pyramidal neurons have a distinct primary apical dendrite that extends
~ 600 μm towards the pial surface, passing through layer III before bifurcating and
ultimately producing a tuft of apical dendrites in layers II and layer I. Importantly,
the apical tuft receives inputs from different origins relative to the proximal apical
or basal dendrites (Spruston, 2008). For example, serotonin application to medial
prefrontal cortical layer V distal apical tufts, but not basal dendrites, increases
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excitatory post synaptic currents (EPSCs-(Aghajanian and Marek, 1997).
Moreover, orexin (hypocretin) inputs to thalamocortical projection neuron axon
boutons arising from intralaminar and midline thalamic nuclei elicits glutamate
release onto distal apical tuft dendritic spines of layer V pyramidal neurons in the
prefrontal cortex. Interestingly, this was associated with large Ca 2+ transients in
only a subset of dendritic spines (Lambe and Aghajanian, 2003). Stimulation of
α4β2 nicotinic acetylcholine receptors (nAchRs) also induces glutamate release
onto layer V prefrontal cortical pyramidal neurons due to actions at axon terminals
of the same thalamocortical neurons (Lambe et al., 2003). Thus, it is possible that
altered glutamatergic neurotransmission arising from thalamic neurons and
regulated by orexinergic, serotonergic, or cholinergic inputs may induce altered
glutamatergic plasticity in layer V PrL-NAc core neurons. Ultimately, this may lead
to circuit level remodeling and sensitivity of these neurons to glutamate inputs that
may drive relapse after abstinence.
It is well known that layer I-III of mPFC contains massive innervation by TH+
(presumably dopaminergic) fibers, at least in the primate PFC (Goldman-Rakic et
al., 1989). Moreover, dendritic spines of distal apical tufts of layer V pyramidal
neurons show an abundance of hyperpolarization-activated cyclic nucleotidegated channel (HCN) immunoreactivity, which colocalize with D1 receptors
preferentially on long thin spines (Paspalas et al., 2013). Thus, although it has not
been definitively shown, the latter finding suggests that, in addition to serotonergic
and orexinergic inputs, layer V prefrontal cortical distal apical tufts also receive
dopaminergic inputs, presumably arising from the VTA. In contrast, glutamatergic
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inputs arising from the BLA preferentially innervate basal dendrites of layer V PrL
cortical pyramidal neurons (Liu et al., 2015). Furthermore, during development,
proximal apical dendrites of layer V prefrontal cortical neurons undergo a
transformational shift in NMDA receptor-dependent excitatory neurotransmission
characterized by an emergence of GluN2B-containing NMDA receptors, which
requires PKA and D1 activity. Such an emergence provides sustained plasticity in
response to ventral hippocampal, but not BLA, inputs (Flores-Barrera et al., 2014).
These findings provide insight into the potential anatomical inputs onto layer V PrL
cortical distal apical tufts which may undergo plasticity following chronic cocaine
SA, ultimately driving post synaptic alterations in form (structural plasticity) and
function (glutamatergic signaling).
In the context of psychopathology, chronic mild stress paradigms have been
shown to reduce the percentage of mushroom-type spines of distal apical
dendrites, but not basal dendrites, in both the CA3 region of the hippocampus as
well as the mPFC (Bessa et al., 2009). Moreover, distal apical tufts of layer V
pyramidal neurons undergo hypotrophic structural plasticity (i.e. loss of dendritic
spines) following chronic stress, which is associated with a loss of orexin and
sertonin-induced EPSCs (Liu and Aghajanian, 2008). Chronic stress also
decreases the surface expression of GluA1 and GluA2 subunits of AMPA
receptors in the mPFC, effects which occur through activation of glucocorticoid
receptors (Yuen et al., 2012). Finally, layer II/III PrL cortical neurons show reduced
spine density, but increased spine volume, following two weeks of abstinence;
alterations which are associated with heightened corticosterone as well as working
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memory deficits following cocaine SA (Radley et al., 2015). This latter finding has
also been shown following chronic stress (Radley et al., 2006), suggesting that
cocaine SA and chronic stress induce similar neuroadaptations, perhaps ultimately
leading to a shared inability of top-down control of behavior. Thus, it is possible
that acute cocaine withdrawal following chronic SA may engage the rodent stress
response which sensitizes during more prolonoged abstinence, ultimately leading
to prefrontal cortical impairments and dysregulation of downstream structures such
as the NAc core.
Time-dependent regulation of structural plasticity: Role of experiencedependent circuit remodeling
The majority of mature dendritic spines in various brain regions are relatively stable
during adulthoood (Trachtenberg et al., 2002). However, several experiments have
shown that structural remodeling of neurons occurs following learning. In the
hippocampus, contextual fear conditioning alters morphological plasticity 24 hours
after learning, specifically in neurons activated during fear conditioning relative to
neurons that were inactive during fear conditioning (Sanders et al., 2012).
Moreover, contextual fear conditioning leads to a hippocampal-dependent
progressive reorganization of anterior cingulate neuron apical dendritic spine
density characterized by elevated density 36 days, but not 24 hours, after
conditioning. Lesions of the hippocampus immediately after conditioning prevent
this elevated spine density weeks after conditioning (Restivo et al., 2009). In the
barrel cortex, dendritic spine formation and pruning occurs following paradigms
that induce functional reorganization, such as contralateral whisker trimming.
Specifically, whisker trimming destablizaes nascent spines, while stabilizing spines
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that were persistent during repeated two-photon imaging (Holtmaat et al., 2006).
It is therefore plausbile that the initial spine head shrinkage observed in PrL-NAc
core neurons during early withdrawal, and the subsequent enlargement of spines
coupled with the elimination of spines after one week of abstinence, may lead to
stabilization of synapses that have a greater influence on PrL-NAc core
transmission, leading to heightened encoding of cocaine-paired stimuli.
What might be the molecular substrates of activity-dependent structural
remodeling? Several lines of evidence point to altered gene transcription in
structural remodeling following associative learning. For example, prolonged
whisker trimming elevates the proportion of thin spines in the contralateral barrel
cortex in wild type, but not CREB-knockout mice. Moreover, in the ipsilateral barrel
cortex, there is a CREB-dependent enlargement of dendritic spines (Pignataro et
al., 2015). Furthermore, in the CA1 field of the hippocampus, CREB inhibition
impairs contextual fear conditioning and leads to actin depolymerization resulting
in the collapse of dendritic spines (Middei et al., 2012). BDNF has been recognized
as a major upstream regulator of CREB-mediated gene transcription and spine
morphogenesis. In the mPFC, BDNF mice containing the knockin Val66Met
polymorphism, that hinders intracellular BDNF transport and secretion (Chen et
al., 2004) show distal apical dendrite atrophy of layer V neurons, characterized by
decreased density and spine head width. They also display decrements in evoked
EPSCs, which is consistent with the above-mentioned effects of stress on apical
dendrites of layer V mPFC neurons (Liu et al., 2012). Thus, it is likely that BDNF
and CREB act in concert to regulate time-dependent changes in structural
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plasticity. Moreover, these two signaling molecules likely exist as core tenants of
activity-dependent structural remodeling, ultimately resulting in a stabilization of
newly formed synapses, and perhaps the coordinated and parallel pruning of other
synapses.
Potential cellular mechanisms mediating PrL-NAc core apical dendrite
structural plasticity: Role of STEP and BDNF
It is possible that the cocaine-induced activation of STEP in the PrL cortex during
early withdrawal serves as a potential mediator of dendritic spine changes in PrLNAc core neurons. Previous work indicates that activation of STEP leads to the
dephosphorylation and inactivation of a key inhibitor of cofilin-mediated actin
depolymerization, SPIN 90, in cultured neurons (Cho et al., 2013), although this is
yet to be demonstrated in vivo. This agrees with findings that STEP suppresses
LTP induction (Pelkey et al., 2002), which is generally associated with enlargement
of dendritic spine heads (Huganir and Nicoll, 2013). Importantly, chronic inhibition
of STEP ameliorates dendritic spine adaptations in a Fmr1 knockout mouse model
of Fragile X syndrome (Chatterjee et al., 2018). Moreover, chronic inhibition of the
upstream activator of STEP, PP2B (calcineurin), has been shown to increase
dendritic branching and spine density in naïve mouse neocortex (Spires-Jones et
al., 2011), although this effect could be due to alterations in other systems
downstream of PP2B, and not necessarily at the level of STEP. Regarding
regulation of AMPA receptors, STEP dephosphorylates tyrosine residues in the
intracellular C-terminal domain of GluA2, promoting endocytosis (Zhang et al.,
2008). Finally, STEP knock-out mice crossed with Tg2576 Alzheimer’s disease
transgenic mice show an attenuation of Amyloidβ-mediated GluA1/2 endocytosis
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in cortical tissue normally present in Tg2576 mice alone (Zhang et al., 2011).
These findings suggest the possible involvement of STEP activation in cocaineinduced structural plasticity and AMPA receptor alterations in PrL-NAc core
neurons. Given the role of STEP-mediated dephosphorylation of p-ERK2 in the
PrL cortex during early withdrawal, leading to subsequent relapse, it would be
interesting to examine whether transient inhibition of STEP specifically in PrL-NAc
core neurons immediately after SA is sufficient to suppress relapse after
abstinence.
Acute stimulation of neuronal cultures in vitro with BDNF leads to a
sustained incorporation of synaptic AMPA receptors through increased association
of GluA2 with Glutamate Receptor-Interacting Protein 1 (GRIP1) and GluA1 with
synapse-associated protein 97 (SAP97) (Jourdi and Kabbaj, 2013). Moreover,
BDNF promotes actin polymerization and dendritic spine growth (Horch et al.,
1999; Tanaka et al., 2008; Bennett and Lagopoulos, 2014). Because the
suppressive effect of intra-PrL BDNF on cocaine seeking is ERK dependent
(Whitfield et al., 2011) and AMPA receptor exocytosis and lateral diffusion into
stimulated synapses during LTP induction is ERK-dependent (Patterson et al.,
2010), it is plausible that one mechanism of action by which an intra-PrL BDNF
microinfusion suppresses relapse is through increased incorporation of AMPA
receptors in dendritic spines of PrL-NAc core neurons during early withdrawal as
has been demonstrated in the NAc (Li and Wolf, 2011). Future studies should
investigate whether this intervention normalizes the cocaine-induced depression
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of dendritic spine head size as well as GluA-IR in large spines of PrL-NAc core
neurons.
Are all PrL-NAc core neurons created equal?
The PrL-NAc core pathway represents a critical node in regulating cocaineseeking, as discussed in detail above. Using a rabies monosynaptic tracing
technique, it was found that the NAc receives input from ~50 different brain
regions. Cortical inputs (including cingulate, orbitofrontal, PrL, IL, insular,
perirhinal, entorhinal, and motor cortices) were found to constitute ~25% of brainwide inputs to the NAc core. PrL cortical neurons innervating the NAc core project
evenly to D1 and D2 MSN’s, whereas medial orbitofrontal cortical neurons
innervate a significantly greater proportion of D1 relative to D2 MSNs (Barrientos
et al., 2018). Both D1 and D2-expressing MSNs innervate the ventral pallidum
(Kupchik et al., 2015), and D1 versus D2 activation differentially regulates cocaineseeking (Lobo et al., 2010) via actions in the ventral pallidum (Heinsbroek et al.,
2017).
Thus, it is plausible that hM3Dq-mediated PrL-NAc core activation
immediately after SA is activating both PrL-NAc core neurons innervating D1expressing MSNs as well as D2-expressing MSNs. Because these accumbens
neurons have different effects on cocaine-seeking when stimulated or inhibited, it
is possible that the overall lack of effect of hM3Dq activation on cocaine-seeking
may be due to differential effects on these divergent NAc MSN subtypes. This
differential activation is further supported by the finding that the majority of hM3Dqexpressing PrL-NAc core neurons were Fos activated, indicating that PrL-NAc core
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neurons innervating both D1 and D2 expressing MSNs were likely to be activated
by CNO during early withdrawal. Furthermore, the experiments performed by
Barrientos and colleagues demonstrated that PrL-NAc core neurons innervating
D1 MSNs preferentially showed reduced apical dendrite spine density following
14, but not 5, days of withdrawal from daily non-contingent cocaine injections.
Thus, our findings that PrL-NAc core neurons show decreased spine density
following one week of abstinence from cocaine SA agree and suggest that our
effects may be specific to PrL neurons innervating D1-expressing MSNs, a subject
for future investigation. Moreover, because Barrientos and colleagues found
structural alterations after 14, but not 5 days, implies that these changes occur as
a result of abstinence duration and not necessarily because of the pharmacological
effect of daily cocaine injections.
Conclusions
Pyramidal neurons within the mPFC are well-positioned to integrate multiple
sensory and neuromodulatory inputs that guide motivated behavior to ensure
survival of a given species. In naïve animals, it could be postulated that the mPFC
acts as a gate that allows for stimuli to induce adaptive, or inhibit maladaptive,
behaviors that facilitate behavioral activation in response to cues that predict
rewards, likely through innervation of the NAc core. The ability to adapt to an everchanging environment likely involves transient alterations in structural plasticity,
glutamatergic signaling, and ultimately gene transcription in PrL neurons
innervating limbic regions that interact with motor programs, such as the NAc core
(Fig. 5.2).
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Figure 5.2. Schematic illustrating “normal” PrL-NAc core neuronal activity. Layer
V PrL cortical neurons’ distal apical tufts receive input from various excitatory and
neuromodulatory regions, facilitating activity-dependent synaptic and structural
remodeling in response to these inputs. These changes may be both upstream
and downstream of transcriptional activity in the nucleus. Specifically, PrL neurons
projecting to the NAc core may undergo activity-dependent alterations in response
to stimuli associated with rewards, ultimately facilitating motor activation via
interactions with D1 and D2-expressing MSNs in the NAc core.
However, following chronic cocaine SA, the PrL-NAc core pathway
undergoes maladaptive plasticity within the first few hours of withdrawal. This is
characterized by decreased CREB phosphorylation, decreased nuclear Fos
expression, as well as decreased GluA1/2 expression in mature dendritic spines
of PrL-NAc core neurons. These neurons may also make up a proportion of those
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that show elevated STEP activity, leading to decreased phosphorylation of ERK2
and GluN2A/B-containing NMDA receptors. It is likely that these effects rely on
altered glutamatergic inputs to PrL-NAc core neurons that may also undergo
maladaptive plasticity (Fig. 5.3).

Figure 5.3. Schematic illustrating dysfuntional PrL-NAc core transmission during
early withdrawal. Chronic cocaine exposure may alter the excitatory and
modulatory inputs to PrL-NAc core distal apical tufts. These inputs result in
hypotrophic structural alterations, which may be due to an imbalance in kinasephosphatase activity (i.e. increased STEP). Ultimately, this may facilitate
dysfunctional PrL-NAc core glutamate transmission during early withdrawal from
cocaine SA.
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Moreover, the altered plasticity in PrL-NAc core neurons is time-dependent,
such that after one week of abstinence (i.e. immediately prior to a context-induced
relapse test), PrL-NAc core neurons may exist in a state of hyper-responsiveness
to glutamate inputs, characterized by elevated GluA1/2 expression in dendritic
spines, as well as increased nuclear p-CREB (Fig. 5.4). Ultimately, this chain of
maladaptive plasticity likely facilitates preferential encoding of drug-associated
stimuli, facilitating the seeking for cocaine, perhaps at the expense of natural
rewards, a key characteristic of addictive disorders.

Figure 5.4. Schematic illustrating dysfuntional PrL-NAc core transmission after
one week of abstinence. Chronic cocaine SA may alter encoding of cocainerelated stimuli by layer V PrL cortical neurons via hypertrophic enlargements in
spine heads and AMPA receptor accumulation in spine heads, as well as elevated
p-CREB-dependent transcription of plasticity-related genes. This likely facilitates
increased PrL-NAc core glutamate transmission, perhaps preferentially in PrL
neurons innervating D1-expressing MSNs in the NAc core.
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Future directions
Most of the experiments described herein have taken advantage of traditional
behavioral pharmacology and biochemical techniques, as well as the recent
advent of pathway-specific viral vector techniques and high-resolution confocal
microscopy. However, the findings from these experiments would be greatly
enhanced by electrophysiological and Ca2+ imaging experiments that would further
reveal mechanisms involved in producing the transient and enduring PrL
adaptations following chronic cocaine exposure, as well as providing a
physiological readout of activity. Moreover, the precise mechanisms mediating
these adaptive effects are unknown. As described above, it is possible that STEP
activation during early withdrawal is involved in these adaptations. Furthermore, it
is probable that one mechanism of action of the suppressive effect of BDNF on
cocaine seeking involves normalizing structural and glutamate signaling
adaptations in PrL-NAc core neurons. Furthermore, future studies should examine
whether the spine changes are positively correlated with p-CREB-IR using twophoton imaging in behaving animals.
An often-underappreciated aspect of glutamate transmission is the
involvement of astroglial cells. Astrocytes play a critical role in glutamate uptake at
synapses through the actions of the high-affinity glutamate transporter GLT1
(Anderson and Swanson, 2000; Shen et al., 2014b), and cocaine-induced
alterations in the proximity of astrocytes to synapses in the NAc core has been
suggested to play a role in altered glutamate transmission implicated in relapse to
various drugs of abuse (Scofield et al., 2016a; Scofield et al., 2016b). Indeed,
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drugs that have shown promise in the treatment of addiction-related disorders,
such as N-acetyl-cysteine, exert most of their effects on astrocytes, particularly by
normalizing drug-induced downregulation in GLT1 (Reissner et al., 2015).
Emerging evidence indicates that perisynaptic astrocytic processes (PAPs)
interdigitate with individual dendritic spines where they regulate the fidelity of
neuronal communication and ensheathe synapses in response to bouts of high
activity (Bernardinelli et al., 2014). An advantage of our pathway-specific labeling
of dendritic spines is that viruses used to label neurons can be co-injected with
viruses that label the fine membrane of astrocytes. Indeed, using this multi-viral
labeling technique, we can observe the degree to which astrocytes associate with
neurons at the level of individual dendritic spines (Fig. 5.5).
Figure 5.5. Representative PAP association with
PrL-NAc core dendrite. A. PrL-NAc core mCherrylabeled neuron (red) surrounded by field of GFAPLck-GFP which preferentially labels asrocytic plasma
membranes (green). B. High magnification inset of
boxed region in A. Note the dense array of dendritic
spine heads surrounded by astrocyte PAPs.
Instances where astrocyte PAPs are within 150 nm of
the dendritic shaft and spines are shown in white.
Scale bars = 50 μm (A), 3 μm (B).
Thus, future experiments should determine whether a) STEP inhibition alters
astrocyte-neuron interactions at spines of PrL-NAc core neurons during early
withdrawal, b) hM3Dq-mediated activation of PrL-NAc core neurons is associated
with altered astrocyte contact, and c) whether PrL-NAc core neuron structural
plasticity and dendritic AMPA receptor expression is associated with altered
astrocyte contact, particularly at enlarged mushroom-type spines. Ultimately,
these experiments would synergize with those presented within this dissertation
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by providing a greater understanding of how drug-induced adaptations in synaptic
plasticity in the PrL-NAc core circuit drive subsequent relapse after abstinence.
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